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Abstract 
Currently, the area of polymeric drug delivery is one of intense international and 
interdisciplinary research. Many of the applications of materials derived from this 
research are focussed on therapeutic applications ultimately to be used in whole body 
systems. Herein, the research described focuses on a novel application of 
multicomponent glycopolymers. 
The majority of pig breading is conducted via artificial insemination. Whilst this offers 
many advantages, one of the major drawbacks is the adverse effect of oxidation on the 
spermatozoa during storage (which can be several days) prior to use. The 
supplementation of vitamin E is highly desirable, however due to its lypophilic 
character it cannot be added directly to the largely aqueous boar ejaculate mixture. 
Polymethacrylate derivatives were synthesised carrying carbohydrate residues, vitamin 
E residues and solubility enhancing amino residues. These vitamin E bearing 
glycopolymers were found to be soluble in aqueous media. 
The interactions of these materials with boar spermatozoa were thoroughly investigated. 
It was demonstrated that supplementation with these glycopolymers significantly 
reduced cellular oxidation under induced oxidative conditions. 
Analogous polymers were also synthesised containing a fluorescent dye. Confocal 
microscopy images were obtained of boar spermatozoa incubated with dye-labelled 
polymers with and without carbohydrate moieties in order to demonstrate that the 
intemalisation ofthe polymers was enhanced by carbohydrate-lectin interactions. 
Craig Fleming, Durham, January 2006 
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Introduction 
1 Introduction 
1.1 Cells 
1.1.1 Cell Membranes 
In order to begin to understand ligand-cell surface interaction(s), one must first 
appreciate the basic structure of the cell membrane itself. 1' 2 The cell membrane is the 
interface between the cell surface and the external environment, and as such provides 
the perfect location and physical platform for interactions, (phospholipids, which make 
up the membrane bilayer, contribute to the operation of cell surface receptors.) One 
popular concept of membrane structure is the "Fluid Mosaic" model, postulated by 
Singer & Nicolson.3 
The fluid mosaic model has two key features: 
i) Membrane proteins and glycoproteins are asymmetrically embedded in the 
lipid bilayer. 
ii) The lipid forms the "matrix" of the membrane and provides a viscous 
medium which permits lateral mobility or diffusion of the protein molecules, 
which are therefore free to interact over relatively large distances. 
In addition to these "standard" membrane regions, specialised regions can be formed 
which have a particular function or importance, for example, the acrosomal and tail 
regions of spermatozoa. 
A schematic of the fluid mosaic model is shown Figure 1.1 in below. 
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Figure 1.1 - Tbe Fluid Mosaic Model4 
This model can be applied to many different cell types but in the context of this thesis, 
the interactions of the sperm cell membrane are of particular importance. 
1.1.2 Mammalian Spermatozoa5 
The male gamete - the spermatozoon (or sperm cell) is an unusual and unique cell. It is 
produced in the testis through a complex process known as spermatogenesis, where it 
undergoes many important changes before it is fully "matured". Once matured it cannot 
go through any further differentiation or division. Its principal purpose at this stage is 
to provide the male pronucleus for a fertilised egg, which of course requires both male 
and female haploid pronuclei. 
Although visually different in some cases (see Figure 1.2 below), sperm cells - across a 
range of species - share the same key components: 
o The acrosome-covered head that contains the DNA, is crucial in the penetration 
of the female egg, and subsequent fertilisation to produce a zygote. 
o The neck containing the centriole is essential for cell division of the zygote. 
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o The tail , essential for propulsion of the sperm cell, powered by the mitochondria 
of the mid-piece. 
As with all other mammalian cell types, it is covered by a plasma membrane, which 
undergoes changes depending on its environment (i.e. during maturation, post-
ejaculation, pre-fertilisation etc.). 
TAI L 
BULL BOAR RAM HORSE MAN RAT COCK 
~ } ACROSOMAL CAP .. c 
~ r POSTACROSOMAL 
····oo NECK REGION 
} MIDDLE PI EC E 
· -ANNULUS 
!"'"'"" '"" r / I } '"' ~__,CE===----
~ 
I 
Figure 1.2- Examples of Mammalian Spermatozoa6 
1.1.3 Sperm Morphology 
The appearance of sperm cells was first reported more than 300 years ago, and despite 
improvements in microscopy over this time, little more was understood about the 
complex internal structure until the advent of transmission electron microscopy in the 
1950s. In general terms the sperm cell can be divided into two main components - the 
flagellum and the head. These can be further subdivided into a number of key parts, all 
of which will be discussed below. 
1.1.3.1 Head 
The primary functions of the sperm head are to enclose and protect the DNA until it is 
delivered during fertilisation. This requires the DNA to be preserved in a stable form 
- 3 -
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until the formation of the male pronucleus. Furthermore the head must facilitate the 
penetration of the egg and possess a means of species-specific sperm-egg recognition. 
It is essential that the head be able to undergo membrane fusion, otherwise fertilisation 
would not be possible. Despite the relatively large number of functions required of the 
head, it has a limited number of structures available with which to perform these tasks. 
Essentially the structure of all mammalian spem1 heads are the same in terms of 
structural content, however the size and shape differs greatly from species to species 
(Figure 1.2). 
1.1.3.2 /fcrosor.ne 
The acrosome is a cap-like covering over the frontal part of the nucleus. Between the 
outer acrosomal membrane (which is immediately beneath the plasma membrane) and 
the inner acrosomal membrane is a narrow cavity filled by the acrosomal matrix, which 
consists of a number of enzymes (e.g. hyaluronidase, acrosin, acid phosphatase, 
phospholipases, N-acetylglucosaminidase, etc.) as well as being rich in carbohydrates. 
Towards the back of the sperm head is the equatorial segment. This region is very 
stable and is devoid of the enzymes present in the anterior section. This section remains 
intact after the acrosome reaction*. The plasma membrane that is on top of the 
equatorial section is the site of sperm-egg recognition and membrane fusion. 
1.1.3.3 Perinuclear r.naterial 
Immediately below the acrosome is a thin layer of perinuclear material which separates 
the acrosome and the nucleus. This structure is stabilised by disulphide bridges and 
appears to glue the two together. Towards the rear of the head this material forms the 
post-acrosomal sheath. This has a seemingly complex structure yet its functional 
significance is not clear. 
* The acrosome reaction takes place when the sperm cell comes into proximity with the egg. This is a 
precursor to fertilisation. 
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1.1.3.4 Nucleus 
The nucleus consists of densely packed chromatin, which is made up of DNA 
complexed to highly basic proteins, known as protamines. These protamines are rich in 
cysteine and arginine and it is the high level of cysteine that leads to the formation of 
disulphide bridges between free thiols. This crosslinking imparts great stability to the 
nucleus. The DNA, which exists in the beta form, is completely inactive until it is 
inside the egg. 
1.1.3.5 Flagellum (tail) 
It is this region that is responsible for both energy production and propulsion. In order 
for fertilisation to occur, cellular motility is essentialt. However motility is not only 
important in terms of penetrating the egg. Prior to this final stage, the cells must travel 
to the egg, often (depending on the species) negotiating cervical mucus along the way. 
The structure of the tail is complex and will be discussed in detail below. However 
common to each piece of the tail is the axoneme, which runs throughout the length of 
the tail. This will be considered in more detail before considering each section of the 
tail. 
1.1.3.6 Axoneme 
The axial filament (or axoneme) extends the entire length of the flagellum. The 
structure of the axoneme is not dissimilar to the cilia or flagella of all eukaryotic cells, 
(the existing knowledge of how the flagella of lower organisms move was applied 
directly to sperm cells). It consists of 9 evenly spaced microtubular doublets that 
surround 2 central microtubules. Each of the 9 doublets consists of 2 sub-units (A & 
B). "A" type subunits are complete microtubules 26 nm in diameter. The "B" type 
t Principally referring to natural fertilisation as a result of sexual intercourse, or artificial insemination, 
however clearly techniques such as Intracytoplasmic Sperm Injection (ICSI) do not require motile sperm 
cells in order to achieve fertilisation. 
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subunits are "C-shaped" and are attached by their free edges to their corresponding A 
tubules (see Figure 1.3 & Figure 1.4 below). 
These microtubules are composed mainly of a protein called tubulin. There is a high 
degree of heterogeneity both within and between microtubules, which is due to tubulin 
existing in both alpha and beta forms, in addition to differences in electrophoretic 
mobility, amino acid composition and phosphorylation sites between the two forms. 
The tubulin molecules are arranged in rows to form protofilaments. These are aligned 
side-by-side to form the microtubule walls. As for both of the central microtubules, the 
A tubules are composed of 13 proto filaments. However, B tubules are made up of 10 
protofilaments. 
Each A tubule has projections or "arms" pointing towards the adjacent B tubule. These 
are 24 nm apart and are designated as inner or outer depending on their position. These 
play an essential role in flagellar movement. They are principally composed of a Ca2+ 
and Mg2+ dependent A TPase isomer of the protein dynein. These dynein arms enable 
adjacent doublets to slide relative to one another (c.f sliding filaments in muscle 
contraction). This is what generates the flagellar movement. 
The nine outer doublets are connected to their neighbouring doublets by links composed 
of the protein nexin. Theses are situated along the length of the tubule doublets (96 nm 
apart) and it is thought that they act as an elastic element. These help to regulate sheer 
forces and retain the symmetry ofthe axoneme structure. 
The central microtubules which are interconnected by a senes of evenly spaced 
linkages, are also surrounded by a pair of spiral fibres attached to the microtubules at 
the levels of the connecting links. 
The function ofthe central pair and the sheath is unclear. 
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Figure 1.3- Electron Micrographs: of Mammalian (mouse) Sperm Cell7 
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Figure 1.4 - Electron Micrograph§ of Mammalian (bull) Sperm Cell Flagellum8 
! (a) Longitudinal section of the junction of the mid piece and principal piece of a mouse spermatozoon 
(boxed area shown in inset). The axoneme, consisting of microtubules, dyne in ATPase and associated 
proteins, is in the core of the flagellum. It is surrounded by outer dense fibres and mitochondria (M) in the 
midpiece, and by fibrous sheath (FS) in the principal piece. (b,c) Cross-sections of the midpiece and 
principal piece, respectively. (d) Cross-section of the axoneme alone, showing the typical '9+2' pattern, 
with a central pair of microtubules surrounded by nine sets of doublets. Scale bar = 200 nm. 
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1.1.3. 7 Connecting Piece 
As the name suggests, this part is the link between the head and the tail, and is 
approximately 0.5 f..lm in length. The structure consists mainly of the capitulum (a 
dense dome-shaped fibrous structure) and the segmented columns. Although the 
arrangement of the segmented columns is quite complex, thus far it has not been shown 
to provide anything more than a simple structural connection. 
1.1.3.8 Outer Dense Fibres 
The outer dense fibres surround the axoneme of eutherian spermatozoa. This complex 
structure is not seen in the flagella of simple invertebrate species. Each one of the 9 
microtubule doublets is associated with an outer dense fibre. These fibres start from the 
back of the connecting piece and end at variable points along the principal piece. The 
size and thickness of these fibres varies from species to species. The fibres consist of a 
dense core surrounded partially by a cortex which is not present on the side closest to its 
respective microtubule doublet. The core consists of a keratin-like protein, which being 
rich in cysteine, is stabilised by disulphide bridges; the outer cortex is not as stable. 
The outer dense fibres tend to be of varying lengths. They seem to have the effect of 
stiffening a portion of the tail, since in invertebrate species, which do not have these 
outer dense fibres, the tail can achieve maximum curvature close to the head, while 
generally in mammalian sperm this is not possible. However, beyond this observation, 
there is no consensus as to any other potential function(s) they may have. 
§(A) Electron micrograph of a cross section of the midpiece of a bull sperm flagellum, showing the 
axonemal inner fibres, the coarse fibres, and the mitochondrial sheath surrounding the coarse fibres 
(courtesy ofthe Biophysical Journal). (8) Longitudinal section of a bull sperm flagellum in the area ofthe 
midpiece junction. Scale bar= 0.1 ,urn. 
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1.1.3.9 Midpiece 
The mid piece refers to the section of the tail which stretches from the connecting piece 
to the annulus (the junction of the midpiece and principal piece). A characteristic of the 
midpiece is a helical sheath of mitochondria around the axoneme. The number of 
mitochondria varies depending on the species. 
In terms of their internal structure, the mitochondria are similar to those seen in other 
cell types; however the outer membrane stability of sperm mitochondria is much greater 
(than other cell types). This stability is exemplified through their resistance to e.g. 
osmotic changes, and may be attributed to the presence of disulphide bonds, although its 
functional significance is unclear. 
The location of the mitochondrial sheath is perfect for supplying A TP to the axoneme, 
thus providing motility. Eutherian sperm have many more mitochondria than some 
invertebrate sperm, and whilst the reason for this is not fully understood, the extra 
potential energy may be required due to the complexities of internal fertilisation. 
1.1.3.10 Principal Piece 
This section is the longest part of the flagellum. It extends from the midpiece to the 
terminal piece. The main feature of the principal piece is the so-called fibrous sheath, 
which consists of two columns in the plane of the central microtubule pair, connected 
together around the circumference by a series of closely packed filaments. 
It has been suggested that the function of the fibrous sheath is similar to that of the outer 
dense fibres. It is extremely stable and, like other areas of the sperm cell, it contains 
many disulphide bridges. In some species, disruption of this sheath has resulted in 
severely impaired motility, suggesting that it is very important. 
- 9 -
Introduction 
1.1.3.11 Terminal Piece 
As the name suggests, this is the end of the flagellum. This is where the microtubules 
terminate, going down in number gradually until the tip of the flagellum is reached. 
1.1.4 Sperm Cell Plasma Membrane 
As with other cell types, the sperm plasma membrane is the boundary responsible for 
protecting the cell, ensuring that it remains intact, as well as forming a dynamic 
interface between the cell and its surroundings. In contrast to other cell types, its 
structure and function are heterogeneous. The evidence for this is physical, chemical 
and immunological. These differing domains also undergo reorganisation at various 
stages ofthe cell's "life time", notably during capacitation**. 
There are five major membrane regions; two distinct regions on the tail, and three on the 
head. Each one is specifically involved with different aspects of the cell function. 
These regions differ in their binding affinity to lectinstt as well as having different lipid 
compositions. There are also areas of differing surface charge. 
The benefit of these unique regions is that the underlying compartments can interact 
independently with their external environment. Exactly how these different membrane 
domains are established and maintained is not fully understood. However, the fact that 
cell apoptosis (death) is accompanied by loss of domain structure is indicative that the 
maintenance ofthese domains is an active process. 
1.1.4.1 Midpiece Region 
The plasma membrane in this regiOn must permit the passage of substrates to the 
mitochondrial sheath. It is probably that changes in this membrane help to mediate the 
changes in cell metabolism during capacitation. 
•• Capacitation is a change in mammalian sperm that occurs after exposure to the female genital tract 
which allows the sperm cell to undergo the acrosome reaction. 
tt A lectin is a protein which can bind to a sugar(s) with good affinity and specificity. 
- 10-
Introduction 
1.1.4.2 Principal Piece Region 
This is the area responsible for generating the cell's movement. Its efficiency hinges on 
the plasma membrane being attached to the axonemal complex, rather than them 
moving independently. 
The annulus divides the membranes of the midpiece and principal piece, and seems to 
behave as a physical barrier which restricts the movement of particles between the two 
domains. 
1.1.4.3 Frontal Acrosomal Region 
The plasma membrane in this region is pivotal in two critical processes: recognition and 
binding to the zona pellucida (of the egg); and fusion with the outer acrosomal 
membrane during the exocytotic acrosome reaction. 
The binding to the zona pellucida Is mediated by glycoconjugates present m the 
membrane. 
1.1.4.4 Equatorial Region 
As previously mentioned, this region is where fusion with the egg occurs. This is only 
possible after the acrosome reaction has occurred. This section of the membrane is very 
stable and appears to act as a barrier, preventing diffusion of particles between the 
anterior/post -acrosomal domains. 
1.1.5 Boar Semen 
As with other mammals, the cellular suspension containing the sperm cells is known as 
semen. Semen is made from secretions from the accessory organs of the male 
reproductive tract, and this liquid component of the semen is known as seminal plasma. 
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The chemical components and characteristics of the semen vary (often greatly) from 
species to species. A typical set of characteristics and components for boar semen is 
shown in Table 1.1 & Table 1.2. 
Table 1.1- Characteristics of boar semen6 
Ejaculate Volume (ml) 150-250 
Sperm concentration ( 106 /ml) 200-300 
Motility (%) 50-80 
Normal morphology(%) 70-90 
pH 7.3-7.8 
Table 1.2- Chemical components of boar semen6 
Component Concentration 
(mg/ml) 
Na+ 5.87 
K+ 1.97 
Ca1+ 0.06 
MgL+ 0.05-0.14 
cr 2.6-4.3 
Fructose 0.09 
Sorbitol 0.06-0.18 
Citric Acid 1.73 
Inositol 3.8-6.3 
Glyceryl phosphoryl choline 1.1-2.4 
Ergothioneine 0.17 
Spermatozoa are primarily made up of nucleic acids, proteins and lipids, with 
approximately a third of the dry weight of the cell made up by the nucleus. 
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1.1.6 Evaluation of Semen 
The fertility of breeding males is generally assessed by examination of the semen. This 
is more practical than directly assessing their ability to produce a pregnancy. 
In the case of boars, this analysis involves examining one or more ejaculates using a 
number of standard protocols. The general minimum requirements for a fertile boar are 
as follows: 
Motility 2: 65%t::: 
Morphological abnormalities :S 20% 
Ejaculate volume between 60-75 ml (sperm rich fraction) 
Concentration of cells in ejaculate of 2: 100 x 106 cells/ml 
The boar ejaculate consists of several fractions. The initial fraction, known as the pre-
sperm fraction, is a translucent fluid which can be easily identified by the person 
collecting the sample. The second fraction is the sperm-rich fraction which is a more 
viscous, whitish, opaque fluid. For the purposes of semen evaluation and ultimately 
successful artificial insemination (AI), only this fraction is collected (although normally 
the total volume ofthe ejaculate is recorded). 
After the sperm-rich fraction there is a final fraction - the post-sperm fraction - which 
is similar in appearance to the pre-sperm fraction. 
The total volume of the ejaculate (normally around 240-250 ml) is affected by a large 
number of factors (age, health, environment, collection procedure, season, frequency of 
collection, breed, etc.). 
The concentration of sperm in the sperm-rich fraction is approximately 6 x 108 
sperm/ml, although this will be diluted substantially prior to AI. 
tt Motility refers to any movement by the cell and can be scored either subjectively or by computer 
assisted methods (CASA). 
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1.1. 7 Morphology 
The number of sperm cells that have an undamaged acrosome is an important indication 
of semen quality. There are a number of techniques utilised when assessing sperm 
morphology. Typically, phase contrast microscopy of "fixed" sperm cells is employed 
to asses the integrity of the membranes; a number of staining techniques are also used to 
assess cellular morphology and viability. 
1.1.8 Semen Quality 
Despite the range of assessment techniques that are available, it remains that the most 
conclusive method of assessing the fertility of a given boar is to achieve pregnancy and 
the birth of live young. Even when the results of a lab assessment are positive and 
suggest good fertility, actual "in field" data can be conflicting. 
In light of this, several attempts have been made to establish a single in vitro parameter 
that could predict the fertility of a given boar. These are as follows: 
• Zona-free hamster ova penetration assa/ 
• Percoll gradients, isolating high velocity sperm 10 
• Assay for detecting integrity of sperm DNA 11 
• Specific sperm membrane proteins correlated to sperm penetrated zona-free 
hamster eggs 12 
• Hemizona binding assay: more spem1 bound leads to increased fertility 13 
• Male pronucleus formation rate 14 
1.1.9 Semen Collection in Boars 
Boars are trained to mount a dummy sow so that semen can be collected. A typical set-
up is shown in Figure 1.5. Once the boar has mounted the "sow" it will begin thrusting. 
At this stage it is necessary for the technician to grasp firmly the end of the boar's penis 
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in order to provide the necessary stimulus for ejaculation. As alluded to earlier, the 
frequency of collection will influence the concentration of sperm in the ejaculate, so 
care should be taken not to collect semen from animals too often. 
Figure 1.5- Boar mounting the dummy sow 
1.2 Pig Artificial Insemination (AI) 
Artificial insemination of pigs was first attempted in the late 1920s by Ivanov. 15 This 
work was investigated further during the 1930s by Milovanov et a/. 15 It was at this time 
that the first diluent components were suggested. From the original studies it was clear 
that only a portion of the cells stored actually survived either during liquid storage, or 
cryopreservation. Reducing temperatures has a tendency to interfere with membrane 
integrity, structure and the cell ' s biochemistry. 
Over the last two decades, the use of preserved semen for AI has more than tripled. 
Statistics suggest that >99% of an estimated 19 million inseminations carried out 
globally, use semen which has been extended and either used on the same day or within 
1-5 days (stored at 15-20°C). 15 
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Since 1975, frozen boar semen has been available commercially, however it accounts 
for less than 1% of all inseminations. Freezing is generally used as a method of storing 
and ultimately supplying a particular genetic line. 
AI in pigs offers many advantages over natural breeding; these include: 
o Genetically superior boars can be used. 
o Fewer boars require to be kept. 
o Time is saved in a synchronised group. 
o Cross-breeding programmes are facilitated. 
o Good record keeping is encouraged. 
o Sub-fertile boars can be identified. 
However, as with any process, there are a number of disadvantages associated with 
using AI: 
o Some training is required. 
o It must be well managed. 
o It is more labour intensive (heat detection, sanitation etc.) 
o Semen has a limited shelflife (undiluted~ 2 hours, extended between 3-7 days) 
Although the technique is widely used and well established, research in and around the 
area of AI continues with vigour. There are many areas that could be improved and 
new technologies are emerging. Improvements in the insemination catheter design, 
improvements in the insemination techniques 16• 17 (e.g. deep uterine insemination, low 
dose insemination etc.), and new diluents/diluent additives 15 that may improve the 
viability of semen over time are just some examples of the areas which are being 
researched and improved. 
1.2.1 Liquid storage 
Commercially, liquid storage is the area of most importance because the majority .of 
farmers and AI stations are using this technology already and are trusting of it, unlike 
the use of thawed frozen semen which is expensive and not well established. Unlike in 
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the case of bull semen for example, boar semen cannot be routinely cryopreseved and 
sold in such a way as to be commercially viable. Additionally, it is the liquid storage of 
boar semen that is of particular relevance in the context of this thesis. 
There are two key factors that affect sperm cell function post-ejaculation: 
i) temperature of collection and storage 
ii) conditions ofthe diluent 
1.2.1.1 Cold shock 
It is well known that boar sperm are extremely susceptible to cold shock. If fresh semen 
is cooled too quickly (i.e. from body temperature 7 <l5°C), there will be a sharp 
decrease in cellular viability. This is exacerbated further if the temperature continues to 
approach 0°C. 
It has been observed that by slowing the rate of cooling from 35°C 7 l5°C, a resistance 
to cold shock can be established. It has been suggested that the effects of cold shock 
could be attributed to the lipid composition of the membrane. A reduction in 
temperature could cause a phase transition in the membrane from liquid to gel. 
Furthermore, since different lipids have different phase transition temperatures, this 
could lead to phase separation within the membranes. 
The amount of cholesterol present in the membrane is thought to affect the 
thermotrophic behaviour of the membranes. 15 The cholesterol/phospholipids ratio is 
very low in boar sperm. This leads to an asymmetrical distribution of cholesterol from 
outer monolayer to inner monolayer. As the membrane components are re-organised as 
a result of the cold shock, the function of the membrane can be affected in a number of 
ways (increased permeability, reduced enzymatic activity etc.). 
- 17-
Introduction 
1.2.1.2 Dilution effect 
During ejaculation, sperm are diluted with fluid from the accessory glands. Under 
normal circumstances, this would maintain the cells for a few hours. In order to 
improve on this, it is necessary to reduce the metabolic activity by adding chemical 
inhibitors or by reducing the temperature. 
The problem is that whilst dilution has the effect of initially boosting activity, this is 
followed by an increase in membrane damage and a loss of motility. There are no 
definite answers as to why this is the case, however it has been speculated that the 
dilution of the protective effect of seminal plasma could be a major factor. 15 It has been 
shown that some of these effects can be countered by inclusion of bovine serum 
albumin (BSA) 15 - now a common feature of many commercial diluents. 
1.2.1.3 Diluents 
There are several important factors in the composition of boar semen diluents: pH, ionic 
strength, type of ions and osmotic pressure. In addition, it is commonplace to include 
antibiotics to prevent bacterial growth occurring during storage. 
Fresh boar semen has a pH of between 7.2-7.5. Motility decreases with decreasing pH. 
Glucose is often a major component of boar semen diluents. However, since boar 
sperm are generally stored in plastic tubes, with very little oxygen present, and since the 
glycolytic metabolism of boar sperm is poor compared to other species, this often leads 
to a decrease in motility. 15 
There are a couple of methods used to control ionic strength. Older diluents used salts 
(e.g. sodium bicarbonate, sodium citrate) to control the ionic strength, however it is 
more common now to rely on zwitterionic buffers such as TES & HEPES. 
One of the most widely used extenders is the Beltsville Thawing Solution (BTS). This 
was (as the name suggests) originally used for thawing frozen boar sperm and has since 
been adapted for use in liquid storage. Many other diluents exist under various trade 
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names, and are designed for use as either short or long term diluents. BTS is typically 
regarded as a short term diluent, while Androhep for example is a long term diluent (see 
Table 1.3). The concentration of sperm cells used for insemination purposes is usually 
between 2 x 109 and 3 x 109 cells -this helps to ensure that the number of live births is 
commercially viable. 
. 15 Table 1.3- Typical boar semen extender components 
Concentration (giL) in 
H20 
Substance Androhep BTS 
Tri-sodium citrate dehydrate 8.0 6.0 
EDTA 2.4 1.25 
BSA 2.5 -
Sodium Hydrogen Carbonate 1.2 1.25 
HE PES 9.0 -
Glucose monohydrate 26.0 37.0 
Potassium chloride - 0.75 
Gentamycin sulfate - 0.3 
Dihydrostreptomycinsulfate 0.81 -
Penicillin-G Sodium salt 0.30 -
1.2.1.4 Duration of storage 
Sperm cells age during liquid storage which leads to a drop in fertility. Even so-called 
"long-term" diluents cannot totally prevent this, although components such as BSA 
(found in Androhep for example) do reduce the effect of ageing. 15 
Despite this, numerous experiments have demonstrated that a decrease in fertility due to 
in vitro ageing is inevitable. Furthermore, it is important to match insemination time 
with ovulation as in vivo ageing of sperm is also a consideration. 
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1.3 Carbohydrates 
It is widely acknowledged that the Earth's most abundant biomolecules are 
carbohydrates. They are unrivalled in the density of information that they are able to 
convey. Plants are able to synthesise cellulose (and other materials) from large 
quantities§§ of C02 and H20 using photosynthesis. Starches and sugars fom1 part of 
people's diets around the world, while the oxidation of carbohydrates to provide energy 
is the most important method in non-photosynthetic cells. 
In plants, insoluble carbohydrate polymers often serve as structural components. Other 
such polymers help to lubricate skeletal joints and are involved in cellular recognition 
processes. Indeed carbohydrate polymers bound to lipids/proteins (known as 
glycoconjugates) act as signalling species. 
Typically carbohydrates have the empirical formula (CH20)n, although this is not 
universally true, since some contain other elements such as phosphorus, nitrogen and 
sulphur. 
Carbohydrates can be split in to 3 main genres: monosaccharides, oligosaccharides and 
polysaccharides***, with glucose being the most abundant monosaccharide. 
Oligosaccharides are short chains of monosaccharide units linked together by glycosidic 
bonds. The most abundant oligosaccharides are the disaccharides (for example sucrose 
which consists of D-glucose and 0-fructose). Within cells, oligosaccharides which have 
3 or more units tend to be joined to other molecules (e.g. proteins/lipids) as 
glycoconjugates. 
Polysaccharides are those with more than 20 sugar units, but often have many hundreds 
or thousands of units. These can be linear (in the case of cellulose for example) or 
branched (e.g. glycogen). The majority of carbohydrates found in nature are 
polysaccharides. 
§§Approximately 100 billion tonnes per year. 
••• Saccharide: from the Greek sakcharon- meaning sugar. 
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The polysaccharides can themselves be sub-divided into two categories: 
homopolysaccharides and heteropolysaccharides. Homopolysaccharides serve as 
structural elements within cells/exoskeletons (e.g. cellulose and chitin), but can also act 
as energy stores of monosaccharides. In some animal tissues, heteropolysaccharides act 
as a matrix for cells/tissues/organs providing protection. 
Polysaccharides tend not to have monodisperse, well defined molecular weights, mainly 
due to their synthesis, which is not as well controlled as the synthesis of proteins which 
are templated via messenger RNA (mRNA). Nevertheless, it is their ability to store and 
carry information that is of particular interest. They are able to guide proteins to the 
correct destination, mediate intercellular interactions, as well as interactions between 
cells and the extracellular matrix. 
As alluded to earlier, a protein or lipid covalently bound to a carbohydrate is a 
biologically active compound known as a glycoconjugate. The structure of 
glycoconjugates is such that the bulk of the structure is made up of the carbohydrate 
moiety, and is therefore often the main site of biological activity, since there are 
multiple binding sites and potential for many H-bonding and electrostatic interactions. 
Two examples of glycoconjugates are glycoproteins and glycolipids. 
The saccharide part of glycoproteins is rich in information and contains highly specific 
sites for recognition and high-affinity binding. Glycolipids are membrane components 
where the hydrophilic head groups are composed of oligosaccharides and, as with 
glycoproteins, act as specific sites for recognition by carbohydrate binding proteins. 
This area of study, known as glycobiology, is today one of the most exciting and active 
areas of cell biology/biochemistry. 
1.3.1 Glycobiology 
This area encompasses the biological aspects of carbohydrates, i.e. how they are 
involved in biological functions. Due to the development of highly sophisticated 
techniques for the analysis of carbohydrate-mediated cellular functions and interactions, 
a greater understanding of these processes has been developed. The synthesis of 
- 21 -
Introduction 
oligosaccharides and glycoconjugates have been essential for glycobiology studies, 
providing a correlation between structure and function. 18 Any such oligosaccharides or 
glycoconjugates must be structurally well-defined; therefore robust synthetic routes are 
essential. The synthesis of oligosaccharides is particularly difficult as it requires 
regiochemical and stereochemical control when forming the glycosidic linkage. The 
Koenigs-Knorr glycosylation 19 was the first viable method reported (in 1901 ), and while 
other methods have since been established,20 vigorous research continues in the search 
C' 1 . . 18 tOr a temat1ve strategies. Whilst such synthetic methods offer a viable route to 
oligosaccharide synthesis, it is of particular interest in the context of this thesis to 
exploit these routes to produce so called glycomonomers, which in tum can be 
polymerised, resulting in glycopolymers. This concept will be discussed in more detail 
within. Nevertheless, the ability to synthesis oligosaccharides, glyconjugates or 
glycopolymers for that matter, allows the interactions between receptors and 
carbohydrates, examples of which can be found in the literature. 18 
The interaction between lectins and carbohydrates is complex, so many synthetic 
carbohydrate polymers are being synthesised so that these interactions can be 
investigated.21 -25 Such materials are referred to as glycopolymers (see later). 
Glycopolymers also have applications in other areas as surfactants,26 detergents,27 food 
additives, drug delivery,28• 29 scaffolds for tissue engineering,30-32 treatment of infectious 
diseases33 and the treatment of HIV. 34 
1.3.2 The sugar code35' 36 
When the word 'code' is used in reference to biological systems, one can be forgiven 
for assuming it is in reference to the genetic code. However, the ability of sugars to 
perform the task of information storage should not be underestimated. The power of 
sugars over amino acids or nucleotides emanates from the fact that sugars are not 
restricted to a single linkage point, but instead the presence of numerous hydroxyl 
groups can facilitate a whole array of possible linkages (e.g. 1-2, 1-3, 1-4, 1-6). 
Moreover, there is further variation possible through the type of linkage at the anomeric 
position (a or~). 
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If one considers that 20 amino acids can yield a total of 6.4 x 10 7 hexapeptide isomers, 
this begins to seem insignificant when, for the same number of sugars, the total is 1.4 x 
1015 oligosaccharides. This fact only serves to reinforce the importance of sugars in 
many aspects of life. 
1.4 Lectins 
A lectin is a protein molecule which can bind to carbohydrates with high specificity and 
affinity. Lectins can easily distinguish between very similar sugars due to the 
placement of H-bonding partners in the carbohydrate recognition domain of the lectin. 
Lectins are crucial in a wide range of cell-cell recognition processes. Lectins are 
present in all organisms; although they were first discovered more than I 00 years ago in 
plants37, they have subsequently been identified in all other life forms (sometimes 
referred to by other names such as toxins, adhesins and hemagglutinins). Species-
specific recognition was discovered after monitoring the phenomenon of re-aggregation 
of dissociated marine sponge cells - which itself is a carbohydrate mediated interaction. 
Other relatively simple species such as arachnids and crustaceans showed evidence of 
red cell agglutination activity (due to the presence ofhemagglutins). It was not until the 
1960s that interactions such as this were known in complex multicellular animals such 
as vertebrates. Early indicators of this came as a result of the work of Ginsburg et al, 38 
who looked at the treatment of blood leukocytes (from the rat), with bacterial 
glycosidases. The lack of sufficient tools at that time meant that a full interpretation of 
results was not possible; however it remains likely that their results were indicative of 
the presence of an endogenous lectin(s). 
Direct evidence for mammalian lectins was serendipitously discovered by Ashwell et 
al. 39 While monitoring the turnover of glycoproteins in the blood using two tritium-
labelled glycoproteins (one with and one without terminal sialic acid groups), they 
observed stark differences in their circulation half-lives. The sialic acid terminated 
proteins remained in circulation for days, while those without sialic acid groups were 
gone within several minutes. These desialyated glycoproteins appeared to be 
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accumulating in the liver. This observation established the existence of the 
"asialoglycoproteinttt receptor (ASGPR)". This mechanism has since been observed 
through other experiments, for example ceruloplasmin is a glycoprotein responsible for 
transporting copper. It contains several oligosaccharide chains terminated with sialic 
acid. When the enzyme sialidase removes these residues, the proteins are then able to 
bind to hepatocytes, and are endocytosed and destroyed. This mechanism is similar to 
that which removes old erythrocytes from the mammalian bloodstream. 
Of particular interest in this report is a galactose binding protein (GBP) present on the 
surface of mammalian spermatozoa,40 which has a similar structure to the well-
characterised asialoglycoprotein receptor39 of hepatic cells. These receptor types are 
specific to f3-linked galactose or GalNAc residues. A diagram showing the 
carbohydrate recognition domain (CRD) of a subunit of the human hepatic ASGPR is 
depicted below. 
Figure 1.6- Ribbon diagram of the Hl-CRD41 
ttt Asialo- meaning without sialic acid. 
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The image contains several key components. The a-helices are shown in purple, the P-
strands in blue, the disulphide bridges in yellow and the calcium ions in green. The 
binding position of the sugar is indicated by the arrow.41 
1.4.1 Classification of Animal Lectins 
Historically, animallectins were classified by the carbohydrate sequences to which they 
showed the highest affinity (e.g. p-galactoside-binding lectins). Due to modern 
molecular cloning techniques, a more systematic approach to nomenclature now exists. 
Work by Drickamer42 suggested two classes of lectins: 
• C-type lectins - so-named due to their requirement of calcium for recognition 
• S-type lectins- since they required thiols 
Since this initial study, further classes have been identified, such as P-type lectins, 
which recognise Man-6-P. 
1.4.2 Lectin-Ligand Interactions 
The binding constants for monosaccharide interactions with lectins are small, typically 
103-106 M-1. However, there is an increase in binding affinity with the number of 
saccharide units due to the multivalent or "cluster effect".43 Affinities of up to 1016 M-1 
have been reported.21 · 44 This occurs when more than one sugar residue of the correct 
type and orientation are clustered together on the ligand. The number and arrangement 
of these sugars has a significant bearing on the interaction between the lectin and the 
sugar.45 The selectivity of these interactions is largely based on H-bonding and Vander 
Waals forces. Further selectivity can occur through bridging cations or water 
molecules. In general, interactions between animallectins and carbohydrates have been 
found to be multivalent, either due to having multiple carbohydrate binding sites, or due 
to the presentation of multiple carbohydrate residues by the ligand, or both. Work has 
been undertaken to gain a better understanding of multivalent ligand/receptor 
interactions. Work by Kiessling et a/,46 has focussed on the use of synthetic multivalent 
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ligands as probes of signal transduction. It is suggested that this approach is 
significantly more valuable than merely studying the function of individual proteins (as 
was the case historically) when attempting to elucidate receptor function. A multivalent 
ligand consists of a central scaffold with multiple copies of a recognition element 
attached. The recognition element of a multivalent ligand can assume a range of forms, 
e.g peptides, carbohydrates, proteins or any moiety that is able to bind to a specific 
receptor. It is noteworthy that the structure of the scaffold is also important since 
factors such as flexibility, shape, size or orientation of the recognition elements etc. can 
have an impact on the biological activity of the multivalent ligand. Furthermore, the 
architecture of the scaffold can play a significant role in the biological response 
observed upon binding to the receptor. It is typical to refer to bioactive monovalent 
entities as agonists or antagonist (e.g. they activate or inhibit a response). However, 
while a single recongnition element may be an agonist or antagonist, it is possible for a 
multivalent ligand to induce the opposite effect depending on the structure of the 
scaffold and how the binding affects e.g. the clustering of receptors.46 
A number of different scaffold morphologies exist that can be used to study receptor 
function, examples of which can be seen in Figure 1.7. Synthetic organic chemistry 
offers routes to a wide variety of well-defined multivalent ligand architectures. As such 
it is possible to examine the change in biological effect based on the structure of the 
multivalent ligand. 
Whilst multivalent ligands serve as powerful tools for the study and elucidation of 
complex multireceptor networks, they may also be applicable as treatments of disease. 
A study by Whitesides et al investigated the use of multivalent ligands as inhibitors of 
the anthrax toxin,47 suggesting that multivalent ligands may not only serve as useful 
biological probes, but may actually have viable and worth-while therapeutic 
applications. 
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Bead 
Figure 1.7- Diagram showing examples of multivalent ligands46m 
In an attempt to mimic nature, much work has focused on synthetic materials rich in 
carbohydrates that can interact with specific lectins. 48 This is complimented by the fact 
that most lectins have several CRDs - thus increasing the potential binding strength. 
Recent work by Chung et a/ investigated the specific interaction of mannosylated 
glycopolymers with macrophage cells mediated by the mannose receptor. They were 
able to demonstrate (via fluorescent microscopy of FITC-labelled polymers containing 
mannosyl, glucosyl and glucoamidyl moieties), that only the mannosylated 
glycopolymers exhibited strong binding to the macrophage cell line carrying mannose 
receptors.48 
1.4.3 Sperm-Egg Binding 
Carbohydrate-lectin interactions dominate the fertilisation process in many vertebrate 
and invertebrate species. For example, in mice, the addition of UDP-Gal or GDP-Fuc 
m The ligands are compared in size to a mammalian lymphocyte. Scale bars are as follows: bead & ceU 
l mm; Jiposome & polymer 0.5 mm; antibody, dendrimer and albumin 0.05 mm. 
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polymers blocked sperm egg binding.5 Recently work by Fang et al has investigated the 
interactions of sperm lectins using carbohydrate modified quantum dots.49 As has been 
discussed, monovalent interactions are weak and subsequently a number of 
carbohydrate carriers (e.g. dendrimers, polymers, liposomes and nanoparticles) have 
been developed in order to take advantage of multivalency. As such, the use of 
quantum dots encapsulated with the biologically important ~-N-acetylglucosamine 
(GlcNAc - see Figure 1.8) were used to investigate interactions on the surface of sea-
urchin sperm cells. In addition, mannose-encapsulated quatum dots were used to 
investigate interactions on the surface of mouse sperm cells. 
OH 
NHAc 
Figure 1.8- Structure of N-acetylglucosamine (GlcNAc) 
It was tentatively concluded from fluorescence microscopy studies that GlcNAc and 
Mannose receptors are distributed differently across the sperm surface since the 
GlcNAc labelled quantum dots were shown to bind selectively to the sperm heads, 
whereas the mannose-encapsulated quantum dots were distributed throughout the head 
and tail of the sperm cell. Fang et a! also demonstrated binding of GlcNAc encapsulatd 
quantum dots to live pig sperm via flow cytometry.49 
1.5 Lipids 
Lipids (or fats) are water insoluble biological molecules of much importance. They can 
be divided into two major groups based on their ability to be hydrolysed by strong bases 
- saponifiable and nonsaponifiable§§§. Lipids are as diverse in biological function as 
they are in their chemistry. The can act as stored energy within biological systems, be 
part of structural elements of membranes, etc. (e.g. phospholipids/sterols), as well as 
§§§ Saponification is the process where fatty acids are hydrolysed by base from their equivalent ester. 
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being electron carriers, hormones, intracellular messengers, to mention a limited sub-
set. 
Fatty acids and phospholipids are amphiphilic in nature, that is, they have both 
hydrophilic and hydrophobic character. In schematic terms one can represent a fatty 
acid as shown in Figure 1.9. Similarly, phospholipids are amphiphilic and can be 
represented schematically as illustrated in Figure 1.9. 
______ ____ __ L_ 
i Polar "Head" i 
I I 
1-----------~ 
~------- - --- - -- -1 I 
: Aliphatic "Tail" : 
I I 
I I 
~---------------
Figure 1.9- Cartoon representation of a fatty acid (black) and a phospholipid (grey) 
Within organisms, lipids used to store energy are in the form of fatty acid derivatives. 
This is essentially akin to burning fossil fuels in an engine, since the fatty acids are 
converted into C02 and H2o ****. Essentially a fatty acid is a carboxylic acid with a 
hydrocarbon chain (from C4 to C36). The compositions vary from fully saturated (i.e. no 
double bonds) to having one or more double bonds. In addition, the saturated chains 
can be either linear or branched. 
Saturated fatty acids tend to be solids, with the melting point increasing with increasing 
chain length, whereas unsaturated fatty acids tend to be liquids at room temperature. 
This can be explained by considering the structure of both saturated and unsaturated 
fatty acids, and how they are able to pack. The inclusion of only one double bond 
introduces a kink in the aliphatic chain which leads to inefficient packing. 
In general , fatty acids are numbered from the carbonyl carbon and their nomenclature 
can be simplified by giving the number of carbon atoms followed by the number of 
double bonds, separated by a colon, so e.g docosahexaenoic acid is 22:6 (22 carbon 
•••• It is noteworthy that sugars provide around half of the energy per mole, compared to fats ( 18.8 kJ/mol 
v 37.7 kJ/mol). 
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atoms, 6 double bonds). In addition, the position of the double bonds can be given by 
superscript numbers following the symbol ~. (e.g. 4,7,10,13,16,19-docosahexaenoic 
acid (DHA) would be represented as 22:6(~4• 7 • 10• 13 • 16• 19)). One alternative nomenclature 
is to give the position of the first double bond based on numbering the chain from the 
opposite end ofthe chain from the carbonyl carbon (e.g. DHA would be represented as 
22:6(n-3) or 22:6(w-3)). In fatty acids where there are multiple double bonds, the 
double bonds are almost never conjugated and most of the fatty acids found in nature 
are in the cis configuration. 
The composition of fatty acids varies depending on the organism of origin. Fish have 
25-30% of fatty acids containing 20-22 carbon atoms, while mammals only have 5-7% 
naturally present. Furthermore fish have 15-30% of fatty acids containing 5-6 double 
bonds, while plants only have 5-6% and mammals less than 1%. Since fatty acids such 
as DHA & EPA are deemed to be important in mammalian nutrition,50 and have 
benefits in reproductive health,5 L 52 it is obvious that food supplementation is important 
in order to gain the necessary amounts of essential fatty acids. It has been suggested 
that deficiencies in these essential fatty acids can lead to cognitive disorders like 
ADHD, dementia and dyslexia. 
OH 
Figure 1.10- cis-4,7,10,13,16,19-docosahexaenoic acid 
1. 6 Vitamin E 
The term "vitamin E" was first coined around 90 years ago to describe a constituent of 
animal feed thought at the time to be important for reproduction. 53• 54 During the mid 
1930s it started to become apparent that vitamin E consisted of more than one 
component, when two compounds of similar activity were isolated and characterised. 53 
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These were designated as a- and P-tocopheroltttt. During subsequent years a further 
two tocopherol compounds were discovered (y- and &-tocopherol), as well as four 
tocotrienols (a-, p-, y-, and 8-tocotrienol). 53 Collectively these compounds make up 
natural vitamin E. These compounds are highly potent, fat-soluble, chain breaking 
(biological) antioxidants. Their hydrophobic nature means that they tend to associate 
with cell membranes, lipids, etc. 
HO 
Figure 1.11 -Structure of 6-chromanol 
All of the above compounds are derivatives of 6-chromanol (Figure 1.11 ). The 
tocopherols are derivatives oftocol and contain a saturated Cwside chain (Figure 1.12). 
HO 
7 
~8 
Figure 1.12- General structure of the tocopherols 
Table 1.4 -The tocopherols 
-Tocopherol -Tocol R1 R2 R3 
a 5,7,8-trimethyl CH3 CH3 CH3 
p 5,8-dimethyl CH3 H CH3 
y 7 ,8-dimethyl H CH3 CH3 
() 8-methyl H H CH3 
- Tocol H H H 
tttt Tocopherol is derived from the Greek words tacos (childbirth) and pherein (to bring forth) due to the 
important role it plays in mammalian reproduction. 53 
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The second series is derived from tocotrienol (Figure 1.13, Table 1.5), and have a triply 
unsaturated side chain at positions 3 ', 7' and 11 '. 
Figure 1.13- General structure of the tocotrienols 
Table 1.5- The tocotrienols 
-tocotrienol R1 R2 RJ 
a 5,7,8-trimethyl CH3 CH3 CH3 
p 5,8-dimethyl CH3 H CH3 
y 7 ,8-dimethyl H CH3 CH3 
8 8-methyl H H CH3 
- Tocotrienol H H H 
Although these 8 compounds exist and are well characterised, it remains the case that 
the most biologically active and subsequently the most commercially important of all 
these compounds, is a-tocopherol. a-Tocopherol is essential in the body to prevent 
cellular damage from free radicals. 55 It cannot be synthesised in mammalian systems 
and therefore must be supplied through feeding and supplementation.53 Its main 
function is to prevent the peroxidation of membrane phospholipids, thus preventing 
membrane damage. 54' 55 If left unchecked, the damage to cell membranes will 
ultimately lead to apoptosis.56 In multicellular organisms, this may not be fatal to the 
entire organism, if cell regeneration is occurring, however in the case of sperm cells 
(especially post ejaculate) the issue is much more serious.56 Since a-tocopherol is 
highly lipophilic, it tends to associate with the interior of the cell membrane bilayers. 55 
In general the radical trapping mechanism of a-tocopherol can be considered as shown 
below. 57• 58 
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aT-OH + R. ~ aT-0· + RH 
aT-0· +Roo· ~non radical products 
Figure 1.14- General radical trapping mechanism 
Elaborating further, a typical radical oxidative reaction scheme for a-tocopherol is 
depicted in Figure 1.15. 
HO ·a 
ROo' 
~ 
c,sH33 c,sH33 
/oo ~a· 0 
0 0 
+ 
c,sH33 C,sH33 1 H,O 
1 H,O 1 H,O 0 
c,6H33 
C,sH33 
OH 1 ~ "m• OH 
0 
0 
HO 
OH 
Figure 1.15- Oxidation products of a.-tocopherol54' 58 
c,sH33 
C,sH33 
OH 
c,6H33 
OH 
It has been shown that the structure of the a-tocopheroxyl radical is stabilised by 
resonance. This is due in part to the structure of the chromanol ring and also to the 
presence of electron donating substituents on the ring (e.g. methyl groups). 53 
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• 
0 
" 
Figure 1.16- Resonance forms of the a.-tocopheroxyl radical53 
a-Tocopherol can also act as an anti-oxidant through non-radical pathways to yield a 
variety of different products. 
HO 
0 0 
HO 0 
Figure 1.17- Non-radical oxidation pathway of a.-tocopherol53 
It is noteworthy that natural and synthetic vitamin E are not exactly the same. In 
naturally occurring vitamin E, the most abundant form is RRR-a-tocopherol, however 
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m contrast, the synthetic form ts all-rae-a.-tocopherol, i.e. it contains all 8 
stereo isomers. 
Logically, one might expect that since, in theory, all stereoisomers have the same anti-
oxidant properties, their biological performance would be similar, however this is not 
the case.53 This tends to suggest that it is not merely the antioxidant activity of a.-
tocopherol that is of importance but that structural aspects are equally or perhaps of 
greater importance. As a result, structural features (or the lack of them), such as methyl 
groups on the ring, stereochemistry of the chiral centres, etc. , are of significance in 
terms of biological activity. 
It has been shown that the configuration at C-2 has a significant effect on the 3D 
structure of the molecule. For example, changing the configuration from R to S at C-2 
results in the angle between the chormanol ring and the phytyl chain being inverted. 
This in turn affects the biological activity. 53 
Figure 1.18- Space-filling diagram showing RRR-a-tocopherol (left) and the synthetic SRR-a-
tocopherol (right). (,n: carbon atom , Blue = C-2, Red = Oxygen. 
1. 7 Drug Delivery 
Drug delivery is of immense importance and research in this area has been gaining 
momentum over the last decade. In particular, the area of polymer therapeutics has 
come to the fore and is an area of intensive research. As discussed recently by Duncan 
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et al, recent years have seen a shift in how polymers are used in biomedical 
applications.59 Previously their applications were limited to biomedical material type 
uses such as prostheses, medical devices, contact lenses, dental materials and 
pharmaceutical excipients. It is only in recent years that polymer-based medicines have 
found their way into routine clinical practice. 59-61 Fortunately and importantly scientific 
research has demonstrated that many polymer-based therapeutics previously consigned 
to the scrap heap can in fact pass both regulatory and industrial development scrutiny. 
It is now widely accepted that e.g. synthetic polymers offer a potential route towards 
more effective treatments oflife threatening or debilitating diseases. 59' 62 
In essence, much of the motivation behind the study of targeted delivery techniques 
stems from the desire to reduce the doses of administered drugs. In no field is this more 
important than in cancer therapy. The Holy Grail in this area is to deliver a highly 
cytotoxic drug to the cancer cells and for only those cells to be destroyed. To date there 
have been many publications detailing targeted delivery techniques for various 
applications such as the treatment of hepatitis,63 gene therapy64' 65 and for treating liver 
tumours. 66' 67 
It is desirable, in the context of this thesis, to be able to produce linear polymers which 
will be site-specific to a receptor on the surface of sperm cells. Among the most 
effective recognition species are moieties such as antibodies, hormones and sugars.68 
Before this concept is discussed in more detail, it is worth considering a more passive 
approach to drug targeting. 
1.7.1 The Enhanced Permeability and Retention (EPR) Effect 
Although (as mentioned earlier) this thesis will consider an active targeting approach, 
other studies have focussed on passive targeting - exploiting the "enhanced 
permeability and retention effect" (EPR effect). This phenomenon was discovered by 
Maeda et al while working on therapies designed to treat liver cancer.67 ' 69' 70 
The EPR effect is the focus of many groups aiming for novel cancer therapies suitable 
for treating common solid tumours such as breast, prostate, lung and colon cancers66 (in 
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the UK in 1998 more people died of cancer than any other disease;66 in 2006, cancer 
affects one in three people in the UK and kills on in four71). Primary and secondary 
metastatic tumours arise from a single abnormal cell. As the tumour grows and exceeds 
a size of around 150-200 Jlfll, vascularisation must be increased.66 It has subsequently 
become apparent that tumour vessels have irregular architectures compared with normal 
cells. Tumour cells are poorly formed with thin walls, and are inherently 'leaky' which 
in tum can lead to extravasation of macromolecular and liposomal drug carriers.66 
This phenomenon of accumulation of macromolecules (or other nanoparticles) within 
solid tumours was largely overlooked for several years, and only the pioneering work of 
Maeda et az7°· 72 (mentioned above) as well as work by Jain et a/,73 started to change 
this. 74 These studies provided a detailed insight into the characteristics of angiogenesis 
i.e. hypervasculature, defective vascular architecture, and impaired lymphatic 
drainage. 59, 66, 71, 74 
Tlw h19h.t f*m•MbtiJty Qf 
the blood vessel in th. tumour 
allom the drug to esape \ 
lov.w permeability of 
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Figure 1.19- Diagram illustrating the 'enhanced permeability and retention' (EPR) effece5 
Generally, low molecular weight entities can diffuse within both normal and tumour 
tissues, via the blood capillaries. However, while macromolecules are unable to pass 
into nom1al tissue, they are able to enter tumour tissues, in part due to their ' leakiness ' 
(see Figure 1.19). The inherent poor lymphatic drainage (alluded to earlier) means that 
not only are macromolecules able to enter the tumour tissue, but also tend to accumulate 
there. 59, 66, 71 , 74 
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The size of macromolecular drugs/drug carriers is therefore of fundamental importance, 
and it has been demonstrated that their molecular weights must exceed 20 kDa (most 
work in recent years has focussed on materials with molecular weights ranging from 20 
- 200 kDa). 74 Plasma circulation time is also an important factor, not to mention renal 
clearance (the threshold of renal clearance is typically 30 - 50 kDa). Indeed some pre-
clinical studies have shown that factors such as the molecular weight, charge, 
conformation, hydrophobicity etc. are highly influential in the degree of accumulation 
within the tumour and on its pharmacokinetic profile. 74 Pre-clinical studies have also 
demonstrated a correlation between tumour size and uptake of polymers; it appears that 
smaller tumours accumulate more polymer than larger tumours. 74• 76 
Nevertheless, there is still much to be understood about the influence of the many 
different factors affecting EPR-mediated uptake. Generally however, polymers should 
have a neutral charge and a molecular weight above c.a. 30 kDa since this ensures a 
long plasma half-life which is of particular importance to ensure significant 
accumulation in the tumour. 59' 71 ' 74 
This simple passive targeting is in contrast to the research being addressed by many 
others (and indeed this author) on specific targeting, be that via antibodies, 
carbohydrates, peptides etc. Although there is some hope that these two approaches 
(EPR/specific targeting i.e. passive and active targeting) can be combined.71 So far, 
only one polymer of this type has progressed to clinical trials. 77 
It is noteworthy that at the turn of the last century, the work by Paul Eirich on the use of 
synthetic small molecules as chemotherapy was initially treated with much scepticism. 
A similar degree of scepticism has initially greeted researchers focussing on polymer-
based products over the last 20 or so years. However it has been observed recently that 
the tide may have turned, since in 2002/03 the FDA approved more macromolecular 
drugs and drug delivery systems than small molecules as new medicines. 59 
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1. 7.2 Polymeric Drug Delivery 78 
The importance of active dmg targeting has been recognised for almost a century.78 
Since then, the conjugation of dmgs to other non-active compounds, in order to improve 
the efficacy by affecting their physiochemical and pharmacokinetic properties, has been 
considered. 79 This was taken a stage further in the 1970s when Ringsdorf proposed the 
idea of polymeric dmg delivery.80 Initially, many of these ideas and concepts were 
regarded with scepticism, however nowadays "polymeric prodmg" is a popular term 
and the area is of increasing interest across a range of scientific disciplines. 
There are a number of reasons for the increasing interest in polymeric dmgs/prodmgs. 
The main interest is because they can overcome many of the problems associated with 
conventional dmgs. From the time that a (low molecular weight) dmg is administered, 
until it is excreted from the body, it will encounter many physiological processes that 
will have effects on its concentration and interaction within the body. It may undergo 
biotransformation(s) or may become bound to tissues, and regardless of whether the 
dmg is free or protein bound, it will ultimately become distributed throughout the body 
rather than being concentrated solely at the site of action. Consequently, one must 
increase the dose above the therapeutic level in order to achieve the required therapeutic 
effect. 
A useful, although perhaps over-simplified, model for polymeric dmgs was postulated 
in 1975 by Ringsdorf.80 In general terms, Ringsdorf's model describes the polymeric 
carriers discussed herein, and these will be examined in more detail in later chapters. 
The model can be considered schematically as shown in Figure 1.20. 
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Figure 1.20- Components of a polymeric drug as proposed by Ringsdorf!O 
Such polymers can be synthesised by statistical terpolymerisation or indeed by block 
copolymerisation (it will be discussed later why terpolymerisation can be 
advantageous). 
We can consider each of the three components in turn. 
(1) Solubiliser: this part ofthe polymer can be tuned to give waterHU or lipid§§§§ 
solubility. Often water solubility is preferred so that the polymer is soluble 
in aqueous physiological media. 
(2) Drug: this must be fixed in such a way as not to affect adversely the activity 
but also so that it can be cleaved easily and the drug regenerated in situ. 
(3) Homing Device: this is the key to delivering the drug with high specificity. 
However, the homing device can be substituted with a non-specific 
resorption enhancer that helps to control the distribution of the polymer 
within the system. 
Ultimately, polymeric drug delivery systems can be categorised into two discrete groups 
- 'controlled drug release systems' and 'targeted drug delivery systems' . These 
mt Achieved by using monomers such as N-vinylpyrrolidone, acrylamides, sulphoxide containing 
acrylates, etc. 
§§§§ Monomer units bearing long alkyl chains. 
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categories arise from the difference between the site of drug release and the site of drug 
action. Generally a 'controlled drug release system' would deliver the drug into the 
system in a controlled fashion, at a rate controlled by some physical or chemical 
response to an action, for example, the use of hydrogels to regulate insulin levels in 
patients with diabetes. As a result of this, the site of drug release and that of drug action 
are different. On the contrary, 'targeted delivery systems' (which are of relevance in 
this thesis) can deliver the active drug directly (or very close) to the site of action, 
avoiding distribution of the active component throughout the whole system, thus 
allowing lower dosage levels to be administered. 
By lowering dosage, one can expect a reduction in adverse side effects or toxicity, and 
indeed low molecular weight drug compounds which were previously too toxic due to 
the dosage levels required to produce a therapeutic effect, could be reconsidered as 
potential drug candidates. 81 
1. 7.3 Receptor Mediated Endocytosis82· 83 
Cells uptake extracellular material via endocytosis and phagocytosis. Endocytosis can 
be split into several categories: 
o Fluid phase endocytosis (or pinocytosis) 
o Recapture 
o Receptor mediated endocytosis 
It is the latter that is of interest in this text. 
Receptor mediated endocytosis (RME) is responsible for the uptake of a number of 
species, including: metabolic ligands; opportunistic ligands (e.g. protein toxins and 
viruses); growth factors; lysosomal hydrolases; immunoglobulins & 
asialoglycoproteins; the uptake of particles is by phagocytosis. 
The ligand in question can either be destined for lysosomal hydrolysis, or diacytosis 
(return to the cell surface) for delivery to storage granules or for transcellular transport 
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(transcytosis). The receptor itself can follow a similar fate pattern in that it can end up 
in the lysosome where it will be destroyed, return to the surface to mediate further 
internalisations, or become involved in transcellular transport. 
A typical cycle of ligands and receptors is shown below (Figure 1.21) where: 
(R) = Receptor 
(L) =Ligand 
L = Lysosome 
Subscripts's ', ' ex ' , & ' i' =surface, external, & internal respectively. 
.-----L 
Degradation 
(R)s 
(R)i (LR)s 
~--~~(LR);) 
Figure 1.21 -Typical ligand/receptor cycle 
(L)ex 
Large molecules, e.g. proteins (or polymers), mainly enter cells via RME.84 It is a 
multi-stage process and is sensitive to environmental factors such as temperature. Cells 
maintained between 0-4°C do not internalise significant amounts of ligands, however 
when cells are at elevated temperatures (e.g. 37°C) internalisation occurs much more 
rapidly. 84 As mentioned, the endocytic pathway is multi-step and in the first instance 
relies on the existence of receptors on the cell surface. 
Surface receptors do not only facilitate the first stage of internalisation, they also do so 
with high specificity. The efficiency of cell receptors is dependent upon the quality of 
the ligand binding. The interaction of a binding site and a ligand will be non-covalent, 
however still of relatively high affinity. Therefore, it follows that there must be 
configurational complementarity between the two, i. e. the interaction is stereo-specific. 
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This concept was the brain-child of Emile Fischer, who proposed the "Schloss und 
Schussel" (lock & key) analogy, and has subsequently been cited on many occassions.35' 
85-89 
There are three important factors of both the receptor and the ligand for selective 
binding to take place: 
i) molecular geometry 
ii) reactive group positioning 
iii) configurational flexibility 
Typically the forces involved in the interaction will be Vander Waals forces, hydrogen 
bonds and ionic interactions (or more generally electrostatic interactions). Although 
these do not themselves ensure high specificity - they do help - since as the distance 
between the ligand and the receptor decreases, the attractive forces will increase. 
The importance of the flexibility of the ligand should not be underestimated, since the 
"docking" of the two will not be quite as straightforward as the "lock and key" 
principle. 
Once a ligand has docked with a surface receptor, the intemalisation process continues. 
The ligand-receptor complex enters so called ( clathrin) "coated pits" on the cell surface 
and the cell membrane closes around the docked species to form an enclosed vesicle. 
This is then invaginated and forms the "early endosome" (see Figure 1.22). When 
several of these are fused together, the endosome (or mature endosome) is created. 
Initially these endosomes may still be clathrin coated, however they quickly lose this 
coating. Endosomes typically have a pH of between 5 and 6, and are deficient in acid 
hyrd0lase content. From the endosomes the ligand-receptor complex then moves to the 
lysosome. The mechanism by which this happens has been studied in the context of 
macrophages and two models have been proposed90 . The first model proposes that the 
content of the endosome is concentrated, perhaps by membrane withdrawal, and then 
acquires lysosomal hydrolases by fusion with lysosomes. The second model suggests 
that lysosomes and endosomes communicate with each other via the passage of vesicle 
populations from one to the next. Regardless of which model is correct, it is evident 
that the transfer of material does occur. This must necessitate that membrane 
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withdrawal occurs yet only very small amotmts of lysosomal hydrolases are found to 
leak into the surrounding medium, which is very surprising. 
Figure 1.22 - Formation of coated pits during endocytosis91 
Once the endocytosed material has entered the lysosome, it can be digested. Lysosomes 
typically have a lower pH than endosomes ( 4.5-5) and are rich in enzymes (e.g. 
esterases, phosphatases, peptidases, glycosidases, oxidoreductases, etc.). 
As mentioned earlier, the receptor can either be recycled, or destroyed. One of the best 
characterised scenarios is that of the asialoglycoprotein receptor.39' 40' 92 Here, both the 
ligand and the receptor are internalised to endosomes. Due to the acidity they are then 
separated; the receptor is conveyed back to the surface and the ligand is sent on to the 
lysosome. 
A simplified diagram depicting a typical RME cycle is shown below in Figure 1.23. 
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Figure 1.23- Receptor Mediated Endocytosis11 
1.7.4 Glycodendrimers 
This thesis largely focuses on the use of linear glycopolymers, however this research 
area is thriving, and a number of fascinating morphologies exist. One such example is 
that of dendrimers. These are branched synthetic polymers that have shown potential in 
a number of biomedical applications.93• 94 The properties of dendrimers are 
substantially different from their linear counterparts and as such their uses/behaviour 
should be considered independently. Indeed aspects such as pharmacokinetics or 
biocompatibility can be tuned carefully through regulation of their synthesis, allowing 
composition/molecular weight to be regulated.94 
Structurally, dendrimers are tree like (dendra - Greek for tree), having multiple perfect 
branches emanating from a central core, and can be synthesised via a divergent or 
convergent approach (see Figure 1.24). 
- 45 -
'Divergenr growth 
• 
'Two-step• 
synthesis 
·coovergent' growth 
Introduction 
• -----· 
Figure 1.24- Schematic showing dendrimer formation via divergent and convergent growth95 
Dendrimers can be based on a wide range of chemistries, which can in tum influence 
factors such as solubility, biological activity etc. Since the properties of dendrimers 
often differ significantly from linear polymer properties, they do have several beneficial 
attributes for biomedical applications,94 e.g.: 
• Tuneable pharrnacokinetic/biodistribution properties through control of 
dendrimer size and conformation. 
• High ligand density - as dendrimer generation increases so does the multivalent 
ligand density at the surface. This can strengthen ligand-receptor binding and 
improve targeting. 
• High structural/chemical homogeneity. This facilitates reproducibility of data 
(pharmacokinetic and material characterisation). 
• Can be functionalised with multiple copies of drugs etc. , allowing drug loading 
to be altered precisely. 
• Controlled degradation achieved via careful choice of dendrimer chemistry. 
Dendrimers may themselves exhibit therapeutic properties, e.g. as described by 
Supattapone et a/, where polyamidoamine (P AMAM) dendrimers where shown to 
stimulate the removal of prion proteins present in infected cells.96 Careful construction 
of dendritic materials can also afford materials displaying multivalent ligands on the 
dendritic polymer surface. Such materials have been shown to inhibit multivalent 
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binding between e.g. cells, viruses, bacteria etc. 94 Of particular interest however is the 
work by Davis et al, on glycodendrimers, and ultimately on a new class of materials -
' glycodendriproteins'. 
Glycodendriproteins are synthetic glycoprotein m1m1c enzymes, which in work 
described by Davis et al, are capable of inhibiting bacterial aggregation.97 Small 
molecules are not viable as blockers of bacterial adhesive events since as monovalent 
carbohydrate ligands are poorly recognised by lections, the therapeutic concentrations 
required would be unrealistically high.97 It has been shown that glycodendrimers can 
mimic the branched carbohydrates found on glycoproteins. When such entities are 
subsequently attached to a protein, this gives rise to the class of materials 
'glycodendriproteins' mentioned earlier. 97 
Glycodendriproteins were constructed by first synthesising carbohydrate bearing 
dendrons which were then attached via a cysteine group in the protein-degrading 
proteinase, subtilisin (from Bacillus lentus (SBL)).93 · 97 The pathogen being targeted 
(Actinomyces naeslundii) binds to P-D-galactose, therefore galactose was the 
carbohydrate of choice attached to the glycodendriprotein.93 · 97 These galactose bearing 
synthetic glycoproteins were first tested using a peanut agglutinin (PNA) model to 
mimic the display of surface lections found on the bacterial surface. Increasing 
galactose antennae correlated with increasing affinity.97 
Davis et al, went on to demonstrate the ability to inhibit the function of the galactose-
binding pathogen (Gram-positive A. naeslindii),93 · 97 which has been shown to 
aggressively colonise oral cavities,98 surgical prostheses99 and internal cavities.97• 100 
Studies demonstrated that a bi-antennary carbohydrate structure was most effective at 
inhibiting bacterial binding. Three properties were found to be key in ensuring optimal 
inhibition: (i) the protein-degrading activity of the construct, (ii) multi-antennary 
carbohydrate display, and (iii) galactose presentation. Glycodendriproteins can also be 
easily modified with alternative carbohydrates for alternative lectin or pathogen 
targets.93· 97 
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Other similar examples have been reported for the treatment of hyperglycaemia in 
diabetic patients 101 and for the potential treatment of influenza. 102 
1. 7.5 Glycopolymers 
The interest in carbohydrate containing polymers, known as glycopolymers has been 
increasing rapidly in recent years. The term glycopolymers can be used to describe both 
natural and synthetic carbohydrate containing polymers. They are in many ways 
analogous to polysaccharides, but there is a fundamental difference between the two. 
Glycopolymers consist of a polymer backbone with sugar side groups, whereas 
polysaccharides have sugars in the backbone. Some examples of naturally occurring 
polysaccharides include: starch, chitin, cellulose etc. Carbohydrates are essential 
components of life, not simply as sources of energy, but as biomolecules involved in 
specific recognition events. Their intrinsic properties such as hydrophilicity and 
biocompatibility make their use in the preparation of biocompatible polymers, with 
pharmacological and biological propetiies, almost inevitable. 103, 104 
Glycopolymers can be synthesised in a number of ways. One method is simply to 
couple a polymerisable group (e,g. a vinyl functional compound) to a sugar. This tends 
to require the protection of the sugar hydroxyl groups. However, there have been other 
methods reported, which use linkers between the saccharide and the vinyl functionality 
which allow preparation of the monomer without the need for protecting groups. The 
advantage of this method is that the syntheses tend to be less time consuming and less 
• 105 
expensive. 
Glycopolymers have a number of potential uses commercially. They can be used as 
thickeners, flocculants, polymeric detergents and if crosslinkers are introduced, they can 
be used as so called "superabsorbers".27 
It is, however, the properties ofbiocompatibility, recognition and hydrophilicity that are 
attractive for the application discussed herein. These properties make glycopolymers 
suitable for biomedical applications such as drug delivery. 106 
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Below are some examples of how synthetic glycopolymers can be prepared. 
1. 7. 5.1 Free radical polymerisation 
The advantage of free radical polymerisation is that it is a well established, robust 
technique. There is wide scope for the use of various solvents/monomers and the 
initiators are generally inexpensive and readily available. However, there are a number 
of drawbacks. The polymers tend to be very polydisperse (PD > 2), end groups are not 
easily controlled, and it is difficult to produce materials of a specific architecture. 
Despite these problems, a large number of glycopolymers have been synthesised in this 
a 
35, 107 
w y. 
The first such synthesis reported was in 1978 by Horejsi and co-workers. 108 They 
synthesised copolymers of acrylamide and allyl glycosides which showed similar 
binding activities to natural polysaccharides. 
In the early 1990s, Kitazawa et al. described a method for producing acrylic monomers 
with pendant saccharide moieties. These were easily polymerised by standard free 
radical methods. 109 
During the ensumg years, a large number of monomers containing mono, di and 
trisaccharides suitable for free radical polymerisation have been synthesised and their 
properties investigated. 35• 107 
More recently, the synthesis of polymethacrylates bearing B-glucose and B-galactose 
moieties by free radical polymerisation has been reported.22• 103• 104• 109-111 The synthesis 
of these monomers via the acetyl protected sugars ensures total B-selectivity due to 
neighbouring group participation of the acetyl groups at 0-2. Both pre-polymerisation 
and post-polymerisation de-acetylation reactions were described, with the former giving 
better defined materials. 
There are many other examples in the literature and this area is likely to continue to 
develop. 
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1. 7.5.2 Ionic polymerisation 
Living ionic polymerisation (either cationic or anionic) offers many advantages over 
conventional free radical polymerisation, and it is no surprise that many glycopolymers 
have been synthesised in this way.35• 107 The attractiveness of being able to synthesise 
polymers of narrow PD (<1.2), with well defined architectures and pre-determined 
molecular weights, is huge. Despite these benefits, both techniques are littered with 
drawbacks. Anionic polymerisation suffers from a need for very dry solvents, high 
purity reagents, monomers that are free of acidic protons or electrophilic substituents, 
sensitivity to oxygen and low reaction temperatures. Cationic polymerisation suffers 
from similar problems, in addition to being unstable due to side reactions. Nevertheless 
there have been many successful reactions reported in the literature.35• 107 
1. 7.5.3 Ring opening polymerisation (ROP) 
The ring openmg polymerisation of heterocyclic compounds, by either amomc or 
cationic routes, is a feasible method of glycopolymer synthesis. 
To date the only group to have pubilished examples of anionic ROP (AROP) of 
glycomonomers is that of Aoi et al. 112 They used glycosylated N-carboxyanhydrides 
(NCAs) to produce glycopolymers. 
0 
OAc 
OAc 
Figure 1.25- Glycosylated NCA35 
Such monomers have also been polymerised via cationic ROP (CROP).35 
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1. 7.5.4 Ring opening metathesis polymerisation (ROMP) 
The attraction of ROMP is its ability to produce well-defined polymers with varying 
architectures. It is also possible, by using Grubbs' catalyst, to have a living 
polymerisation. Nevertheless, there are a number of drawbacks to this method: it is 
sensitive to both N2 and 0 2 gases; there are only a few suitable monomers currently 
available; and the removal of the transition metal catalyst could be an issue (especially 
for biological applications). 
Grubbs and Fraser have demonstrated the synthesis of several sugar bearing copolymers 
via ROMP. Polymerisations were carried out at 50°C, which yielded polymers of 
narrow PD. 113 
RR'=H 
RR' = -COCH3 
RR' = -SiEt3 
RR' = -CPh3 0 
N 
H RO 
OR 
Figure 1.26- Glycosylated norbornene derivatives35 
OR' 
Glucose derivatives of 7-oxanorbomene have been synthsised by Mortell et a/. 114-116 
and have been shown to bind to the lectin Concanavalin A. 
1. 7.5.5 Nitroxide mediated radical polymerisation (NMRP) 
Thus far there have been only a few examples in the literature of glycopolymers 
synthesised via NMRP. The first example of this was from Ohno et a/. 117 who 
synthesised two glycomonomers suitable for NMRP. 
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OR 
0 
HN 
RO 
R=Hor Ac 
RO 
Figure 1.27- Glycosylated monomer for NMRP35 
The polymerisation of the unprotected monomer was found to be controlled, however it 
did not proceed to high conversion. In contrast, the acetylated monomer was also 
controlled and had a conversion of ~90%. The difference between the two was 
attributed to retardative transfer to the hydroxyl groups of the unprotected monomer 
during polymerisation. 
Other groups continue to research the area ofNMRP of glycosylated monomers. 
1. 7.5.6 Copper-mediated living radical polymerisation (CMLRP) 
As in the case of NMRP, there have not been many examples of glycopolymers 
produced using this technique. Work by Ohno et al.ll8 resulted in controlled 
polymerisation of 3-0-methacryloyl-1 ,2 :5,6-di-0-isopropylidene-D-glucofuranose 
(MAipGlc). 
F 
Figure 1.28- Glycosylated monomer for CMLRP35 
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However, in the context of this report, the work of Li et a/. 103' 110 who reported the 
controlled polymerisation of 2-(2' ,3' ,4' ,6' -tetra-0-acetyl-P-D-glucopyranosyloxy)ethyl 
acrylate (AcGlcEMA) is of greater relevance. After polymerisation the polymer was 
deprotected using sodium methoxide, and found to have a PD of 1.4. 
A cO 
OAc 
Figure 1.29- 2-(2' ,3' ,4' ,6'-tetra-0-acetyl-(3-o-glucopyranosyloxy)ethyl acrylate (AcGicEMA)35 
The first example of CMLRP of unprotected sugar monomers was reported by Narain 
and Armes, 119 using 2-gluconamidoethyl methacrylate. This monomer was polymerised 
under aqueous conditions at ambient temperatures, and delivered well-defined materials 
oflow PD (~1.5). 
0 
H 
o~N 
OH 
0 
OH 
OH OH 
Figure 1.30- 2-Giuconamidoethyl methacrylate (GAMA)35 
1. 7.5. 7 Reversible addition-fragmentation chain transfer (RAFT) polymerisation 
In general tenns, RAFT polymerisation has been a very versatile technique suitable for 
a wide range of monomers, functionality, and conditions- even in aqueous media. 
Lowe et a/. 120 reported the RAFT polymerisation of 2-methacryloxyethyl glucoside 
under aqueous conditions and without the use of protecting group chemistry. They 
achieved a well defined material of controlled molecular weight and low PD. 
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X 
HO 
OH 
Figure 1.31 - 2-methacryloxyethyl glucoside (mixture of anomers) 
They were also able to synthesise block copolymers, indicating that re-initiation was 
possible and hence that the polymerisation had living character. 
1.8 Summary 
The area of targeted delivery is an increasingly important one, across a range of 
applications and scientific disciplines. Whilst the majority of examples cited in the 
literature focus on targeting cells within a host biological system, such as the human 
body, this report focuses on a more unusual choice of cell type. 
Glycopolymers are only one solution to cell targeting, and many other examples of 
targeted delivery use alternative strategies such as anti-bodies or polypeptides exist. 
The aim of this research project was to design a glycopolymer containing vitamin E 
moieties that was capable of delivering vitamin E to boar spermatozoa through receptor 
mediated endocytosis. Once internalised the polymer would be attacked by cellular 
enzymes, releasing vitamin E molecules within the cells. It was hoped and expected 
that this enhanced cellular concentration of vitamin E should result in the cells 
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exhibiting an increased resistance to oxidation. Such an invention ts desirable for 
several reasons: 
• Cellular oxidation ultimately leads to apoptosis 
• Vitamin E is insoluble in aqueous media (boar spermatozoa are suspended in an 
aqueous based medium) 
• Lectin-sugar interactions can be highly specific resulting in targeted uptake 
The results of this research project are detailed throughout the remaining chapters of 
this thesis. 
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2 Vitamin E polymer synthesis 
2.1 Introduction 
The use of vitamin E has been described for several completely different areas of 
polymer synthesis. Work by Johnston et al. focuses on the use of vitamin E as an 
antioxidant to inhibit polymerisation of monomers in storage. 1 A second application, 
discussed by Al-Malaika, is the inclusion of vitamin E in polymer melts during 
processing to help the stability of the product.2 However, it is the third application that 
is of most relevance to this report: the derivatisation of a-tocopherol to produce 
monomers suitable for radical polymerisation/co-polymerisation; to produce novel 
polymeric materials of biological significance. 
This area has not been explored widely, or at least there have not been many 
publications involving the polymerisation of vitamin E monomers reported in the 
literature. Nevertheless, there are some examples worthy of mention. 
In 1985 Nakaya et al. reported the synthesis of a methacrylate based derivative of a-
tocopherol containing a phospholipid analogue. This monomer was homopolymerised 
in an attempt to create a polymethacrylic phospholipid analogue.3 Studies then had 
focussed on creating such structures that mimicked biological membranes. It was hoped 
the inclusion of a vitamin E analogue would also help afford protection to these 
artificial membranes in the same manner that vitamin E is essential for the maintenance 
of biological membranes. 
Figure 2.1 -Methacrylate monomer containing vitamin E moiety 
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A decade or so later a similar material, this time based on an acrylamide functionality 
was reported.4 A novel monomer containing vitamin E and an analogue of 
phospatidylcholine was synthesised, and was found to form bilayer structures similar to 
phospholipids. They used these materials to study systems that behave similarly to 
biological membranes. 
Figure 2.2 - Acrylamide monomer containing vitamin E moiety 
The formation of bilayer type structures formed by polymers of this monomer was 
confirmed by X-ray diffraction analysis. 
More recently still, and perhaps of greater relevance, is the work by San Roman et al. 
who synthesised and polymerised a methacrylic derivative of vitamin E. 5 Since then, 
the use of this monomer in the synthesis ofhydrogels with HEMA as a co-monomer has 
been described.6 These were shown to have beneficial effects in the treatment of 
damaged tendons.7 Oritz et al conducted experiments on damages Achilles' tendons, 
and the results were impressive. In the groups treated with hydrogels containing 
vitamin E moities cell proliferation after 10 days was significantly greater than that of 
the control group. The group concluded that since no evidence of foreign body reaction 
was detected in the treated group, such hydrogels could be used and indeed improved by 
including specific growth factors within the hydrogels. 
Further work by this group has highlighted the use of this monomer in the preparation 
of acrylic bone cements (used in hip replacements for example). 8 These materials were 
found to be more biocompatible than conventional materials (e.g. PMMA) and cells 
were able to adhere to them, retain their morphology and proliferate. 
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As far as the author can ascertain, these examples represent a comprehensive list of the 
literature currently available on the polymerisation of vitamin E derivatives. 
Furthermore, to the best of this author's knowledge, the work reported herein represents 
the first example of glycopolymers containing vitamin E moieties. This work is 
described in a European patent application,9 briefly in a recent preprint, 10 and in this 
article 11 • 
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2.2 Results and discussion 
2.2.1 Glycomonomers 
The acetyl protected monomers AcGalEA (la) and AcGalEMA (lb) were synthesised 
by coupling the glycosyl donor 1,2,3,4,6-tetra-0-acetyl-P-D-galactopyranose with the 
glycosyl acceptors 2-hydroxyethyl acrylate and 2-hydroxyethyl methacrylate 
respectively, in anhydrous dichloromethane (DCM) using boron trifluoride diethyl 
etherate (BF3Etz0) as the Lewis acid glycosidation promoter. 12- 15 There are a number 
of other effective promoters reported in the literature (e.g. trimethylsilyl 
trifluoromethanesulfonate (TMSOTf), 16• 17 tin chloride (SnC14) 18• 19 and iron chloride 
(FeCh)20• 21 ). The reaction between the acetylated sugar and the alcohol is specific for 
the P-anomer due to neighbouring group participation of the 2-0Ac group. The reaction 
proceeds as follows: 
---l~ H 
OAc 
H H 
H 0------o~ ------ H 
H H R 
H 
R = H (I a), Me (lb) 
Figure 2.3 - Glycosidation of galactose pentaacetate 
Monomers la and lb were purified by flash column chromatography. Product la was 
recovered as a colourless white solid, while product 1 b was a colourless viscous oil, 
both in reasonable yield ( 44 and 41% respectively). Both products were characterised 
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by IR and NMR spectroscopy, mass spectrometry, elemental analysis and polarimetry. 
Both monomers were soluble in a range of organic solvents. 
yo 0~~0 H 
-0 
HO I O~~O H 
-----< HH lH 0 ~ 
0 O~ H 
R 
O~~O H 
0 __.-:;::; ---
H 
R 
H 
O~~O H 
H 0 __.-:;::; 
M~H H 
R 
R = H (la, 2a), Me (lb, 2b) 
Figure 2.4 - De-acetylation of galactosyl monomers 
The de-acetylation of monomers la and lb was achieved by addition of catalytic 
quantities of sodium methoxide in methanol (see Figure 2.4). Despite monitoring the 
reaction closely by TLC (acetonitrile:water, 9:1 ), it was not possible to achieve 
quantitative yields as there is a tendency for the acrylic ester to cleave during the 
reaction. The de-acetylated products both have Rr values of~ 0.5, while the cleavage 
product has an Rr = 0.2. The mechanism for cleavage is shown below in Figure 2.5. 
When the evolution of the spot for the cleaved product wass observed by TLC, the 
reaction was stopped by adding the cation exchange resin (DOWEX® 50WX2-200). 
This results in a mixture of products ranging from a small amount of fully acetylated 
product, through partially acetylated, fully de-acetylated and cleaved product and 
therefore necessitated purification by flash column chromatography 
(chloroform:methanol, 8:2). This yielded products 2a and 2b as clear colourless oils 
(72% and 92% respectively). It is noteworthy that it was possible to recover these 
monomers by freeze-drying from aqueous solution, however for reasons that are not 
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entirely apparent the product yielded is generally insoluble in any solvent. It appears 
that during the freeze-drying process the monomers either polymerise or become highly 
crosslinked due to hydrogen bonding interactions. Attempts to solubilise these 
materials in the presence of urea (known to disperse H-bonded networks) were 
unsuccessful. 
OR' 
OR' 
H 
OH O~~r>\) H 
H . 0) ~ 
MeO~ H 
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MeOH 
Figure 2.5- Cleavage of galactosyl monomers 
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These monomers were fully characterised by NMR and IR spectroscopy, mass 
spectrometry, elemental analysis and polarimetry. There was no evidence of protecting 
groups from either 1H or 13C NMR spectra. In addition the absence of the carbonyl 
absorption bands in the region 1760-1745 cm-1 of the IR spectra supported this. 
2.2.2 a-Tocopheryl monomers 
The synthesis of monomers 3a and 3b (see Figure 2.6 - Strutures of a-tocopheryl 
monomersbelow), based on the anti-oxidant molecule a-tocopherol was achieved by 
reaction of a-tocopherol with acryloyl or methacryloyl chloride5 respectively, in 
anhydrous DCM in the presence of base (triethylamine). The reactions were monitored 
using TLC (Rr = 0.66, DCM) and both products were purified by flash column 
chromatography (DCM) to yield yellow viscous oils in good yields (86 and 78% 
respectively). Both monomers were fully characterised by IR and NMR spectroscopy, 
mass spectroscopy and elemental analysis. 
The synthesis of such molecules for use in free radical polymerisation may initially 
appear counter intuitive, since the presence of anti-oxidants in a free radical 
polymerisation could retard or inhibit the polymerisation. Indeed the use of a-
tocopherol for such a purpose is the subject of a US patent application 1• In the case of 
-67-
Chapter 2 -Vitamin E Polymer Synthesis 
a-tocopherol, its anti-oxidant mechanism requires the phenolic alcohol, and so the 
monomer can be considered as a "protected" anti-oxidant. 
3a 
0 
3b 
Figure 2.6- Strutures of a-tocopheryl monomers 
2.2.3 Scale-up 
It is noteworthy that the synthesis of both the galactose and vitamin E bearing 
monomers has been successfully scaled to >50 g scale in house and during the course of 
the project was scaled-up further by an external company. The reaction proceeded well 
and yields were notably high. In these examples, however, the product was not purified 
further by flash chromatography prior to use. In this case the ability to crystallise these 
monomers would have been very useful as this would have offered an easier method 
from which highly pure monomers could be obtained, but to date this has only been 
shown for a glucose monomer (AcGlcEMA). 13• 22 
2.2.4 Polymers 
The primary objective of the polymer synthesis was to obtain water soluble polymers 
containing P-D-galactose and a-tocopherol residues. A large number of copolymer 
syntheses were attempted, initially focussing on polymers of AcGalE(M)A and 
VE(M)A and deprotecting these materials post-polymerisation. Unfortunately this was 
fraught with difficulties and although some copolymers were synthesised, none of these 
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had the required water solubility. As such, further characterisation of these materials 
was not conducted. 
However, in addition to the problems associated with product solubility, a number of 
other factors were highlighted during these reactions. Work by Ortiz et al. 
demonstrated the synthesis of a-tocopheryl methacrylate and showed that it could be 
homopolymerised, albeit not to high conversion (ca. 40%).5 They have also 
demonstrated the synthesis of copolymers of VEMA with HEMA. Their work indicated 
that based on the reactivity ratios of these two monomers, VEMA is more likely to react 
with HEMA than with itself, leading to the conclusion the VHV triads are far more 
likely than VVV or VVH for example.5• 7 
Having achieved little success with copolymers, focus turned to terpolymer systems 
which contained sugar and vitamin E moieties, in addition to a third hydrophilic 
monomer, aimed at imparting the required aqueous solubility. The initial choice of this 
third monomer was HEMA. Rather surprisingly, this work was not very successful, as 
the materials obtained were not only insoluble in water but, in many cases, were also 
insoluble in any solvent. In order to understand the reason(s) for this, two 
homopolymerisations of HEMA were attempted in parallel, one using a commercially 
available sample and the other using HEMA that was distilled prior to use. The 
monomers were dissolved in acetone with AIBN (1.5 wt%) and heated at 50°C for 24 
hours. Both reactions yielded seemingly identical but insoluble white solids, although 
the material obtained from the sample of distilled HEMA did appear to swell slightly in 
water. It was suggested that this could be a result of transesterification, 23 which was 
resulting in the in situ generation of dimethacrylates which were in turn cross-linking 
the polymers and rendering them insoluble. 
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0 
0~ 
0 
Figure 2. 7 - Mechanism of dimethacrylate formation from HEMA 
The mechanism above demonstrates clearly that purification of HEMA prior to use may 
not be sufficient to avoid such impurities being present as they can form spontaneously. 
Indeed the problem is not limited to HEMA but can occur as an intermolecular reaction 
between HEMA and AcGalE(M)A or GalE(M)A or indeed between two sugar 
monomers (see Figure 2.8 & Figure 2.9). 
OR' 
OR' 
R' = H, OAc; R= H, CH3 
Figure 2.8- Transesteritication of HEMA with sugar monomers 
- 70-
Chapter 2- Vitamin E Polymer Synthesis 
OH 
OH 
OH 
OH 
0~0H 
R=H, CH3 
Figure 2.9- Intermolecular transesterification of sugar monomers 
These reactions go some way to explaining the insolubility of some of the polymers. 
A voiding transesterification may not be possible; however it is possible to avoid the 
generation of di-functional monomers, and thus avoid crosslinking of the polymer, by 
adding methanol as a co-solvent during polymerisation. The methanol becomes 
involved in the transesterification reactions instead of other monomer molecules, which 
in tum results in the formation of methyl (meth)acrylate as shown in Figure 2.1 0. 
RO 
~OH + )yo" 
0 
Figure 2.10- "Trick" to avoid formation of di-functional monomers 
Having overcome the problems associated with crosslinking, the preparation of a series 
of terpolymers 4a-12a (poly[2-(2 '3 '4' 6' -tetra-0-acetyl-~-D-galactosyloxyl)ethyl 
acrylate-ter-a-tocopheryl acrylate-ter-2-( dimethylamino )ethyl acrylate]) was attempted. 
These polymers contained DMAEA as the solubility promoter, in place of HEMA, since 
DMAEA can become protonated in aqueous conditions and thus aid solubility. These 
were obtained as off-white powders by polymerisation of la, 3a and DMAEA at 
various ratios (Table 2.1) with AIBN in DMF at 50°C for 24 hours. The use of 
methanol as a co-solvent in the polymerisation was not employed in these reactions, 
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since the protected sugars are not able to trans-esterify. 1H and 13C NMR spectra of 
these materials proved that there were no vinyl protons or carbons remaining. 
la 3a DMAEA 
(mg) (mmol) (mg) (mmol) (mg) (mmol) 
4a 15 0.034 15 0.031 270 1.89 
Sa 30 0.067 15 0.031 255 1.78 
6a 60 0.134 15 0.031 225 1.57 
7a 15 0.034 30 0.062 255 1.78 
Sa 30 0.067 30 0.062 240 1.68 
9a 60 0.134 30 0.02 210 1.47 
lOa 15 0.034 60 0.124 225 1.57 
lla 30 0.067 60 0.124 210 1.47 
12a 60 0.134 60 0.124 180 1.26 
Table 2.1 - Polymer feed ratios for parallel polymer syntheses 
It is important to remember that these polymers are not easily characterised. In general 
terms, polymers can be more difficult to characterise by conventional means such as 1 H 
and 13C NMR due to their solution behaviour compared to small molecules (e.g. long 
relaxation times, leading to peak broadening and poorer resolution). This is exacerbated 
for polymers 4a-12a because they contain three different monomer units. Subsequently 
peak broadening leads to overlapping peaks, which in tum makes a definitive 
characterisation difficult. Furthermore, during dialysis an insoluble brown residue was 
observed in most cases. Some of this was isolated and identified by 1 H NMR as 
containing unreacted VEA. Nevertheless, the choice of monomers meant that typically 
there were areas in the 1H NMR spectrum that were unique for each monomer, which 
enabled a tentative conclusion that all three monomers were incorporated. For polymers 
4a-12a many of the spectra were very similar, which was to be expected, since these 
materials only differed in the ratio of the three components. 
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-------.----,--
5 3 2 1 0 ppm 6 5 4 3 
Figure 2.11- 1H NMR spectra of polymers 9a & Ita 
However, before these materials could be assessed for their biological activity, it was 
first necessary to deprotect the sugar moieties. This is not as straightforward as 
deprotecting the monomer, since the reaction is not easily monitored (TLC is not 
possible, and 1 H NMR ambiguous since the methyl acetate by-product of the reaction 
has peaks in a similar region to residues of the protected sugar). As a result, it is not 
possible to determine when the polymer has been fully deprotected, which results in an 
ill-defined polymer. The effect of pre/post-polymerisation deprotection of homo-
glycopolymers is discussed by Ambrosi et a!., 13 where it was concluded that better 
defined polymers were obtained by deprotecting the monomer rather than the polymer. 
The extent of deprotection can be assessed qualitatively by weighing the polymer before 
and after deprotection since there should be a resultant weight loss due to loss of the 
acetyl groups. 
An additional problem associated with this method of glycopolymer synthesis is that, 
during the deprotection, it is possible to cleave sugar/tocopherol or DMAEA residues 
from the backbone, since they are all attached by ester linkages, which are susceptible to 
attack by methoxide. Despite polymers 5b-12b all being water soluble, yields were 
low, and there was not sufficient material to perform meaningful biological 
experiments. Indeed the few experiments that were conducted tentatively suggested that 
there was very little uptake of vitamin E by the cells. This may be due in part to the fact 
that many of the sugar residues may still have been mono- or di- acetylated and 
therefore interaction with cellular receptors was not optimal, or (and possibly just as 
likely) that there was simply not enough material present initially to give a measurable 
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amount of vitamin E. These aspects will be discussed in more detail in later chapters. 
Indeed it is possible that some of the sugar residues were removed during deprotection. 
What is noteworthy is that although the sugar residues were acetyl protected, it was 
possible to dissolve these polymers in water. This vindicates the choice of DMAEA as 
the solubility enhancing monomer. 
In order to avoid the problems associated with post-polymerisation deprotection, 
polymer 13 was synthesised. Poly[2-(P-D-galactosyloxyl)ethyl acrylate-fer-a-
tocopherol acrylate-ter-2-( dimethylamino )ethyl acrylate] was obtained by the 
terpolymerisation of la, 3a and DMAEA in a mixture of anhydrous DMF and methanol 
using AIBN as the free radical initiator at 65°C for 24 hours. The crude product was a 
brown tar, which after purification by dialysis resulted in an off-white solid in good 
yield (64%). As expected this polymer was readily soluble in water and the 1H NMR 
spectrum indicated that all three monomer components had been incorporated. The 
broad peak at around 0. 7 ppm is due to the methyl protons on the aliphatic chain of the 
a-tocopheryl moiety. From 3-3.8 ppm there are broad signals relating to the protons on 
the ring of the sugar moiety and at around 4.2 ppm there is a broad signal due to one of 
the CH2 groups ofthe DMAEA, see Figure 2.12. 
The result of elemental analysis did not match the expected values based on monomer 
feed, however this is easily explained. Although all three monomers were acrylates, it 
is likely that the reactivity ratios of these monomers would be quite different. In 
addition, the a-tocopheryl monomer is hindered due to steric factors. As previously 
mentioned, there was often evidence of unreacted a-tocopheryl monomer during the 
dialysis process, manifested as a brown insoluble material which floated on the 
dialysate. With this in mind, it would perhaps be possible to calculate the composition 
more accurately, by analysing the insoluble residues after dialysis. The biological 
activity of this material will be discussed in more detail in a later chapter. 
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Figure 2.12- 1H NMR spectrum of 13 
Following on from the relative success of polymer 13, a second analogous material was 
synthesised (13- 13.5 mol% 2a: 7.9 mol% 3a: 78.7 mol% DMAEA c.f 14 -14.2% 2b: 
12.9 mol% 3a: 72.9 mol% DMAEA). The reaction of DMAEA, 3a and 1b with AIBN 
in a mixture of anhydrous DMF and methanol at 70°C for 24 hours gave polymer 14 
after purification of the crude material by dialysis and recovery by freeze drying. As 
expected this material was water soluble and analysis by 1H NMR showed many 
similarities to that of the spectrum of 13. Once again there were many broad 
overlapping peaks making a thorough interpretation extremely difficult, however 
distinctive regions were once again visible. 
1111 1 1111 1 1111 1 1111 1 1111 11111 11111 11111 11111 1 1111 1 1111 1 1111 11111 
5.5 5.0 4.5 4.0 3.5 3 {) 2.5 2.0 1.5 1.0 {) 5 01>""' 
Figure 2.13- 1H NMR spectrum of 14 
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The methyl groups on the aliphatic chain of the a-tocopheryl residues give rise to the 
signal at around 0.7 ppm. From -3-3.8 ppm are peaks resulting from the sugar ring 
protons, and at 4.30 there is a broad resonance relating to one of the DMAEA CHz 
groups. 
The reason why this spectrum is so poorly resolved is doubtless due, to some extent, to 
the very high molecular weight of this polymer, which is in the order of millions. 
Aqueous GPC analysis gave the molecular weight values as: Mn (8.65 ± 0.34) x 105; 
Mw (2.73 ± 0.11) x 106; Mz (1.15 ± 0.14) x 107. This is in good agreement with the 
results of chloroform GPC analysis: Mn 9.65 x 10 ; Mw 3.63 x 106; Mz 7.64 x 106• 
These results suggest polydispersities of 3.16 and 3.76 respectively, which are also in 
reasonable agreement. Clearly it is expected that the PD of a random terpolymer 
prepared by conventional free radical polymerisation would not be narrow, as is 
illustrated not only by the values but by the shape of the chromatograms. 
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Figure 2.14- Chromatogram from chloroform GPC: red = refractive index; green = light 
scattering; blue = differential pressure (viscosity) 
Once again the elemental analysis was not exactly as predicted based on the monomer 
feed; however this is due to the reasons expressed earlier. It would appear that there has 
been a lesser incorporation of the DMAEA monomer in this material, since the amount 
of nitrogen found by elemental analysis is lower than expected. In order to gain a better 
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understanding of the level of Vitamin E present in the polymer, it was studied by UV 
spectroscopy. 
In order to assess the amount of a-tocopherol present in the polymer, the extinction 
coefficient of a-tocopheryl acetate in acetone was established from solutions of known 
concentration. This was then used to back-calculate the concentration of cx.-tocopheryl 
monomer in the polymer. 
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Figure 2.15- Calibration curve for a-tocopheryl acetate 
The equation of the line shown above was found to bey = 1960. 5x. (i.e. the extinction 
coefficient, E = 1960.5 g·' em·' L since the path length was 1 em). This equation can be 
used to calculate the amount of vitamin E present in a solution of the polymer. From a 
solution of polymer of known concentration and known volume, it is possible to relate 
an absorbance value to a molar concentration of cx.-tocopheryl moiety. This can in tum 
be converted to a value in terms of weight per unit vo lume. Using this procedure a 
value of 36 wt% of Vitamin E in the polymer was calculated. Using this information 
combined with the elemental analysis information, we can tentatively suggest that the 
composition was different from the monomer feed, such that the level of incorporation 
of DMAEA was lower than expected and the level of vitamin E slightly higher than 
expected. However there are two further complicating factors. Firstly it is possible that 
despite taking care to ensure that the polymer was rigorously dry prior to elemental 
analysis, it is possible that the polymer (being so hygroscopic) could have some water 
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associated with it. Additionally, as described earlier, there is a mechanism by which 
methyl methacrylate could be formed through the transesterification of methanol and 
sugar monomer. This could in turn be incorporated into the polymer (albeit in small 
amounts) meaning that technically the polymer is a quaterpolymer. 
Despite these apparent problems it is interesting to note that the incorporation of the 
vitamin E component remained consistent during subsequent syntheses as is illustrated 
in Figure 2.16. 
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Figure 2.16- UV absorption curves for 3 different samples of polymer 14• 
As in the case of the sugar and vitamin E monomers, the synthesis and purification of 
this material was successfully scaled-up to a kilogram scale. Large scale-dialysis was 
achieved using a continuous circulation flow-through system. 
2.2.5 Concluding Comments 
In summary, monomers of galactose and vitamin E were synthesised according to 
methods previously described in the literature.5• 12-15 A range of polymers were 
synthesised which contained both sugar moieties and vitamin E. Unfortunately, many 
of these materials were unsuitable for the intended application either due to their 
• The magenta line represents a sample synthesised by the author, the blue line is a sample synthesised in 
a scaled-up synthesis by an external contractor. The dotted line represents a sample also synthesised by 
the author but the reading was recorded on a different spectrometer. 
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inherent insolubility in water, or poor in vitro activity. As such these materials were not 
studied more fully. Two polymers (13 and 14) were synthesised which contained the 
two essential components, and were found to be soluble in a range of solvents, 
including water. These were analysed by a number of analytical techniques and 
ultimately assessed for activity within biological systems. The results of the in vitro/in 
vivo work will be discussed in a later chapter. 
The ability to synthesise glycopolymers suitable for drug delivery applications has been 
demonstrated. These systems can be considered as prototypes as there are many 
potential areas for improvement such as the use of controlled polymerisation techniques 
to produces materials of defined molecular weight and/or architecture. Research into 
the controlled polymerisation of glycomonomers is described in a number of literature 
articles and theses. 24-27 
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2.3 Experimental 
2.3.1 Materials 
1 ,2,3,4,6-Penta-0-acetyl-P-D-galactopyranose (98% ), a-tocopherol (a-T, 97% ), boron 
trifluoride diethyl etherate (purified, redistilled), 2-hydroxyethyl acrylate (HEA, 96%), 
2-hydroxyethyl methacrylate (HEMA, 99+%), acryloyl chloride (98+%), methacryloyl 
chloride (98+%), 2-dimethylamino ethyl acrylate (DMAEA, 98%), 2-dimethylamino 
ethyl methacrylate (DMAEMA, 98%), anhydrous methanol (99.8%), anhydrous N,N-
dimethylformamide (99.8%), and cation exchange resin DOWEX® 50WX2-200 were 
purchased from Aldrich. Azoisobutyronitrile (AIBN, 97%) was obtained from BDH, 
and purified by recrystallisation from methanol prior to use. Dichloromethane (DCM) 
was distilled over calcium hydride under N2, HEMA, HEA, acryloyl chloride and 
methacryloyl chloride had inhibitor removed prior to use by passing through a plug of 
basic alumina. All other chemicals were used without further purification. 
2.3.2 Instrumentation 
NMR-spectra were recorded on a Varian Unity 300, Varian Mercury 200 or Bruker 
A vance 400 spectrometers; all chemical shifts were referenced to residual solvent as an 
internal standard. Infrared (IR) spectra were obtained using a Perkin Elmer 1600 Series 
FTIR spectrometer with samples prepared as either Nujol mulls or potassium bromide 
discs. Mass spectra were obtained using a Micromass Platform spectrometer in 
ionisation mode ES+. UV spectra were measured on either a Shimadzu UV-2101PC 
spectrophotometer, or a ATI Unicam UV/VIS UV2 spectrophotometer, in stoppered 
quartz cuvettes with a 1 em path length. Optical rotations were measured on a Jasco P-
I 020 Polarimeter. Chloroform GPC analyses were carried out using a Viscotek TDA 
301 with a Plgel 10).! MIXED-B column connected to a triple detection system, with a 
flow rate of 10 ml min-1 and an injection volume of 100 )..tl. Samples analysed by 
aqueous GPC, were determined by aqueous size exclusion chromatography coupled to a 
Water 410 RI detector and a Wyatt DAWN DSP MALLS, using a TSK GMPW 
column. The mobile phase consisted of 80% water, 20% methanol, 0.05 M NaN03 and 
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2.5 ml r1 1.0 M NaOH at a flow rate of 0.8 ml min" 1• Molecular weight averages were 
calculated using Astra 32 software. Elemental analyses were obtained with an Exeter 
Analytical Inc. CE-440 Elemental Analyser. Lyophilised products (dialysis membrane 
MWCO 12-14 kDa) were obtained using a Christ ALPHA-1-4 freeze-dryer with a 
LDC-1 M controller. 
2.3.3 Synthesis of monomers and polymers 
2.3.3.1 2-(2', 3', 4', 6'-tetra-0-acetyl-~D-galactosyloxy/)ethyl acrylate, AcGa/EA 
(la) 
A mixture of I, 2, 3, 4, 6-~-D-galactose pentaacetate (5 g, 12.8 mmol), 2-hydroxyethyl 
acrylate (1.5 g, 12.8 mmol), molecular sieves (10 A, 10 g) in anhydrous 
dichloromethane ( 40 ml) was stirred under an atmosphere of nitrogen at 0°C. A 
solution of boron trifluoride diethyl etherate (1 0 ml, 78.8 mmol, 6 eq.) in anhydrous 
dichloromethane (30 ml) was then added drop wise, with stirring, to the reaction 
mixture. The mixture was then allowed to further react overnight at room temperature 
under a flowing nitrogen atmosphere. 
The solution was subsequently washed with distilled water (3 x 40 ml) and the organic 
layer dried over magnesium sulphate. After filtration and evaporation, the product was 
purified by flash chromatography (ethyl acetate:hexane, 2:8, increasing to 4:6), giving 
product la (2.5 g, 44%) as a white solid. 
- 81 -
Chapter 2 -Vitamin E Polymer Synthesis 
H 0~ 0 11a 0 H 15~ 0 
0 H11b 
13 H 
[a] 0 = -6.55 (c = 5.90, CHCh), (C 19H26012, Expected: C 51.12; H 5.87, Found: C 50.96; 
H 5.76), IR (Nujol mull, cm-1): 3066 (med.) =CH; 2980, 2966, 2887 (med.) -CH; 1747 
(sharp) -C=O; 1637 (sharp) -C=C; C-0-C (sharp) 1295, 1220, 1174, 1065. 1H NMR 
(CDCh, 200 MHz): 1.97-2.14 (4s, 3H13, 3H 15, 3H17, 3H19), 3.81 (m, 1H7, 1\8 = 5.0 Hz, 
125 = 11.6 Hz), 3.89 (t, 1H5, 1\6 = 6.4 Hz), 4.0 (m, 1H7, 137_8 = 3.81 Hz, 127 = 11.7 Hz), 
4.10 (m, 2H6, 136-5 = 6.4 Hz, 126 = 12.8 Hz), 4.30 (m, 2Hs, 13s-7 = 5.0 Hz, 12s = 10.5 Hz), 
4.50 (d, 1H1, 1\2 = 7.8 Hz), 4.97 (dd, 1H3, 1\4 = 3.4 Hz, 133-2 = 10.4 Hz), 5.17 (dd, 
1H2, 132-1 = 7.9 Hz, 132-3 = 10.4 Hz), 5.37 (d, 1H4, 134-3 = 3.3 Hz), 5.83 (d, 1Hllb, 1311 b-IO 
=10.3 Hz), 6.10 (dd, 1HIO, 13to-lla = 17.7 Hz, 13to-llb = 10.3 Hz), 6.43 (d, 1Hlla, 13lla-IO = 
17.2Hz). 13C NMR (CDCh, 100 MHz): 20.8-20.9 (C 13, C15, C 17, C19), 61.5 (C6), 63.5 
(C8), 67.2 (C4), 67.6 (C7), 68.8 (C2), 70.9 (Cs), 71.0 (C3), 101.5 (C,), 128.3 (C10), 131.5 
(C11), 166.1 (C9), 169.5-170.6 (C12, C,4, C,6, C,s). MS (ES+): rnlz = 469 (M++Na). 
2.3.3.2 2-(2', 3', 4', 6'-tetra-0-acetyl-P-D-ga/actosy/oxyl)ethyl methacrylate, 
AcGalEMA (lb) 
A mixture of 1, 2, 3, 4, 6-P-o-galactose pentaacetate (5.00 g, 12.8 mmol), 2-
hydroxyethyl methacrylate ( 1.67 g, 12.8 mmol), molecular sieves ( 10 A, 10 g) in 
anhydrous dichloromethane ( 40 ml) was stirred under an atmosphere of nitrogen at 0°C. 
A solution of boron trifluoride diethyl etherate (1 0 ml, 78.8 mmol, 6 eq.) in anhydrous 
dichloromethane (30 ml) W(lS then added drop wise, with stirring, to the reaction 
mixture. The mixture was then allowed to further react overnight at room temperature 
under a flowing nitrogen atmosphere. 
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The crude material was purified as described in 2.3 .3 .1 giving product 1 b (2.4 g, 41%) 
as a colourless oil. 
18 
A 11 0 0 
20~0 
191 
0 
H 0~ 0 11a 0 H ~ 0 H~H 0 16 
0 13 0 H11b 
14 12 
[a]0 = -0.3 (c = 0.50, CHCh), (C20Hzs012, Expected: C 52.17; H 6.13, Found: C 51.70; 
H 6.10), IR (Nujol mull, cm-1): =C-H (med.) 3066; -C-H (med.) 2980,2996, 2889; C=O 
(sharp) 1758, 1744, 1720; C=C (sharp) 1637; C-0-C (sharp) 1246, 1170, 1078, 1056. 
1H NMR (200 MHz, CDCh): 1.94 (s, 3Hl2), 1.97, 2.00, 2.03, 2.14 (s, 3H14, 3H16, 3H1s, 
3H20), 3.79 (m, IH7, 1\s = 4.6 Hz, 127 = 11.3 Hz), 3.86 (m, 1Hs, 136-5 = 6.2 Hz), 4.02 
(m, IH7), 4.11 (m, 2H6), 4.27 (m, 2Hs, 13s-7 = 4.5 Hz, 128 = 7.6 Hz), 4.52 (d, 1H1, 131_2 = 
7.8 Hz), 4.95 (dd, 1H3, 133-4 = 3.3 Hz, 1\z = 10.3 Hz), 5.16 (dd, 1Hz, 13z_ 1 = 7.9 Hz, 132_3 
= 10.4 Hz), 5.32 (d, 1H4, 134_3 = 3.3 Hz), 5.58 (s, IHIJb), 6.12 (s, 1H11 a). 13C NMR (100 
MHz, CDCh): 18.16 (C,z), 20.55 20.47 (C14, C,6, C,s, Czo), 61.2 (C6), 63.4 (Cs), 66.9 
(C4), 67.3 (C7), 68.6 (Cz), 70.7 (Cs), 70.8 (C3), 101.2 (C,), 125.8 (CJO), 136.0 (C 11 ), 
167.0 (C9), 169.3, 170.2, 170.3, 170.8 (C13, C,s, C11, C,9). MS (ES+): m/z = 483 
(M++Na). 
2.3.3.3 2-(P-D-ga/actosy/oxy/)ethyl acrylate, GalEA (2a) 
1a (1.0 g, 2.2 mmol) was dissolved in 10 ml of anhydrous methanol, and stirred under 
N2 for approximately I 0 minutes. Subsequently, 20 ml of sodium methoxide solution 
[0.0 I M, in MeOH] was added. The solution was stirred at room temperature, and the 
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reaction monitored by TLC (acetonitrile:water, 9:1, Rf= 0.5). The reaction was stopped 
after 25 minutes when the formation of a cleavage product was observed (Rf = 0.2). 
Cation-exchange resin (DOWEX 8W50) was added to neutralise the solution. The resin 
was removed by filtration and the crude product was obtained after evaporation of the 
solvent. The material was purified by flash chromatography (chloroform:methanol, 8:2) 
to afford product 2a (0.45 g, 72%) as a colourless, viscous oil. 
H 0~ 0 11 a HO H 
H 0 
H11b 
H 
[a] 0 = +7.2 (c = 0.29, H20), (C11H1sOs, Expected: C 47.48; H 6.52, Found: C 47.56; H 
6.42), IR (Nujol mull, cm-1): -OH (broad) 3385; =CH (med.) 3304; -CH (sharp) 2935, 
2888; -C=O (sharp) 1718; C=C (sharp) 1637; C-0-C (sharp) 1299, 1216, 1146. 1H 
NMR (200 MHz, CD30D): 3.32 (m, 1H2, J32~3 = 10.9 Hz), 3.50 (dd, 1H3, J34_3 = 3.1 Hz, 
J\_3 = 10.9 Hz), 3.54 (m, 1H5), 3.63 (m, 2H6), 3.74 (d, lH4, J34_3 = 3.1 Hz), 3.82 (m, 
1H7), 3.97 (m, 1H7), 4.24 (m, 2Hs), 4.30 (d, 1HI, J31-2 = 6.6 Hz), 5.88 (d, 1H11b, J311b-IO = 
10.3 Hz), 6.16 (dd, 1Hto, J311a-IO = 17.2 Hz, J311b-IO = 10.3 Hz), 6.41 (d, 1HIIa, J311a-10 = 
17.3 Hz). 13C NMR (D20, 100 MHz): 61.1 (C6), 64.3 (C8), 67.9 (C7), 68.8 (C4), 71.0 
(C2), 72.8 (Cs), 75.3 (C3), 103.2 (C1), 127.5 (Cto), 132.8 (C11), 168.5 (Cg). MS (ES+): 
m/z = 301 (M++Na). 
2.3.3.4 2-(fl-D-galactosyloxyl)ethyl methacrylate, GalEMA (2b) 
1b (1.0 g, 2.2 mmol) was treated as described in section 2.3.3.3, resulting in product 2b 
(0.59 g, 92%) as a viscous colourless oil. 
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0\-----\ 
0 
[a]o = +18 (c = 0.15, H20), (C12H2oOs, Expected: C 49.31; H 6.9, Found: C 49.09; H 
6.82), IR (Nujol mull, cm-1): -OH (broad) 3427; =C-H (med.) 3018; -C-H (med.) 2936, 
2897; C=O (sharp) 1718; C=C (sharp) 1636; C-0-C (sharp) 1251, 1162, 1077, 1044. 
1H NMR (200 MHz, CD30D): 1.93 (s, 3H12), 3.4 (m, 1H2), 3.49 (m, 1H3), 3.52 (m, 
1Hs), 3.72 (m, 2H6), 3.82 (d, 1H4, 134-3 = 3.1 Hz), 4.05 (qd, 2H7, 137_8 = 4.1 Hz, 127 = 
11.5 Hz), 4.22 (m, 2Hs), 4.29 (d, 1HI, 132-I = 7.8 Hz), 5.63 (s, 1Hllb), 6.15 (s, 1 H11 a). 
13C NMR (100 MHz, CD30D): 17.6 (C12), 61.0 (C6), 64.6 (Cs), 68.0 (C7), 68.7 (C4), 
70.8 (C2), 72.9 (C3), 75.3 (Cs), 103.3 (C1), 127.2 (C 10), 135.9 (C1 I), 169.8 (C9). MS 
(ES+): m/z = 315 (M++Na). 
2.3.3.5 a-Tocopheryl acrylate, VEA (3a) 
a-Tocopherol (6.20 g, 14.4 mmol) and triethylamine (2.64 ml) were dissolved, with 
stirring in anhydrous DCM (75 ml) under N2 and cooled to 0°C. Acryloyl chloride 
(1.64 ml, 20.2 mmol) was then added dropwise with stirring. The solution was stirred 
for a further 10 minutes at ooc and then allowed to reach room temperature. The 
reaction was monitored by TLC (Rf: 0.66, DCM). Once the reaction was deemed to be 
complete, the solution was washed (3 x 50 ml 0.1 M NaOH, 3 x 50 ml water), and the 
organic layer dried over magnesium sulphate, and filtered. The solvent was removed in 
vacuo and the residue purified by flash chromatography (DCM) to yield product 3a 
(5.95 g, 86%) as a yellow oil. 
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H 21a 
, .. "Y~( 15 24~ 9a sa 1a 
H 0 11 
24b 
19a 12 10 6 1b 
18a 
(C32H520 3, Expected: C 79.29; H 10.81, Found: C 79.03; H 10.73), IR (Nujol mull, cm-
1): =C-H (med.) 3055; -C-H (med.) 2925, 2867; C=O (sharp) 1743; C=C (sharp) 1637; 
C-0-C (sharp) 1232, 1159, 1109, 1081. 1H NMR (250 MHz, CDCh): 0.82 (m, 3H1b, 
3Hia, 3Hsa, 3H9a), 1.07-1.37 (m, 2H11, 2Hw, 1H9, 2Hs, 2H7, 2H6, 1Hs, 2H4, 2H3, 2Hz, 
1HI), 1.4 (m, 3Hl3a), 1.54 (m, 2Hl2, J312-11 = 6.6 Hz), 1.80 (m, 2HI4, J31s-14 = 6.7 Hz), 
1.99 (s, 3Hisa), 2.03 (s, 3HI9a), 2.10 (s, 3H2la), 2.6 (t, 2His, J314-I5 = 6.7 Hz), 6.0 (dd, 
1H24a, J324a-23 = 10.4 Hz, J224a-24b = 1.4 Hz), 6.3 (dd, 1H23, J323-24b = 17.3 Hz, J323-24a = 
10.4 Hz), 6.6 (dd, 1H24b, J3z4a-23 = 16.8 Hz, J2z4a-24b = 1.4 Hz). 13C NMR (125 MHz, 
CDCh): 12.1 (C2la), 12.3 (Cisa), 13.2 (CI9a), 19.9 (Csa), 20.0 (C9a), 20.6 (Cis), 21.3 
(CII), 22.9 (Cia), 23.0 (Cib), 24.2 (CBa), 24.7 (C7), 25.1 (C3), 28.2 (CI), 31.3 (C14), 32.9 
(Cs), 33.0 (C9), 37.5 (C4), 37.6 (C6), 37.7 (Cs), 37.8 (CIO), 39.6 (C2), 40.2 (C 12), 75.3 
(C13), 117.7 (CI6), 123.3 (C21), 125.2 (C19), 127.0 (Cis), 128.1 (C24), 132.4 (C23), 140.5 
(Czo), 149.7 (C 17), 165.0 (C22). MS (ES+): m/z = 507 (M++Na). The a-Tocopherol is a 
racemic mixture, and the assignments were done with reference to the work of Ortiz et. 
al..s 
2.3.3.6 a-Tocoplteryl methacrylate, VEMA (3b) 
a-Tocopherol (2.5 g, 5.8 mmol) and triethylamine (0.84 ml) were dissolved, with 
stirring in anhydrous DCM (20 ml) under N2 and cooled to 0°C. Methacryloyl chloride 
(0.74 ml, 7.5 mmol) was then added dropwise with stirring. The solution was stirred for 
a further 1 0 minutes at ooc and then allowed to reach room temperature and left to react 
overnight. Subsequently, the solution was washed (3 x 25 ml 0.1 M NaOH, 3 x 25 ml 
water), and the organic layer dried over magnesium sulphate, and filtered. The solvent 
was removed in vacuo and the residue purified by flash chromatography (DCM} to yield 
product 3b (2.20 g, 78%) as a yellow oil. 
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24 21a 
'~H,JyO 25~ 9a 5a 1a 
0 11 H 
25b 
19a 10 6 1b 
18a 
(C33H540 3, Expected: C 79.46; H 10.91, Found: C 79.33; H 10.80), IR (Nujol mull, em· 
1): =C-H (med.) 3052; -C-H (med.) 2954, 2932, 2866; C=O (sharp) 1733; C=C (sharp) 
1637; C-0-C (sharp) 1246, 1142, 1107. 1H NMR (200 MHz, CDCh): 0.88 (m, 3H1b, 
3Hia, 3H5a, 3H9a), 1.10-1.30 (m, 2Hll, 2HIO, 1H9, 2Hs, 2H7, 2H6, 1Hs, 2H4, 2H3, 2H2, 
lH1), 1.38 (m, 3Hl3a), 1.53 (m, 2Hl2), 1.77 (m, 2H14, 1315-14 = 6.8 Hz), 1.99 (s, 3Hisa), 
2.03 (s, 3HI9a), 2.10 (s, 3H2la), 2.11 (s, 3H24), 2.60 (t, 2His, 1314-15 = 6.8 Hz), 5.80 (t, 
1 H25a, 1325b-25a = 1.6 Hz), 6.40 (s, 1H2sb)- 13C NMR (125 MHz, CDCh): 11.8 (C21a), 
12.1 (Cisa), 12.9 (CI9a), 18.5 (C24) 19.6 (Csa), 19.7 (C9a), 20.6 (Cis), 21.0 (C11), 22.6 
(Cia), 22.7 (Cib), 23.9 (Cl3a), 24.4 (C7), 24.8 (C3), 28.0 (C1), 31.0 (C14), 32.7 (C5), 32.8 
(C9), 37.2 (C4), 37.3 (C6), 37.4 (Cs), 37.5 (CIO), 39.4 (C2), 40.4 (C12), 75.0 (C13), 117.4 
(C 16), 123.0 (C21), 125.0 (C19), 126.6 (Cis), 126.8 (C25), 135.9 (C23), 140.5 (C20), 149.3 
(C 17), 165.9 (C22). MS (ES+): m/z = 522 (M++Na).5 
2.3.3. 7 Poly{2-(2 '3 '4 '6 '-tetra-0-acetyl-P-D-ga/actosyloxy/)ethyl acrylate-ter-a-
tocoplteryl acry/ate-ter-2-(dimethy/amino)ethy/ acrylate} (4a -12a) 
The syntheses of these 9 terpolymers is summarised in Table 2.1. These were 
synthesised in parallel using a Radley's 12 Station Reaction Carousel mounted on an 
IKA electronic hotplate stirrer. 
The general procedure was as follows: 
A solution of 2a (15 mg, 0.034 mmol), a-tocopheryl acrylate (15 mg, 0.031 mmol), 
DMAEA (270 mg, 1.89 mmol) and AIBN (4.5 mg, 1.5 wt% w.r.t. monomers) in 
anhydrous DMF (0.9 ml, 30 wt% monomer solution) was prepared. The solution was 
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degassed and then heated at 50°C under an atmosphere of nitrogen, with stirring, for 24 
hours. 
la 3a DMAEA 
(mg) (mmol) (mg) (mmol) (mg) (mmol) 
4a 15 0.034 15 0.031 270 1.89 
Sa 30 0.067 15 0.031 255 1.78 
6a 60 0.134 15 0.031 225 1.57 
7a 15 0.034 30 0.062 255 1.78 
8a 30 0.067 30 0.062 240 1.68 
9a 60 0.134 30 0.02 210 1.47 
lOa 15 0.034 60 0.124 225 1.57 
lla 30 0.067 60 0.124 210 1.47 
12a 60 0.134 60 0.124 180 1.26 
Table 2.1- Polymer feed ratios for parallel polymer syntheses 
Subsequently the solvent was removed in vacuo, the crude residue was re-dissolved in 
THF and precipitated into petroleum ether (40°C- 60°C b.p.). The resulting precipitate 
was collected by filtration, dissolved in distilled water, purified by dialysis against 
distilled water (using a Dispo-dialyser, MWCO 1000) and lyophilised, giving the 
polymer as an off-white powder. The product was stored under vacuum in a desiccator 
over phosphorous pentoxide. 1H NMR spectra were characteristic of polymer samples, 
broad over-lapping peaks were evident. The product yields and molecular weights are 
shown for in Table 2.2. 
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Yield GPC (DMF) 
(mg) (%) Mn Mw 
Sa 81 27 7360 7380 
6a 132 44 12700 17600 
7a 30 10 12500 13100 
8a 159 53 9950 14800 
9a 102 34 6350 14500 
lOa 99 33 5630 9840 
lla 39 13 7650 12900 
12a 120 40 7580 15500 
Table 2.2 - Yield and molecular weight of polymers prepared with carousel reactor 
2.3.3.8 De-acetylation ofterpolymers Sa -12a (5b- 27b) 
The de-acetylation of the polymer series Sa-12a is summarised in Table 2.3. With the 
exception of 12a, all of the de-acetylations were carried out in the Radley's 12 Station 
Reaction Carousel on an IKA hotplate stirrer. 
Yield 
(mg) NaOMe [O.OJM] (ml) (mg) (%) 
Sa 38.4 0.1 19.6 51 
6a 67.7 0.2 42.7 63 
7a 15.1 0.05 2.0 13 
8a 65.1 0.1 26.0 40 
9a 41.8 0.2 20.9 50 
lOa 42.8 0.05 15.4 36 
lla 13.5 0.1 3.5 26 
12a 61.0 0.2 48.0 79 
Table 2.3- Summary of De-acetylations 
A general procedure was as follows: 
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Samples were dissolved in anhydrous methanol (5 ml) to which the sodium methoxide 
solution was added (at the volume shown in Table 2.1) and stirred under an atmosphere 
of nitrogen for 2 hourst. Subsequently DOWEX® 50WX2-200 cation exchange resin 
was added to remove Na + ions. After stirring for approximately 15 minutes, the 
solution was filtered and the solvent removed in vacuo. The crude polymer was then 
dissolved in water and lyophilised. This yielded the products as off-white powders. 
2.3.3. 9 Poly{2-(~D-ga/actosyloxyl)ethyl acrylate-ter-a-tocophery/ acry/ate-ter-2-
(dimethy/amino)ethy/ acrylate] (13) 
A solution of 2a (150 mg, 0.539 mmol), 3a (150 mg, 0.309 mmol), DMAEA (450 mg, 
3.14 mmol) and AIBN (11.3 mg, 1.5 wt% w.r.t. monomers) in a mixture of anhydrous 
DMF (1.8 ml) and anhydrous methanol (0.45 ml) was prepared. The solution was 
degassed (via the freeze, pump, thaw method) and then heated at 65°C under an 
atmosphere of nitrogen, with stirring, for 24 hours. 
Subsequently the solvents were removed in vacuo, the crude material re-dissolved in 
distilled water, purified by dialysis against distilled water (1000 MWCO membrane), 
and lyophilised to yield polymer 13 (674 mg, 64 %) as a cream powder. 
(-(2a)J3.5-(3ah.9-(DMAEAhs.r, Expected: C 64.41; H 9.3; N 3.5, Found C 61.5; H 8.7; N 
3.9), IR (KBr, cm-1): -OH (broad) 3422; -CH (med.) 2946, 2929, 2868; -C=O (sharp) 
1734; -CH (sharp) 1459; -CH3 (med.) 1380. 1H NMR (200 MHz, D20, significant 
peaks): 0.71 (broad s, 3H9a, 3Hsa, 3Hia, 3Hib, tocopheryl group), 3.04-3.80 (sugar ring 
protons), 4.17 (broad, CH2-CH2-0-, DMAEA). 
2.3.3.1 0 Poly{2-( ~D-ga/actosyloxyl)ethyl methacrylate-ter-a-tocophery/ acry/ate-ter-
2-(dimethy/amino)ethy/ acrylate} (14) 
A solution of 2b (217 mg, 0.74 mmol), 3a (325 mg, 0.67 mmol), DMAEA (542 mg, 
3.79 mmol) and AIBN (16.3 mg, 1.5wt% w.r.t monomers) in a mixture of anhydrous 
methanol (0.65 ml) and anhydrous DMF (2.6 ml) was prepared. After degassing, the 
t CF27 was reacted on its own initially to establish an appropriate duration for the reaction. This reaction 
was stopped after I hour and 15 minutes. 
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solution was stirred under nitrogen at 70°C for approximately 24 hours. The solvents 
were removed under vacuum, the residue dissolved in water, purified by dialysis against 
de-ionised water (1000 MWCO) and lyophilised to yield polymer 2 (820 mg, 76 %). 
[a] 0 = -1.7° (c = 25, MeOH), (-(2b)t4.2-(3a) 12.9-(DMAEA) 72.9-, expected C 63.0; H 9.2; 
N 4.9, Found C 60.71; H 8.9; N 3.7); IR (KBr, cm- 1): -OH (broad) 3422; -CH (med.) 
2950, 2927, 2867; -C=O (sharp) 1734; -CH (sharp) 1458; -CH3 (med.) 1380. 1H NMR 
(200 MHz, D20, significant peaks): 0.70 (broad s, 3H9a, 3Hsa, 3Hia, 3Hib, tocopherol 
group), 3.04-3.82 (sugar ring protons), 4.30 (broad, -CH2-CH2-0-, DMAEA). GPC 
(H20): Mn (8.65 ± 0.34) X 1 05; PD = 3.2; GPC (CHCh): M0 9.65 X 105; PD = 3.8. 
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3 Vitamin E polymer properties 
3.1 Introduction 
This chapter investigates some of the physical properties of polymer 14, the preparation 
of which is described in Chapter 2. Whilst it is primarily the biological properties of 
this material that are of most interest in the context of this research, some of the 
physical properties are worthy of mention, and could themselves be relevant in certain 
biological systems, or indeed provide possible alternative methods to the type of drug 
delivery system being investigated. 
The components of the polymer being studied help to impart certain physical properties. 
Firstly, the fact that the polymer contains both hydrophilic and hydrophobic 
components could give rise to micellar behaviour, although one must bear in mind that 
the polymer was prepared via standard free radical methods and not by controlled 
radical polymerisation, thus the structure is most likely random in nature and will not 
possess well-defined blocks. Nevertheless, any observed aggregation of these types of 
polymers could offer the possibility of micellar drug delivery systems, where 
metabolites that are not easily modified such that they can be polymerised, could simply 
be trapped within a polymeric micelle. 
There are several characterisation techniques relevant in this area: atomic force 
microscopy (AFM); light scattering; scanning electron microscopy; and qualitative 
micellisation studies. 
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3.2 Results and Discussion 
When preparing aqueous solutions of glycopolymers containing vitamin E, they were 
observed to froth when agitated. This qualitative observation presented the possibility 
that these materials may be surface active. Previous work by Ambrosi 1' 2 had reported 
critical aggregation concentrations (CACs) for surface active homoglycopolymers, 
therefore it was highly conceivable that terpolymers containing hydrophilic and 
hydrophobic components could also be surface active. Furthermore, work conducted by 
this author3 had indicated that polymers containing DMAEMA were surface active in 
certain circumstances. Specifically, random copolymers of DMAEMA and MMA at a 
molar ratio of 50:50 were shown to reduce the surface tension of water from 0.071 Nm-1 
to 0.061 Nm-1 at 25°C at a polymer concentration of 1.8 gdm-3. 
As a result of this observation, and based on the results previously reported, a number of 
experiments were conducted, which were designed to demonstrate whether or not these 
materials were also surface active. 
Firstly, it was decided to measure the CAC, therefore, a series of solutions of accurate 
concentration were prepared, and analysed by dynamic light scattering. Each sample 
was analysed 6 times and an average value taken. The CAC is calculated by monitoring 
the number of particles counted during each scan. In very dilute solutions, one would 
expect very few counts to be observed, while in more concentrated solutions, it is more 
likely that the light will be scattered by aggregated material, and hence the number of 
counts will be increased. By plotting the number of counts per second against 
concentration, one can establish the CAC. 
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Figure 3.1 depicts a plot of counts per second against concentration for polymer 14. At 
this scale the location of the CAC is not immediately obvious. The CAC can be 
calculated in two ways. If the graph is plotted accurately then the CAC can be read 
from the graph as the point were the two lines intersect. Alternatively, the CAC can be 
obtained by setting the equations of the two lines equal to each other and solving for x. 
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Figure 3.2- Intersection of the two lines on the CAC graph for 14 
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The CAC of 14 can be obtained approximately by inspecting Figure 3.2. The lines 
intersect at approximately 0.025 mg/ml. This can be verified and stated more accurately 
by solving the equations. The equation of the red line is: 
y = 10.325x + 0.238, (1) 
The equation of the blue line is: 
y = 19.626x. (2) 
Therefore for the same value of y, x = 0. 026. This value is in good agreement with the 
visual interpretation of the graph. 
The light scattering experiment not only indicates the CAC but also gives an indication 
of the size of the aggregates that are present in solution at the various concentrations. 
Obviously the particle size is not monodisperse, i.e. there is a distribution of particle 
sizes. This information can be used to gain an average size of the aggregates. The 
average particle size is obtained from a plot of signal intensity against diameter (nm) on 
a log scale. This gives a unimodal plot for each concentration, which in tum gives the 
average particle size. Above the CAC the average particle size was found to be ~ 30 nm 
(see Figure 3.3 below). This data would suggest that the ESEM images shown later in 
this chapter (obtained from the spin-coated samples), do not contain any meaningful 
information. 
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Figure 3.3- Particle size (nm) distributions for aqueous solutions of 14 
3.2.1 Micellisation 
One area of interest under the heading of drug delivery is the use of micelles or vesicles 
to deliver drugs to a target cell or organ. The idea is to create a material which has 
hydrophilic character on the outside of the spherical particle, perhaps with targeting 
groups attached, and a hydrophobic core. The hydrophobic core is then able to trap a 
hydrophobic "drug" inside and essentially protect it until it reaches its target, where-
upon it is released. In the context of this report, our aims were to produce soluble linear 
polymers with our "drug", in this case Vitamin E, bound to the polymer backbone by an 
enzymatically cleavable linker. However, in light of the results of the CAC 
measurement which suggest that the polymer forms aggregates in aqueous solution at a 
concentration above 0.025 mg/ml, it was of interest to assess, at least qualitatively, if 
such a micellar delivery system was possible.4-8 
To each of two vials containing approximately 10 ml of water was added approximately 
250 mg of Sudan Red dye. One of the vials also had polymer 14 added at a 
concentration of 0.04 mg/ml. Both vials were stirred/shaken vigorously for 1 hour, then 
left to settle. This process was repeated for a number of days in order to disperse the 
solid dye in the aqueous solution, the sealed vials were left at room temperature for 3 
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weeks. Subsequently, the remaining insoluble material was removed from both vials by 
filtration, and the two samples were compared. The polymer solution was observed to 
have solubilised some of the water-insoluble dye, giving a pink colouration to the 
polymer solution. The vial containing water only was colourless. 
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Figure 3.4- Micellisation of water insoluble dye in solution of 14 
Spurred on by the interesting observations obtained from light scattering studies and 
dye solubilistation it was decided to assess the behaviour of the polymer when 
concentrated onto a surface. In order to determine whether or not spherical (or 
approximately) spherical particles were formed, atomic force microscopy (AFM) was 
attempted. As discussed earlier, the material was soluble in a range of solvents. This 
afforded the opportunity to use a volatile organic solvent for the purposes of spin 
coating. Two concentrations of polymer solution (in chloroform) were used to prepare 
samples. Solutions of 0.1 mg/rnl and 0.01 mg/ml of polymer solution were spotted onto 
the surface of the AFM disks (steel AFM discs coated with HOPG) and spin coated. 
These disks were analysed by AFM in tapping mode, to avoid deformation of the 
material by the AFM tip. In both cases images were obtained which demonstrated the 
formation of "spherical" aggregates, i.e. shapes either approximating to spheres or 
spheres further aggregated together. The size of these basic aggregates was found to be 
in the region of7-10 nm. 
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Figure 3.5- AFM image of 14 at a concentration of 0.1 mg/ml· 
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Figure 3.6- AFM image of 14 at a concentration of 0.01 mg/ml* 
• Atomic Force Microscopy (AFM) analysis of polymer 14. Samples (from 0.1 mg/ml and 0.01 mg/ml 
solutions) were measured in tapping mode using an etched silicon probe on a Nanoscope IV, spring 
constant (k): 20-100 Nm"1, resonant frequency: 200-400 kHz, nominal tip radius of curvature: 5-l 0 nm, 
cantilever length: 125 1-!ffi, cantilever configuration: single beam, no reflective coating. 
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The samples used to produce the above images were also examined briefly by 
environmental scanning electron microscopy, in so-called "low vacuum" mode. This 
mode avoids the need to sputter samples with gold prior to analysis as the build up of 
charge on the surface of the sample(s) is dissipated by the low level of water vapour (ca. 
0.4 Torr) introduced into the chamber. The images obtained indicated the presence of 
both large and small aggregates. Work by Ambrosi 1 had suggested that a core-shell 
type structure could be observed from ESEM images of glycohomopolymers. The 
ESEM images of this material appeared to show something similar, however whilst 
such structures may be present it is not possible to draw this conclusion from the images 
obtained. It is possible that the images observed are a result of glowing of the sample 
due to electronic bombardment. 
a) 
b) 
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Figure 3.7- ESEM images of 14 spin coated onto HOPG substrate at, a) IOOOx and b) 8000x 
As was previously discussed and will be seen from further data, these images are far too 
large to represent polymer aggregates and possibly show that there is still water present 
in the sample. Since analysis of dry, spin-coated samples was inconclusive, samples 
were subsequently analysed in wet mode. 
Since the images obtained in low vacuum mode had been inconclusive, a number of 
images were also obtained in "wet mode" of the ESEM, using 3 concentrations of 14 in 
water (40 mg/ml, 1 mg/ml and 0.1 mg/ml). At higher concentrations it appears that the 
polymer forms a continuous layer rather than discrete spherical particles, although it is 
conceivable that this layer is composed of closely packed spherical particles (Figure 3.8 
& Figure 3.9). 
Figure 3.8- ESEM image of 14 at a concentration of 40 mg/ml, IOOOX magnification 
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Figure 3.9- ESEM image of 14 at a concentration of 40 mg/ml, 2000X magnification 
Very little structural detail is present in these samples, although it was clear from the 
analysis which areas of the sample stub contained polymer and which did not, as the 
metal glows white in the electron beam. Indeed the size of the structural effects 
observed in the above images is of a similar order of magnitude to those images 
obtained in low vacuum mode. 
At lower concentrations, there is evidence that as the polymer is dehydrated, spherical 
particles form and these tend to self-associate into larger aggregates (Figure 3.1 0). This 
is not entirely surprising, and is in agreement with the results observed by light 
scattering. 
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Figure 3.10- ESEM image of 14 at a concentration of 1 mg/ml, 1577X magnification 
This is further illustrated by increasing the magnification as shown in Figure 3.11 and 
Figure 3.12 below. 
Figure 3.11 - ESEM image of 14 at a concentration of 1 mg/ml, 3154X magnification 
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Figure 3.12- ESEM image of 14 at a concentration of 1 mg/ml, 6308X magnification 
Images such as these are similar to those obtained for glycopolymers investigated by 
Ambrosi. 1 A further reduction in the initial concentration of polymer solution placed in 
the sample stub on the Peltier stage did not result in further detail or resolution in the 
1m ages. 
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3.3 Concluding remarks 
Whilst the focus of this thesis is on the biological aspects of these types of polymeric 
species, it is important to investigate their physical properties, which may in some 
instances be important in their application. Polymer 14 was found to be surface active, 
which is probably due in part to the presence of a cationic species in the polymer, but 
may also be attributed to the mixture of both hydrophilic and hydrophobic components 
along the polymer backbone (i.e. the sugar and vitamin E moieties). The fact that 
images obtained from more concentrated polymer solutions indicated layers of polymer 
rather than spherical aggregates is understandable when one considers the effect of 
allowing a solution of polymer to evaporate in the atmosphere. In this case a waxy 
residue is formed, which may explain those images. However, by reducing the 
concentration and keeping some water vapour in the microscope chamber, it was 
possible to visualise spherical particles. Such images were also obtained for other 
materials, and will be discussed in detail later. 
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3.4 Experimental 
Polymer 14 was prepared as described in Chapter 2. Sudan Red B (dye content 97%) 
was purchased from Aldrich and was used without further purification. Highly ordered 
pyrolytic graphite 03389 (10 mm x 10 mm x 2 mm) was purchased from Agar 
scientific. 
3.4.1 Atomic Force Microscopy (AFM) 
The instrument used to obtain the AFM images of polymer 14 was the MultiMode™ 
Nanosope IV (MM-SPM) manufactured by Digital Instruments. The images were 
obtained using Tapping Mode AFM. 
Laser adjustment knobs 
Figure 3.13- MultiModeTM Nanoscope IV (MM-SPM) 
Tapping mode was chosen as the samples are quite soft. In contact mode such samples 
would easily be deformed, thus giving inaccurate results. Tapping mode AFM uses a 
stiff crystal silicon probe which is oscillated at its resonant frequency . This gives the tip 
the required energy to break free of surface tension forces. As the name suggests, in 
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tapping mode the tip is not in permanent contact with the sample, but only comes into 
contact with the surface at the lowest point of the tip's oscillation. 
Figure 3.14- SEM image of a TappingMode AFM crystal silicon tip attached to a vibrating 
cantilever9 
However, the tip is very brittle and without care it can easily be broken during use. In 
order to avoid this, the AFM uses highly sophisticated software with a number of user 
editable parameters, which must be correctly set in order to ensure safe operation. 
3.4.1.1 Sample preparation 
Double sided adhesive tape was placed on a steel sample disk ( 15 mrn diameter). On 
top of this, a piece of HOPG was placed by pressing the two surfaces together (HOPG 
and adhesive), and then peeling away the HOPG. This leaves a very thin layer of 
HOPG behind on the steel disk. 
The sample was dissolved in chloroform and applied to the HOPG surface by spin 
coating. It was then mounted onto the magnetic stage and the tip lowered into position 
electronically. 
Obtaining AFM images can be difficult, and is affected by a number of factors e. g. 
choice of substrate, sample concentration, etc. The choice of substrate and coating 
teclmique came as a result of work previously carried out by Mason 10. He observed, as 
had been previously reported, 11 ' 12 that optimal sample preparation was paramount if 
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successful visualisation of samples was to be achieved. Initial attempts by Mason, to 
obtain images from samples coated onto silicon substrate proved fruitless. 10 It was 
suggested that this was as a result of poor adhesion between the silicon and the polymer, 
as weak interactions can lead to poor images being obtained. 1° For this reason HOPG 
was chosen as it was suggested that graphite may interact more strongly with any n-
alkyl groups present in the sample. Polymer concentrations of between 0.01 mg/ml and 
0.001 mg/ml had proved to be optimal, combined with the use of HOPG as the 
substrate, therefore the experiments described herein were designed with this insight in 
mind. 
Polymer 14 was dissolved in chloroform at a concentration of 0.01 mg/ml and 0.1 
mg/ml. Polymer solutions were applied to the graphite substrate and spin-coated at 
2000 rpm for 2-3 minutes. The parameters for AFM measurements were as follows: 
Atomic Force Microscopy (AFM) analysis of polymer 14. Samples (from 0.1 mg/ml 
and 0.01 mg/ml solutions) were measured in tapping mode using an etched silicon 
probe on a Nanoscope IV, spring constant (k): 20-100 Nm-1, resonant frequency: 200-
400 kHz, nominal tip radius of curvature: 5-10 nm, cantilever length: 125 lim, cantilever 
configuration: single beam, no reflective coating. 
3.4.2 Light Scattering 
The critical aggregation concentration (CAC) and particle size measurements were 
measured using a ZetaPlus Zeta Potential Analyser, with BI-MAS Multi Angle Sizing 
Option, manufactured by Brookhaven Instruments Limited. A series of aqueous 
solutions was prepared from very low concentration (0.004 mgmr1) to "high" 
concentration (1 mgmr1). These were filtered prior to analysis using PALL Acrodisc® 
Syringe Filters (0.2 lim HT Tuffryn® Membrane), in order to remove large dust 
particles, placed into cuvettes and analysed. 
The technique used is called photon correlation spectroscopy (PCS) of quasi-elastically 
scattered light (QELS), which is based on correlating the fluctuations of the average, 
scattered laser light intensity. According to the manufacturer, this system offers many 
advantages: 
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• Run speed ( 1 to 2 minutes) 
• Accuracy (±1% for monodisperse samples) 
• No calibration required 
• Suitable for measuring particles, polymers, emulsions, colloids etc., in a range of 
solvents. 
The principles behind the measurement are as follows. There is a light detector at a 
fixed angle with respect to the incident light beam, and at a fixed distance from the 
scattering sample (i.e. the sample containing light scattering particles). The light that is 
scattered by the particles reaches the detector. The particles will be moving randomly 
in the liquid (as a result of diffusive Brownian motion), and the distance travelled by the 
scattered waves from the particle to the detector will vary as a function of time. These 
waves will either interfere constructively or destructively, depending on the distance 
travelled. This results in an average intensity with superimposed fluctuations (Figure 
3 .15). The decay times of these fluctuations are related to the diffusion constants and 
therefore, the particle size. Small particles lead to faster decaying fluctuations than 
larger particles. The decay times can be determined by either a spectrum analyser 
(frequency), or in this case using a correlator (time). 
In essence the correlation works by assuming that if two variables are highly correlated, 
then a change in one can be used to predict a change in the other. The software used is 
not only able to calculate the particle size based on these correlations but has the 
advantage of an algorithm to remove erroneous results caused by dust. 
Scattering 
Intensity 
Time 
Figure 3.15- Fluctuations about the average scattered intensity 
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3.4.3 ESEM 
Environmental scanning electron microscope images were obtained using a FEI Philips 
XL30 Environmental Scanning Electron Microscope, in low vacuum mode. The 
samples used in this mode were the same as those used for AFM analysis. 
Images were also obtained in "wet mode". These experiments were carried out using 
the same microscope, this time with a Peltier sample stage and gaseous secondary 
electron detector (GSED), to produce the images. Samples were placed in a metallic 
stub (1 em diameter, 0.5 em depth), and the temperature was controlled by the Peltier 
cooling stage using water/propanol as the coolant. A drop of sample was placed on the 
stub and the chamber pumped down to a pressure of approximately 4 Torr. The sample 
was monitored during evacuation by means of the in situ CCD camera, and was found 
to be stable (i.e. no boiling of the sample was observed). The samples were cooled to 
~2°C and surrounded by water vapour at a pressure of~ 3 Torr. The accelerating 
voltage and spot size were 15kV and 5.0 respectively. 
3.4.4 Solubilisation 
Polymer 14 was dissolved in high purity water at a concentration of 0.04 mg/ml. To 
this solution, Sudan Red (250 mg) was added. This mixture was vortexed and shaken 
vigorously for several hours each day over a period of 3 weeks, before removing the 
insoluble dye particles by filtration. The solution was then photographed and compared 
with a sample of high purity water treated in exactly the same way, with the exception 
of the addition of polymer. 
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4 Biological experiments with multi-component 
polymers 
4.1 Introduction 
It is commonplace in both research laboratories and AI stations to assess the condition 
of sperm cells at various stages e.g. immediately after ejaculation, prior to insemination 
or at intervals in between. When doing so it is normal to consider the so called "sperm 
quality parameters" which allow the cells to be benchmarked. These parameters include 
appearance, assessment of cell motility (including quality of movement\ cell viability, 
cellular morphology, as well as the volume of the ejaculate and its concentration. The 
results of these studies provide invaluable information for the commercial user, who 
does not wish to inseminate with immotile cells, but also provide useful data to the 
researcher on how the environment or additives affect the cells compared with control 
samples. Although there are a number of valuable semen evaluation methods/tests 
widely used, there is no substantial evidence that a particular test (or tests) can predict 
semen fertility. So whilst predicting poor quality semen is relatively easy, 
differentiating between medium and high fertility samples in not simple. 
In addition to the standard sperm quality parameters, additional analyses were necessary 
when the cells were incubated with the novel polymer systems. These studies included: 
vitamin E assays; oxidative stress measurements; confocal microscopy; effect of 
polymers on the post-thaw motility of bull semen; effect of polymers on post-sortt 
motility; effect of Prospem1 TM ± polymer on boar semen. 
• Motility is first scored as a percentage of the cells that are moving. In addition, the quality of this 
movement is given a score (from 0-4) which further indicates whether or not the cells are swimming, fast 
and in straight lines (4), or moving slowly on the spot (0). Motility is generally scored subjectively, but 
can also be measured by computerised systems such as CASA {Computer Assisted Sperm Analysis). 
t This term refers to semen which has been separated into X andY chromosome bearing cells using a 
Cytomation Moflo® flow cytometric sorter. 
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4.2 Results and discussion 
Two polymers were selected from the range synthesised to be used in the biological 
assessment of these materials. Ultimately, after a number of experiments this was 
reduced to one polymer and the focus of the work remained on this material. These 
polymers contained vitamin E since it had been shown that the inclusion of vitamin E in 
vitro had beneficial effects on the sperm quality parameters1• It is worth pointing out 
that vitamin E cannot be added directly to the ejaculate due to its lack of solubility in 
the aqueous medium ofthe extended semen. 
4.2.1 Motility and viability studiest 
Polymer 13 was assessed in several in vitro experiments. Initial experiments focussed 
on two main aspects, namely cellular motility, and the cells' ability to resist oxidative 
stress. However, since these systems were entirely novel, the amount of polymer 
required was unknown, therefore, many initial experiments were needed to optimise 
fully the concentration of polymer required for effective treatment. 
One of the first experiments conducted with polymer 13 monitored the motility and 
viability of boar sperm cells against untreated control samples, in a commercial diluent 
(BTS) at l8°C over a 6 day period. The polymer-treated samples had a polymer 
concentration of 0.2 mg/ml. Unfortunately this resulted in a statistically significant 
decrease in cellular motility, and although the number of live cells was similar between 
the two groups, there were statistically more dead cells after 6 days of incubation. 
t Unless otherwise indicated, biological parameters were assessed by Dr. Andre Maldjian, Department of 
Veterinary Medicine, University of Milan. 
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Table 4.1 - Percentage of motile cells over time± 0.2 mg/ml of polymer 13 
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Figure 4.1 -Percentage of motile cells over t ime± 0.2 mg/ml of polymer 13 
Table 4.2- Percentage of viable cells± 0.2 mg/ml polymer 13 (determined by eosin staining) 
Control Polymer 
Day %Live %Dead %Damaged %Live %Dead %Damaged 
1 71 ± 2.8 18 ± 0.9 11 ± 1.9 71 ± 2.8 18 ± 0.9 11 ± 1.9 
3 74 ± 5.3 12 ± 2.3 14 ±3 .7 83 ± 1.2 10 ± 1.0 7 ± 2.2 
6 74 ± 3.0 9 ± 2.2 17±1.4 75 ± 2.5 15 ± 0.4 10 ± 2.8 
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Figure 4.2- Percentage of viable cells± 0.2 mg/ml polymer 13 (determined by eosin staining) 
From the results shown in Table 4.1 & Table 4.2, and Figure 4.1 - Percentage of motile 
cells over time ± 0.2 mg/ml of polymer 13& Figure 4.2 it was not clear whether there 
was too much polymer present in solution or not enough. Too much polymer may have 
induced negative effects in terms of motility as a result of causing an imbalance in the 
intracellular osmotic pressure, however since the control samples also showed a fairly 
rapid decline in cellular motility, it is conceivable that the decrease was due to oxidation 
perhaps, in which case more polymer may be required. With this in mind a second 
experiment was conducted, this time using polymer 13 at a concentration of 1 mg/ml. 
This concentration was chosen as it would deliver the equivalent of approximately 0.2 
mg/ml of vitamin E (based on the composition of the polymer). This experiment was 
conducted over 5 days. Once again the polymer treated cells were found to have lower 
motility and viability than those of the control samples. It was hypothesised that the 
reduction in motility could be explained due to the cells being immobilised by 
polymeric material bound to their outer surface, however washing the cells in 
physiological buffer and re-suspending them in BTS did not result in a significant 
improvement in motility (1.3% -7 3%). 
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Table 4.3- Percentage of motile cells± 1mg/ml of polymer 13 
% Motile 
Day Control Polymer 
1 91 ± 1.6 91±1.6 
3 82 ± 1.9 10 ± 4.3 
5 22 ± 6.5 1.3 ± 0.8 
Figure 4.3 - Percentage of motile cells± 1 mg/m l of polymer 13 
Table 4.4- Percentage of viable cells± I mg/m l of polymer 13 
Control Polymer 
Day %Live %Dead %Damaged %Live %Dead %Damaged 
1 80 ± 2.2 12 ± 0.3 8 ± 1.9 80 ± 2.2 12 ± 0.3 8 ± 1.9 
3 76 ± 1 13 ± 1.6 11 ± 0.7 77 ± 1.6 16 ± 2.2 7 ± 3.8 
5 80 ± 3.3 11 ± 1.4 9 ± 1.9 70 ± 2.0 24 ± 3.1 6 ± 1.1 
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Figure 4.4- Percentage of viable cells± I mg/ml of polymer 13 
From the results shown in Table 4.3 & Table 4.4 and Figure 4.3 & Figure 4.4 it is 
obvious that, even at the relatively low concentration of 1 mg/ml, the polymer is 
detrimental to cellular motility. With this in mind an experiment was conducted with a 
polymer concentration of 0.02 mg/ml, i.e. not only lower than the last experiment but 
lower than the first attempted concentration of 0.2 mg/ml. 
Table 4.5 - Percentage of motile cells ± 0.02 mg/ml of polymer 13 
%Motile 
Day Control Polymer 
1 72 ± 1.5 72 ± 1.5 
3 61 ± 3.3 56± 3.4 
5 28 ± 1.8 28 ± 1.9 
8 7 ± 1.2 10 ± 1.5 
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Figure 4.5 - Percentage of motile cells ± 0.02 mg/ml of polymer 13 
From the results shown above in Table 4.5 & Figure 4.5 it is evident that the lower 
concentration of polymer is not having the detrimental effect on motility observed 
previously for the higher concentrations. The differences between the two groups 
(control and polymer) were not found to be statistically significant. Obviously it is not 
possible to compare the motility results exactly from experiment to experiment, not 
least because they were carried out on different days, but also because there is likely to 
be natural variation in the performance of the cells, since each sample is clearly unique. 
The viability of the cells in the presence of the polymer at 1 mg/ml was lower than 
control and furthermore, the number of damaged cells was much higher than those in 
the control samples (see Table 4.4 and Figure 4.4). In this experiment one would expect 
that since a much lower concentration of polymer was used, this difference should be 
markedly reduced, or perhaps even show a benefit as a result of the polymer 
supplementation. 
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Table 4.6- Percentage of viable cells± 0.02 mg/ml of polymer 13 
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Figure 4.6- Percentage of viable cells± 0.02 tng/ml of polymer 13 
As was expected the lower concentration of polymer resulted in better results in terms 
of cellular viability. The number of live cells had decreased significantly on day 5 for 
the control samples, however a significant decrease in live cells was not observed in the 
polymer treated samples until day 8 (see Table 4.6 and Figure 4.6). Although the 
number of damaged cells was marginally higher for the polymer treated samples, the 
number of dead cells was lower than both control and previous experiments. 
As alluded to earlier, natural variation between samples can have an effect on results. 
The incubations with polymer 13 at 0.02 mg/ml were repeated (see Table 4. 7 and Figure 
4. 7) with a different batch of sperm cells and whilst the general trend was the same as 
the results shown above, the longevity of the cells was markedly increased, although the 
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temperature of incubation was slightly higher in this case (20°C compared with 18°C 
previously). 
Table 4. 7- Percentage of motile cells± 0.02 mg/ml polymer 13 
%Motile 
Day Control Polymer 
1 80 ± 0.7 80 ± 0.7 
3 69 ± 0.8 70 ± 1.7 
5 60 ± 3.6 61 ± 2.0 
8 53± 2.6 53± 1.7 
10 36 ± 5.9 47 ± 2.9 
12 42 ± 2.0 39 ± 3.5 
Figure 4. 7- Percentage of motile cells± 0.02 mg/ml polymer 13 
The motility in both groups is very similar and indeed the cells remain motile for an 
exceptional amount of time compared with typical results. In terms of cellular viability 
there were significantly more live cells in the treated samples on day 8, and the treated 
group remained higher than control from day 8 to day 12. 
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Table 4.8 - Percentage of viable cells ± 0.02 mg/ml of polymer 13 
%Live 
73 ± 1.4 
71 ± 3.2 
74 ± 2.0 
67 ± 1.0 
65 ± 3.1 
60 ± 3.2 
80 
70 
60 
50 
Control 
%Dead 
16 ± 0.6 
18 ± 0.7 
19 ± 2.5 
20 ± 1.0 
22 ± 2.9 
31 ± 1.9 
%Damaged 
11 ± 0.8 
11 ± 3.5 
7 ± 2.7 
13±1.1 
13 ± 2.1 
9 ± 1.5 
%Live 
73 ± 1.4 
72 ± 0.7 
72 ± 0.9 
72 ± 1.4 
68 ± 1.3 
62 ± 2.9 
Polymer 
%Dead %Damaged 
16 ± 0.6 11 ± 0.8 
21 ± 0.5 7±0.4 
23 ± 1.4 5 ± 1.3 
19±1.1 9± 0.7 
19 ± 1.8 13 ± 2.8 
29 ± 4.4 9± 2.2 
• li\€ (control) 
o li\€ (polymer) 
!'A Dead (control) 
~Dead (polymer) 
c 40 
§I Damaged (control) 
DID Damaged (polymer) 
30 
20 
10 
0 
3 5 8 10 12 
Time (days) 
Figure 4.8- Percentage of viable cells± 0.02 mg/ml of polymer 13 
Other experiments were conducted at higher concentrations to ensure that the 
conclusions about the appropriate concentration for a non-detrimental effect on sperm 
quality parameters were correct. The results of these incubations were in good 
agreement with those described above. 
The effect of polymer concentration on cellular motility over several days can be 
considered graphically for the polymer 13. These results must be interpreted with 
caution, since (as has been mentioned already) the fact that the experiments were carried 
out on separate samples introduces natural heterogeneity. 
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Figure 4.9- Summary of cellular motility(%) versus time (days) at various concentrations of 
polymer 13 
This graph illustrates well the natural variation between samples (see day 1), and also 
that lower polymer concentrations do tend to produce better motility results, in spite of 
natural variation. 
As mentioned earlier in the chapter, motility can also be given a score which indicates 
the extent to which the cells are motile. Clearly, for the purposes of fertilisation, a cell 
which is merely moving on the spot, or swimming in tight circles, is not as "fertile" as a 
cell swimming in straight lines. The trend in terms of motility score was the same as for 
motility in general, i.e. at higher polymer concentrations the cells had a lower quality of 
movement compared to control, but at lower concentrations of polymer the motility 
score was the same and on occasion better than control. This observation may indicate 
that when the polymer concentration is higher, it is having an influence on the function 
of the tail, or more particularly an effect on the function of the mid-piece, as this region 
is critical to cellular motility and any damage to this region would be detrimental to 
cellular motility. 
Cellular viability was improved by using lower concentrations of polymer. However a 
more interesting point of observation is that the number of damaged cells was generally 
lower in the samples treated with polymer. The reasons for this are not entirely clear, 
since the number of dead cells was higher in certain instances. It is conceivable that 
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damaged cells were adversely affected by the polymer treatment such that they quickly 
died, and subsequently the number of damaged cells is lower, but the number of dead 
cells is higher. 
Figure 4.10- Summary of live cells(%)± polymer 13 at various concentrations versus time (days) 
Although there clearly are differences between the two groups (treated and untreated, 
see Figure 4.1 0), they were generally not significant as is clearly illustrated in the figure 
shown above. Once again the evidence of natural variation is evident from the day 1 
time point values. 
o Control •0.02 mg/ml 
35 CJ Control 11 0.02 mg/ml (2) 
30 r:.!l Control l'SI0.2 mg/ml 
DIJ Control m 1 mg/ml 
25 
-~ 20 
"C 
Ill 15 CD 
0 
10 
5 
0 
3 5 6 8 10 12 
Time (days) 
Figure 4.11 -Summary of dead cells(%)± polymer 13 at various concentrations versus time (days) 
- 124-
Chapter 4 -Biological Experiments With Multi-Component Polymers 
In this instance the trend is more obviously polymer concentration dependent. For 
lower concentrations of polymer in solution, the number of dead cells appears in general 
to be lower than the control samples (see Figure 4.11 ), however when higher polymer 
concentrations were used the trend is reversed. This emphasises the observations made 
with regard to the effect of polymer concentration on motility. 
Figure 4.12- Summary of damaged cells(%)± polymer 13 at various concentrations versus time 
(days) 
The number of cells damaged appears not only to be influenced by the polymer 
concentration used, but also on the condition of the sample at day 1. For example, 
looking at the green bars in Figure 4.12 above, we can see that over 5 days there is little 
change in the number of damaged cells in both experimental groups, this is also the case 
for the groups represented by the blue lines. These two groups represent the highest and 
lowest polymer concentrations respectively, suggesting that the amount of polymer 
present is not having a noticeable effect on the number of damaged cells. 
It is worth reiterating at this stage that the purpose of this particular polymeric material 
was to prevent oxidative damage to the cells, and that any positive effects on motility or 
viability would be regarded as an additional benefit. However it was obviously of 
importance that the use of the polymer in the semen samples did not have any adverse 
effects on sperm quality parameters, which is why these measurements are of 
paramount importance. 
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Polymer 14 was also subjected to in vitro testing and initially compared with 13. It was 
hypothesised that 14 may perform better than 13 since the former contains more vitamin 
E moiety per unit weight. An initial experiment to assess the performance 14 in 
comparison to 13 and control was conducted using polymer concentrations of 0.02 
mg/ml (see Table 4.9 and Figure 4.13 below). 
90 
80 
70 
- 60 ~ 
e.- 50 
CD 
~ 40 
::!: 30 
20 
10 
Table 4.9- Percentage of motile cells ± 0.02 mg/ml of polymer 
%Motile 
Day Control 13 14 
1 71 ± 3.4 71 ± 3.4 71 ± 3.4 
3 64 ± 3.0 69 ± 4.0 76 ± 2.2 
6 10±1.1 21 ± 4.6 18 ± 4.2 
8 6 ± 1.6 6±3.2 10 ± 3.8 
o Control 
0 +,-~--~~~----L--~~~~-L--~~~-~--L--~~~-~ 
3 6 8 
Time (days) 
Figure 4.13- Percentage of motile cells versus time (days) at polymer concentrations of 0.02 mg/ml 
In general there was not much difference between the groups, although on day 3 the 
cells treated with polymer 14 were significantly more motile than those of the control 
group. This was the only time period where a significant difference was observed. In 
terms of cellular viability there was little difference found between all three groups. In 
this experiment the cellular viability was assessed by fluorimetry rather than by eosin 
staining. The former technique is believed to be more accurate, and is based on 
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recording the number of damaged cells only. The percentage of damaged cells found in 
each group is shown and illustrated in Table 4.10 & Figure 4.14 below. 
Table 4.10- Percentage of damaged cells± polymer 
%Damaged 
Day Control 13 14 
1 11 ± 0.4 11 ± 0.4 11 ± 0.4 
3 10 ± 0.6 10 ± 0.2 11 ± 0.3 
6 18 ± 1.3 21 ± 2.8 23 ± 1.9 
8 26 ± 0.7 26 ± 4.7 30 ± 1.4 
Figure 4.14- Comparison of damaged cells(%) versus time for polymers 13 & 14 at 0.02 mg/ml 
These results are encouraging as there would be no reason to suspect that 14 should 
behave in an entirely different manner to 13. Nevertheless, there was a preference to 
continue further in vitro studies with 14 rather than 13 due to the additional vitamin E 
moieties. Results based on vitamin E uptake by the cells will be discussed in more 
detail later in this chapter. 
The "therapeutic" concentration of 14 was reduced further to deliver the same quantity 
of vitamin E as 13 at 0.02 mg/ml. In this experiment, motility was only assessed until 
day 3 with the focus being on cellular viability and resistance to oxidation (see later). 
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Table 4.11 - Percentage of damaged cells± polymer 14 
%Damaged 
Day Control 0.013 mg/ml 0.02 mg/ml 
1 7 ± 0.2 7 ± 0.2 7±0.2 
3 11 ± 0.4 11 ± 0.7 11 ± 0.6 
6 15 ± 0.6 14 ± 1.3 17 ± 0.7 
8 22 ± 1.4 28 ± 0.4 27 ± 0.3 
Figure 4.15- Comparison of damaged cells(%) after incubation with two concentrations of 
polymer 14 versus time 
These results (Table 4.11 & Figure 4.15) indicated that there were significantly more 
damaged cells in both treated groups on day 8 compared to control samples. It was 
hypothesised that the seemingly more reliable technique of fluorimetry could be 
artificially increasing the value for the polymer treated samples, due to the inherent 
fluorescence of the vitamin E species being released inside the cells. 
Despite the number of damaged cells appearing higher on day 8 in the experiment 
described above, it was accepted that the concentration of 0.013 mg/ml seemed to be 
giving acceptable results in terms of the standard sperm quality parameters. As such 
similar experiments were repeated to assess their reproducibility. Nevertheless it must 
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be reiterated that producing a "typical" or "standard" response curve based on a 
particular polymer concentration is simply not possible due natural variation. 
Cells were incubated± 0.013 mg/ml of 14 over an 8 day period at l8°C in a commercial 
diluent (BTS). The results obtained were very encouraging as both motility values and 
viability values indicated that there were significant benefits in the treated groups at 
various time points throughout the incubation period. 
Table 4.12- Percentage motility± 0.013 mg/ml of polymer 14 
%Motile 
Day Control 14 
1 73 ± 1.7 73 ± 1.7 
3 54± 2.4 66 ± 0.8 
4 54± 3.1 71 ± 2.4 
5 48 ± 1.4 59± 2.4 
6 35 ± 2.0 39 ± 3.8 
8 2± 0.6 5 ± 0.5 
In this particular experiment the cellular motility was significantly different on days 3-5 
and on day 8 (see Table 4.12 & Figure 4.16). Whilst the purpose ofthis material is not 
to boost the motility of the cells, it is encouraging that it is not hindering it. The 
difference is more obvious in the figure shown below. 
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Figure 4.16- Cellular motility± polymer 14 versus time 
In addition to showing potential benefits in terms of motility, in this example there were 
also associated benefits in terms of cellular viability. In contrast to previous results 
where as time progressed during incubations the number of damaged cells increased 
more in the treated group, in this example the number of damaged cells was statistically 
lower from day 6 onwards (see Table 4.13 & Figure 4.17). This makes interpretation of 
this result difficult. 
Table 4.13- Percentage of damaged cells± polymer 14 
%Damaged 
Day Control 14 
I 12 ± 0.2 12 ± 0.2 
3 12 ± 0.3 13 ± 0.3 
4 12 ± 0.4 13 ± 0.2 
5 15 ± 0.4 15 ± 0.7 
6 18 ± 0.4 14 ± 0.3 
8 34 ± 0.6 21 ± 0.2 
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Figure 4.17- Damaged cells(%) versus time (days) incubating with polymer 14 (0.013 mg/ml) 
Another point of consideration was the "shelf-life" of the polymer product and this was 
investigated for polymer 14. In general, polymer solutions were stored frozen and were 
thawed prior to use. One area of concern was the possibility that during storage in 
aqueous solution, some of the ester linkages could be hydrolysed and some of the key 
components (sugar or vitamin E) could be lost. Although there were some differences 
found between samples of "old" (i.e. frozen and thawed > 10 times) and "new" 14, 
these were not found to be significant at all time points. The results are summarised in 
Table 4.14 & Figure 4.18 below. 
Table 4.14- Percentage of motile cells± 0.013 mg/ml of 14 
%Motile 
Day Control "old" "new" 
1 82 ± 3.3 82 ± 3.3 82 ± 3.3 
2 65 ± 2.9 77 ± 1.7 73 ± 1.7 
5 45 ± 2.9 52± 4.4 45 ± 8.7 
7 23 ± 1.7 36 ± 0.1 20 ± 7.6 
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Figure 4.18- Comparison of "old" and "new" batches of 14 effect on motility versus time 
It is interesting to note that although there appeared to be more motile cells in the group 
treated with "old" polymer, this result was not reflected in the viability results which 
actually found more damaged cells in this group (although not statistically more- see 
Table 4.15 & 
Figure 4.19). The reasons for this are not clear, but it was accepted that the storage of 
the material in deep freeze and subsequent thawing and re-freezing was an acceptable 
protocol. 
Table 4.15- Percentage of damaged cells± 0.013 mg/ml of 14 
%Damaged 
Day Control "old" "new" 
22 ± 0.3 22 ± 0.3 22 ± 0.3 
2 23 ± 0.9 22 ± 0.3 24 ± 0.3 
5 26 ± 1.2 25 ± 0.4 26 ± 0.4 
7 22 ± 1.3 25 ± 2.2 16 ± 3.4 
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Figure 4.19- Comparison of "old" and "new" batches of 14 effect on cell damage versus time 
Several other similar experiments have been conducted using polymer 14 in order to 
assess the reproducibility of these results. In general terms, incubation of the sperm 
cells in the presence of this polymer exhibits neither a positive nor negative effect 
(examples of both have been recorded). This is important but of much greater 
importance and interest is the ability of the sperm cells to uptake these glycopolymers 
and make use of the pendant vitamin E groups. These aspects are discussed in more 
detail below. 
4.2.2 Vitamin E Uptake and Oxidative Stress Measurements 
Both polymer 13 and polymer 14 were used to assess the ability of the cells to uptake 
polymer molecules, release vitamin E and subsequently use this additional vitamin E to 
protect themselves against iron-induced oxidation. Having conducted many 
experiments to fine-tune the concentration, the uptake of 13 was measured over a period 
of several days, using a polymer concentration of 0.02 mg/ml. The concentration of 
vitamin E present within the cells was determined by removing approximately 750 
million cells (15 ml) from incubating samples, washing and subsequently lysing them 
and analysing the resulting material by HPLC. HPLC analysis was conducted 
(excitation at 295 nm, emission at 330 nm) on a system fitted with a Hypersil column 
(250 x 4.6 mm, 5 mm) run with 97% MeOH: 3% water (v:v) as an eluent system. Prior 
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to analysis spermatozoa were homogenized and tocopherols extracted as described by 
Dvorska et al. 2 In short, a pellet of 500 x 106 spermatozoa was obtained after two 
centrifugations (2000g for 10 min at 5°C), the pellet was washed and resuspended 
between centrifugations using a physiological solution in order to eliminate all 
contamination from the polymer remaining in solution. Then the pellet was 
resuspended in 0.7 ml of NaCl 0.7% (wt:v) and 1 ml of ethanol with 3 ml of hexane 
were subsequently added and the samples vortexed for 20 s. Samples were centrifuged 
as described above, the hexane layer containing the tocopherols was collected and left in 
the dark. The hexane extraction was repeated thrice (3 ml each time). Finally, samples 
were dried under nitrogen at 40°C, resuspended in methanol and analysed by HPLC. § 
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Time (days) 
Figure 4.20- Uptake of vitamin E versus time± 13 (0.02 mg/ml) after incubation at l8°C over an 8 
day period 
As is clearly visible from Figure 4.20 above, there is a significant and measurable 
difference in the amount of vitamin E present in cells incubated with and without 
polymer. There is no suggestion (despite the appearance of the graph) that the uptake is 
linear, however clearly there is some time related increase for this particular material. 
A similar experiment was conducted for polymer 14, which was incubated at the same 
concentration as 13. As one might expect this led to an even higher concentration of 
vitamin E present within the cells. Again the lines on the graph are purely to aid the 
§These analyses were conducted by Dr Andre Maldjian. 
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visibility of the points and in no way suggest any particular uptake kinetics (see Figure 
4.21). 
~ 3500 l 
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:a, 25oo-~ 
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~ i 1500 I 
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2 1000 l 
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Figure 4.21 -Uptake of vitamin E versus time± 14 (0.02 mglml) after incubation at l8°C over an 8 
day period 
One of the obvious problems with these data is the small number of data points, 
however this is almost entirely unavoidable due to the number of cells available for 
analysis since large numbers are needed for each single analysis and each analysis is 
done in triplicate (at least). Nevertheless, what is of both interest and value is that these 
data suggest (qualitatively at least) that the cells are able to intemalise the polymer, and 
release the vitamin E, by enzymatic means. In order to assess this potential further, 
TBARS3 assays were conducted. Oxidation of the cells was induced artificially by 
incubating in the presence ofFeS04. 
4.2.2.1 Oxidative Stress Measurements 
As already mentioned, the kinetics of uptake are not well understood, and although an 
appropriate dose concentration has been established, these experiments were conducted 
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at a number of different polymer concentrations m order to assess the impact on 
oxidation**. 
In this example, there were 3 experimental groups (control, + 0.02 mg/ml of 14, + 0.1 
mg/ml of 14). These were incubated at 37°C for 2 hours before the addition of FeS04 
[0.8 mM], and incubated for a further hour. The amount of MDA was then assessed 
spectrophotometrically3. 
Table 4.16- Oxidation product after incubation of boar sperm cells for 2 hours with polymer 14 at 
37°C, followed by I hour with FeS04 [0.8 mM[ at 37°C 
MDA (ng/109 cells) 
Control 3789 ± 491 
14 (0.02 mg/ml) 3808 ± 227 
14 (0.1 mg/ml) 2448 ± 232 
Over such a relatively short incubation time, it was only the group treated with the 
higher polymer concentration that was able to reduce significantly the amount of 
cellular oxidation. Although this concentration is in practice too high, due to the knock-
on effects of lower motility and higher cellular damage, it does illustrate that the cells 
are able to intemalise the polymer and release a significant amount of vitamin E over a 
short period of time . 
.. Although in general the procedure was the same, a number of variables were used, for example, the 
amount of time the cells were incubated with polymer prior to oxidation, and the temperature of 
incubation prior to oxidation. 
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Figure 4.22 - Oxidation product after incubation of boar sperm cell for 2 hours with polymer 14 
solutions at 37°C, followed by I hour with FeS04 10.8 mMI at 37°C 
In addition a second experiment was conducted using the lower polymer concentration 
(0.02 mg/ml) and lower temperature (18°C) for a longer incubation period (3 days) prior 
to the oxidative stress. The reason that the higher concentration of polymer was not 
also tested is that the number of live cells may not have been sufficiently high to 
achieve meaningful results, as has been shown previously. 
Table 4.17 - Oxidation product after incubation of boar sperm cells for 3 days with polymer 14 at 
I8°C, followed by I hour with FeS04 10.8 mM I at 37°C 
MDA (ng/1 09 cells) 
Control 11984 ± 630 
14 (0.02 mg/ml) 6198 ± 1360 
One immediately apparent difference between this set of data and the previous set is the 
amount of oxidation in the control sample. This would tend to suggest that the cell s are 
much more vulnerable to oxidation after several days of storage than they are shortly 
after ejaculation. Nevertheless, in the treated group there has been sufficient uptake of 
polymer and release of vitamin E to reduce significantly the amount of oxidation by 
approximately half. 
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Figure 4.23- Oxidation product after incubation of boar sperm cells for 3 days with polymer 14 at 
18°C, followed by 1 hour with FeS04 )0.8 mMI at 37°C 
This shows that when using a lower polymer concentration, more incubation time is 
required in order to get a sufficient/significant amount of vitamin E released within the 
cells. It is likely that the actual incubation time required lies somewhere between 2 
hours and 3 days. 
Similar experiments were conducted this time using a longer incubation period prior to 
the addition of FeS04• This yielded some interesting observations, some of which may 
have been expected, but others which were initially surprising based on previous 
experiments. 
Table 4.18- Oxidation product after incubation of boar sperm cells for 8 days with polymer 14 at 
I8°C, followed by 1 hour with FeS04 )0.8 mM) at 37°C 
MDA (ng/1 09 cells) 
Control 2384 ± 95 
14 (0.02 mg/ml) 4 10 ± 9 
14 (0.0 13 mg/ml) 1119 ± 279 
From these results it is clear that the polymer treatments once again reduce the amount 
of oxidation occurring. However, contrary to the previous experiments, there appears to 
be a greater amount of oxidation in the control after 3 days of incubation compared to 8 
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days. In this example, the overall level of oxidation is comparable with the values 
obtained for oxidation after short incubation time, and much less than the values 
measured after 3 days. This once again indicates the problems associated with the 
natural variation encountered when working with live biological systems. 
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Figure 4.24- Oxidation product after incubation of boar sperm cells for 8 days with polymer 14 at 
18°C, followed by 1 hour with FeS04 J0.8 mMI at 37°C 
Both polymer treated groups significantly reduced the production of MDA compared to 
the control group, which is in good agreement with results obtained previously. 
This experiment was repeated, this time focussing on the lowest polymer concentration 
to ensure the best level of reproducibility possible (i.e. taking natural variation into 
consideration). Again there was a significant reduction in the amount of MDA 
produced after induced oxidation, however once again the overall amount of MDA 
produced in both groups was significantly different compared with previous 
experiments. 
Table 4.19- Oxidation product after incubation of boar sperm cells for 8 days with polymer 14 at 
I8°C, followed by 1 hour with FeS04 J0.8 mMJ at 37°C 
MDA (ng/1 09 cell s) 
Control 5328 ± 421 
14 (0.013 mg/ml) 517 ± 43 
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The polymer reduced the amount of MDA produced to around a tenth of the control 
value. This was statistically significant, and as previously noted, in good agreement 
with the trend previously observed in similar experiments of this natme. 
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Figure 4.25- Oxidation product after incubation of boar sperm cells for 8 days with polymer 14 at 
18°C, followed by 1 hour with FeS04 10.8 mMI at 37°C 
It is of note that, although throughout many experiments comparing the sperm quality 
parameters of control and polymer-treated samples there have been both positive and 
negative results in terms of motility and viability, there has never been a poor result in 
terms of reducing oxidation. This emphasises the actual efficacy of this material in 
vitro - a polymer for the delivery of anti-oxidant to sperm cells. 
However there is a bigger picture to consider. As can be observed from earlier data, 
there is a naturally occurring amount of vitamin E present within boar spermatozoa. 
Polymeric materials such as 13 or 14 aim to increase this through in vitro incubation, 
however it is possible to manipulate this naturally occurring level through dietary 
means. In the context of this report, there was a desire to investigate the effect of these 
polymeric materials on sperm cells that had been enhanced in vivo by feeding boars 
with a specialised food supplement containing a number of essential factors (DHA, 
selenium and vitamin E for example). Previous work has shown that this food 
supplement had benefits in terms of sperm qual ity, and ultimately in terms of fertility. 4-7 
With this in mind, studies were conducted to investigate the differences between boars 
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fed ProSperm™ (the supplement in question) and those on a conventional diet, with and 
without polymer treatment in vitro. 
4.2.3 Effect of feed supplementation and in vitro polymer addition on 
sperm qualitytt 
A small scale study was conducted using 7 boars. There were 3 boars (Marco, Jorg and 
Karl) in the control group and 4 boars (Bruno, Norbert, Leo and Ingo)H in the 
Pro Sperm ™ group, although for the purposes of this experiment the ejaculates from the 
boars in each group were pooled prior to analysis. It is known already4-7 that this feed 
supplementation helps to increase the concentration of sperm cells in the ejaculate, as 
well as improving their motility and viability. Ideally, a positive correlation between 
the sperm improved by feed supplementation and the subsequent in vitro polymer 
supplementation would be observed. This particular study only focussed on cellular 
motility and viability, which although not ideal, does form the basis for further future 
studies. 
There were 4 experimental groups, referred to herein as Control ± polymer and 
ProSperm™ ±polymer. The polymer was included at a concentration of 0.02 mg/ml. 
The results obtained from this study are encouraging (see Table 4.20 & Figure 4.26). 
tt Until indicated otherwise, the experiments detailed from this point onwards were conducted by the 
author. 
H All ejaculates were obtained from standard commercial breeding boars housed according to UK/EU 
standards for artificial insemination centres. The boars were between 9 and 14 months of age and of high 
reproductive capacities. 
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Table 4.20- Percentage motilities measured over 8 days 
Control 
82 ± 3.3 
63 ± 8.8 
63 ± 3.3 
80± 0 
72 ± 1.7 
65 ± 2.9 
54 ± 4.2 
2 
Control + 14 Pro Sperm 
82 ± 3.3 
73 ± 3.3 
77 ± 7.3 
82 ± 1.7 
75 ±1.4 
66 ± 3.0 
62 ± 1.7 
3 
73 ± 1.7 
75 ± 2.9 
73 ± 4.4 
77 ± 4.4 
72 ± 1.7 
66 ± 0.8 
60 ± 0 
• Control 
IZI ProSperm 
4 
Time (days) 
5 
ProSperm + 14 
73 ± 1.7 
78 ± 2.5 
75 ± 2.9 
75 ± 0 
72 ± 1.7 
67 ± 1.7 
63 ± 4.4 
o Control + 14 
lSI ProSperm + 14 
6 8 
Figure 4.26- Percentage motilities measured over 8 days- comparison of control versus ProSperm 
+/- polymer 14 
From these data, the average motilities over the entire 8 day period were calculated and 
found to be as follows. 
Table 4.21 - Average motilities over the 8 day incubation period 
Motility(%) 
Control 69 ± 3.7 
Control+ 14 74 ± 2.9 
Pro Sperm 71 ± 2.2 
ProSperm + 14 72 ± 1.9 
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Whilst it is acknowledged that these results are not statistically significant, there does 
appear to be a tentative trend. Furthermore, these results corroborate earlier 
experiments which identified this polymer concentration as having no negative effect on 
the sperm quality parameters of motility and viability. What is interesting is that the 
control group appears to perform marginally better than the Pro Sperm ™ group 
(although once again the lack of a statistical difference is acknowledged). 
Another interesting observation (although it is treated with caution due to the lack of 
statistical significance) is apparent when plotting the data in Table 4.20 and applying 
linear trendlines, the two control groups appear to have parallel trend lines, with the 
polymer treated group being above the standard control. Such an obvious trend is not 
visible for the ProSperm™ groups, however polymer treated group is again marginally 
better. 
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Time (days) 
Figure 4.27- Average motilities versus time showing parallel trend lines 
Of course, these trendlines must be regarded with caution, as the loss of motility over 
time is clearly not linear. Indeed, extrapolation of these lines to zero motility suggests 
that the cells would be motile for between 32 and 43 days (depending on the 
experimental group) which is clearly invalid. 
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In terms of cellular viability, there was no obvious trend in relation to the different 
treatments. Furthermore, although there were differences in the numbers of 
live/dead/damaged cells, these were not found to be significant. 
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Figure 4.28- Percentage of live cells during 8 days incubation period+/- polymer 14 
Throughout the experiment there are very few differences observed between all of the 
groups although admittedly the group with the lowest number of live cells on day 8 
appears to be the group which had both polymer treatment and ProSperm™. In general 
however, all four groups remain fairly constant throughout. 
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Figure 4.29- Percentage of dead cells during 8 day incubation period+/- polymer 14 
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The results shown here tend to mirror those shown for the number of live cells, since the 
ProSperm™ plus polymer group has the worst result. This is made slightly worse since 
this group actually started from a lower number of dead cells on day 1. Nevertheless 
these results must be treated with caution, since they were not found to be statistically 
significant. 
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Figure 4.30- Percentage of damaged cells during 8 day incubation period +/- polymer 14 
Finally, if we examine the number of damaged cells recorded during the incubation 
period, we see a trend similar to that previously noted. The polymer treated groups tend 
to show fewer damaged cells compared to controls. Interpreting this result 
optimistically one can suggest that the polymer treatment (and indeed the ProSperm™ 
in this instance) helps to reduce the number of damaged cells, however it is 
acknowledged that it can also be interpreted as a knock on effect of the number of dead 
cells being increased in the treated groups. It is possible that the result reflects a 
combination of these two factors. 
4.2.4 Sex Sorted Semen 
In addition to the use of polymers to deliver anti-oxidants and other metabolites to 
sperm cells for use in standard AI conditions, there were some exploratory studies 
conducted using sex sorted semen. Commercially the use of sex-sorted boar semen is 
- 145-
Chapter 4- Biological Experiments With Multi-Component Polymers 
not currently viable since it requires 8 hours of sorting to produce enough semen for 1 
insemination. However, the process is being exploited commercially in the sale of sex 
sorted bull semen, which requires less time and has the added benefit of being suitable 
for cryogenic storage. 
In the first instance we investigated the use of the polymer (14) containing vitamin E, 
on sorted bull semen. The experiment was qualitative and certainly preliminary, 
however the results were interesting and encouraging. Experimentally, two groups were 
considered. The control samples were sorted as per normal protocols, while the samples 
treated with polymer were sorted into a mixture of polymer dissolved in BTS and TRIS 
sheath fluid (0.25 ml of BTS containing polymer 14 at a concentration of 0.02 mg/ml 
and 0.25 ml of TRIS). After collection, 4 samples from each group were pooled and 
washed by centrifugation. Samples were assessed for motility at three stages during the 
procedure: immediately prior to sorting, immediately after sorting, and after 40 hours of 
storage at 5°C (followed by 25 minutes of incubation at 37°C). The results are 
described below§§. 
Table 4.22- Effect of polymer 14 on motility of sex sorted bull semen 
Motility(%) 
Time point Control Polymer 
Pre-sort 85 85 
Post-sort <1 0 40-50 
40 hrs 20 50-60 
These results were encouraging, however it was suggested that the positive effect could 
be due entirely, or in part to the use of BTS which is not normally included in the 
collection fluid. With this in mind, the experiment was repeated using a positive control 
(BTS only). In addition to assessing motility, acrosomal morphology was also 
investigated. 
§§ In this instance only the Y chromosome-bearing semen were analysed. Motility was assessed 
subjectively and blind. 
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Table 4.23- Acrosomal morphology of Y chromosome-bearing bull semen, 24 hours after sorting 
(%) 
Normal Swollen Dissolving Dissolved 
Control 42 0 57 
BTS control 55 0 0 45 
Polymer 14 64 0 0 36 
In terms of acrosomal integrity, there appears to be a slight positive effect from using 
BTS, which is further enhanced by the inclusion of polymer 14. The results of the 
motility studies followed a similar pattern although the control was considerably less 
motile than the other two groups. 
Table 4.24- Motility of bull semen 24 hours after sorting 
(%) 
Control <10 
BTS control 60-65 
Polymer 14 70 
These results are consistent with those discussed above, however as can be seen from 
the table, there is not a large difference between the BTS control and the polymer 
sample. This would suggest that the inclusion of BTS does have a positive bearing on 
the cells. It should be noted again that although these motilities were assessed 
subjectively, they were assessed blind. Further motility assessments were conducted on 
day 2 and day 6, the results of which are detailed below. 
••• These terms are visual descriptions used to describe the morphology of the acrosomal region of the 
sperm head under microscopic examination. 
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Table 4.25- Motility of stored, sorted bull semen 
(%) 
Day2 Day6 
Control 0 0 
BTS control 40-50 20 
Polymer 14 40-50 30 
These experiments represent a preliminary study into alternative uses of glycopolymers 
containing vitamin E, and their use with alternative species. Whilst these results were 
not the subject of statistical analysis, it seems fair to comment tentatively that the 
exposure of these highly stressed sperm cells to a polymer containing vitamin E had a 
positive effect. 
A similar experiment was conducted using boar semen in place of bull semen. Again 
only the Y chromosome-bearing cells were used. On this occasion, due to the length of 
time required to sort the required number of cells for each group, a positive control was 
not measured. The cells were collected into the two media (control and BTS/TRIS + 
polymer as previously described) and washed by centrifugation. They were then 
incubated at 15°C. Motilities were assessed after 24 hours, firstly at 15°C and 
subsequently after incubation at 3 7°C for 15 minutes. 
Table 4.26 - Motility of sorted boar semen after 24 hours 
(%) 
Control 15 5 
Polymer 14 25 5 
The difference here is not as stark as in the case of bull semen however there does 
appear to be a slight beneficial effect. This concept was further explored in experiments 
conducted by Joanne Leigh.8 Her experiments demonstrated the deleterious effects of 
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the DNA binding dye and the laser used in the sex sorting procedure. Experiments were 
conducted similar to those shown above, where the cells were sorted into a solution 
containing polymer 14. The results echoed those already described, although somewhat 
more convincingly since the diluent used in these examples was a long term diluent 
(Androhep) rather than a short term diluent (BTS). 
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Figure 4.31- Effect of including polymer 14 in the sorting collection medium (T=24 brs) 
Once again, as shown for both bull and boar semen, including polymer 14 in the 
medium into which the sorted cells are collected shows an improvement in post-sort 
cellular motility. 
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Figure 4.32- Effect of including polymer 14 in the sorting collection medium (T=48 hrs) 
It was subsequently demonstrated that incubating boar sperm cells with polymer 14 (at a 
concentration of 0.02 mg/ml) prior to sorting had beneficial effects on the post-sort 
motility. This area is undoubtedly worthy of further research as the preliminary results 
were very encouraging. 
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Figure 4.33- Effect of24 hour incubation with 14 on post sort motility 
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Whilst it is obvious that there is a benefit for the first few days after sorting, the 
difference is much less as time elapses further. Clearly the effect of sex sorting in 
general can be observed since both unsorted samples remain very motile even after 11 
days. The effect is even more significant when the pre-incubation with polymer 14 is 
extended from 24 hours to 48 hours. 
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Figure 4.34- Effect of 24 bour incubation witb 14 on post sort motility 
The above figure (Figure 4.34) demonstrates that not only is there a benefit associated 
with pre-incubation with polymer 14, but that pre-incubation in a commercial extender 
(in this example Androhep was used), can also have a benefit on post-sort motility 
compared to the standard protocol of sorting almost immediately after semen collection. 
Of course, what is not clear at this stage is how these pre-sort incubation steps affect the 
post-sort fertility of the sperm, although motility is generally accepted as a good marker. 
4.2.5 Fluorescent polymers 
Having established that the treatment of the sperm cells with glycopolymers containing 
vitamin E results in free vitamin E within the cells, it seemed logical to attempt to 
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visualise the uptake of polymer into these cells using confocal microscopy. In order to 
achieve this, a polymer was synthesised which contained a fluorescent species in place 
of vitamin E. The fluorescent species in question was hostasol. Hostasol is used 
commercially as a filler to colour plastics.9 The synthesis of hostasol methacrylate from 
the hostasol starting material is shown in Figure 4.35. 
~,Jy 
N 0 
pTSA 
HO~NH2 CIJy 
Figure 4.35 - Synthesis of hostasol methacrylate 
This monomer was supplied by Prof. D Haddleton and although used without further 
purification, it was analysed by 1 H NMR spectroscopy prior to use. The monomer was 
terpolymerised with DMAEA and 2b in a mixture of methanol/DMF (I :4) using AIBN 
as the free radical initiator. This yielded a bright orange solid following dialysis and 
lyophilisation polymer 15. 1 H NMR of this material provided limited information due 
to the molecular weight of the polymer combined with its multi-component nature. 
Indeed the results of the elemental analysis of the material did suggest that all 
monomers (both sulphur and nitrogen were detected, indicating the presence of the 
Hostasol and DMAEA monomers respectively- not withstanding the polymer's bright 
orange colour) had been incorporated, but not at the ratios dictated by the monomer 
feed. This is not entirely surprising since this trend was also observed following the 
synthesis of polymers 13 and 14 as discussed in Chapter 2. Furthermore the author had 
no information regarding the reactivity ratios of the three monomers. Nevertheless, 
despite the random incorporation of the three monomers, the resultant polymer was 
water soluble- almost certainly due (in part at least) to the use of a cationic monomer 
(as discussed in Chapter 3). 
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The UV -vis absorption, emissiOn and excitation spectra for both the monomer and 
polymer were recorded in various solvents. The absorption spectrum for the hostasol 
monomer was recorded in DCM. Subsequently the excitation fluorescence spectrum 
was recorded in both DCM and cyclohexane 
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Figure 4.36 - Absorption spectrum of hostasol monomer 
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Figure 4.37- Corrected excitation spectra of hostasol monomer (emission at 545 nm) 
The emission spectra for the monomer were recorded in both DCM and cyclohexane 
(i.e. a polar and a non-polar solvent). 
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Figure 4.38 - Emission spectra of hostasol monomer in DCM 
1.6E+06l 
1.4E+06 ~ 
1.2E+06 
1.0E+06 
8.0E+05 
6.0E+05
1 
4.0E+05 
2.0E+05 
O.OE+OO ! 
0 200 400 
\ 
'i 
' 'll, v. 
\ 
'. 
--excitation at 258 nm 
excitation at 440 nm 
excitation at 479 nm 
600 800 1000 
wavelength (nm) 
Figure 4.39 - Emission spectra of hostasol monomer in cyclohexane 
From these spectra we can see that the monomer was found to emit between 
approximately 460 nm - 650 nm. It was expected that this would not change after 
polymerisation since the chromophore should not be affected chemically by 
polymerisation. The excitation spectra for 15 in water and DCM were measured and 
found to be in good agreement with the spectra recorded for the monomer, indicating 
that there was no significant difference in the fluorescence as a result of polymerisation. 
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Figure 4.40- Corrected excitation spectra of 15 (emission at 545 nm) 
In addition, the emission spectra for 15 were also measured and compared with those 
recorded for the monomer. Once again the results were in good agreement; further 
supporting the assumption that polymerisation of the monomer does not affect its 
fluorescence. 
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Figure 4.41 -Emission spectra of 15 in water 
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Figure 4.42- Emission spectra of 15 in DCM 
The differences between the spectra recorded in water and those recorded in DCM are 
largely due to the differences in the concentration of polymer in solution. It is not 
possible to compare the 15 in water spectra with equivalent spectra for the monomer, 
since the monomer is not water soluble. However, inspection of Figure 4.38 and Figure 
4.42, the emission spectra for monomer and 15 in DCM, show that the difference is in 
the intensity of the signal - again due to the species being at different concentrations in 
solution. 
These data were subsequently used when analysing the cells treated with the fluorescent 
polymer 15 by confocal microscopy. There were initially two confocal microscopy 
experiments conducted using 15 with boar spermatozoa. Solutions of polymer at two 
concentrations (1 mg/ml and 0.02 mg/ml) were incubated with the cells at l8°C over 5 
days. The cells were then washed to remove any residual polymer and fixed onto 
microscope slides using the DNA binding dye DAPI (see Figure 4.43). 
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Figure 4.43- Structure of DAPI 
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The primary objective of this experiment was to establish how well the cells could be 
imaged by this method and to arrive at a suitable experimental concentration of polymer 
in solution. From these experiments it became clear that using a polymer concentration 
of 1 mg/ml resulted in the fluorescence being far too intense. Indeed even at a 50th of 
the concentration, there was still a relatively high level of background fluorescence. 
Nevertheless, useful images were obtained. The purpose of the DAPI DNA staining 
dye was to make initial localisation of the cells more straightforward. For these initial 
experiments, the excitation wavelength used was 488 run. 
Figure 4.44 - Cells stained with lS (l mglml), 63X magnification 
Figure 4.44 demonstrates that images were obtainable even at high polymer 
concentrations, however these were far more difficult to optimise due to high levels of 
background fluorescence. As such, the focus of the discussion will be on the lower 
concentration incubations. 
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Figure 4.45 - Sperm cells stained with DAPI, 40X magnification 
It is noteworthy that in Figure 4.45, only the heads of the sperm cells are visible. This is 
simply due to the fact that DAPI only binds to the DNA of the cell. Since, in the case of 
sperm cells, the DNA is localised in the head, the tails are not visible. 
Figure 4.46- Sperm cells stained with 15 (0.02 mg/ml), 40X magnification 
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Figure 4.46 clearly illustrates that the cells incubated with 15 are stained throughout the 
head and the tail, since the dye is not specific to any particular cellular compartment. 
The figure shown below illustrates that not only is the fluorescent polymer present 
throughout all of the sperm cell, it is also present within all of the cells in the sample, or 
at the very least, it is visible in all of the cells stained by the DAPI (which it is 
reasonable to assume will stain all of the sperm cells). 
Figure 4.47- Overlay of Figure 4.45 and Figure 4.46, showing tbe presence of tbe 15 in all of tbe 
cells 
These cells were also analysed at higher magnification (63X), an example of such an 
image is shown in Figure 4.48. 
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Figure 4.48- Sperm cells stained with 15 (0.02 mg/ml), 63X magnification 
In addition to these images, a series of images in the z plane (z stacks) was created. 
These were designed to ascertain if the polymer was simply coated onto the outside of 
the cell surface or if it had been fully internalised. 
Figure 4.49- Montage of z stack slices of cells incubation with 15 (0.02 mglml) 
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Each slice is approximately 0.2 J.lm thick and the sequence shown is from top to bottom 
(from the top left hand square to the bottom right hand square). This helps to confirm 
that the glycopolymers are internalised by the sperm cells, although they do not confirm 
that the process is receptor mediated. However it also suggests that the thickness of the 
sperms cell heads is around 4 J.lm. This is not consistent with literature values for this 
species which suggest thicknesses in the order of 1 J.lm. 10• 11 However, this exaggeration 
of depth by confocal microscopy is known and has been discussed in several 
bl . . 12-16 pu 1catwns. 
In order to assess the effect of the galactosyl residues on the polymer, a second 
fluoresecent polymer was synthesised with MMA in place of the sugar residue. As in 
the case of 15 the resultant polymer was bright orange in appearance and was also water 
soluble. 1H NMR analysis of the material proved to be qualitative, and the results of 
elemental analysis were again not in good agreement with monomer feed ratios, 
however this is likely to be due to the factors discussed earlier. 
This polymer (16) was then incubated with the cells in parallel with 15 in order to 
assess if there was any difference in the amount of material taken up by the cells. One 
observation from the first set of confocal experiments, was that not only was 0.02 
mg/ml a more suitable concentration of polymer, but that 5 days incubation was 
probably more time than was necessary. Therefore, these experiments were conducted 
following an incubation period of 8 hours and using polymer concentrations of 0.02 
mg/ml. In addition, images were viewed at both 488 nm, and 514 nm, the latter 
appearing to highlight more structural features of the cells. 
The excitation and emission spectra for 16 were measured and found to be similar to 
that of both the monomer and 15. 
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Figure 4.50- Excitation spectrum of 16 in DCM (excitation at 545 nm) 
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Figure 4.51 -Emission spectra of 16 in DCM 
Prior to conducting the confocal microscopy experiment, it had been assumed that the 
non-glycosylated polymer would show no uptake if the process was sugar-mediated. 
Initially, observations were therefore rather disappointing. Cells incubated with the 
sugar-free polymer were also found to be fluorescent. 
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Figure 4.52 - Cells incubated witb 16 at 0.02 mglml for 8 boors, 63X magnification 
This image is presented in a colour map format ttt which shows the intensity of the 
fluorescence signal (blue= no signal, red= intense signal). This manipulation makes 
comparison of different samples measured, using the same experimental parameters and 
settings, more straightforward than comparing the green images on a black background. 
Whilst this result was initially greeted with disappointment, the following image taken 
of the cells incubated with 15 re-ignited the possibility of a sugar-mediated uptake 
mechanism being at least partially responsible for intemalisation of the polymer. 
ttt This format is analogous to an image produced by an infra-red heat detection camera. 
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Figure 4.53- Cells incubated with 15 at 0.02 mg/ml for 8 hours, 63X magnification 
By comparing Figure 4.52 and Figure 4.53 it is clear that there is more material present 
in the cells that were incubated with the polymer containing galactose residues. This 
would tend to suggest that there are at least two mechanisms responsible for the uptake. 
It seems likely that there is a reasonable amount of polymeric material which enters the 
cell via a diffusive mechanism, while the presence of sugar on the polymer also 
provides the opportunity for receptor-mediated uptake to occur. The uptake of material 
is also relatively fast, since these images were recorded after only 8 hours of incubation 
with both polymers. Previous in vitro studies had suggested that the level of vitamin E 
within the cells was very low on the first day of incubation, a result which at face value 
is in contrast to the results with the fluorescent polymers. However, it is the thesis of 
this author that the uptake has two key steps - i) the uptake of the material itself; ii) 
subsequently, the release of the active component. Since these polymers will fluoresce 
regardless of whether the dye is bound to the polymer or not, it is not possible to infer 
anything regarding the speed of release from these images. Therefore, it has been 
postulated that the uptake of these glycopolymers is rapid, and the rate limiting step is 
the hydrolysis ofthe active component from the polymer. 
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In order to ascertain if this theory was valid, cells were incubated with 15 (at a 
concentration of 0.02 mg/ml) over a 5 hour period, and samples were taken at one hour 
intervals. These samples were washed 3 times by centrifugation, before being spun 
onto glass slides. These were then analysed in turn using confocal microscopy. The 
results supported the theory that uptake is extremely rapid as no obvious differences 
were observed between the samples. 
Figure 4.54- Cells incubated with 15 for I boor 
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Figure 4.55 - Cells incubated with 15 for 5 hours 
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4.3 Conclusions 
It has been demonstrated that sperm cells incubated in the presence of glycopolymers 
with pendant vitamin E moieties can significantly reduce cellular oxidation under 
induced oxidative conditions, without having an adverse effect on key sperm quality 
parameters. This suggestion was further corroborated by using polymer incubation 
pre/post sorting - a process which inherently damages cells (presumably not only via 
oxidative pathways). Numerous experiments focussing on cellular motility and viability 
demonstrated that when the polymer concentration was lower, there was a neutral 
impact on sperm quality parameters. 
Although the results of induced oxidation experiments etc., tentatively and qualitatively 
suggested that these polymeric species where being internalised by the sperm cells, 
further investigations using fluorescently labelled glycopolymers provided more 
substantial evidence of intemalisation. This work has recently been the subject of a 
publication in Nature Chemical Biology. 17 
In summary- sperm cells incubated with glycopolymers containing pendant vitamin E 
moieties, are significantly less damaged, compared with control samples, during 
oxidative stress. It is hypothesised that the mechanism for uptake is receptor-mediated 
via the complementary interaction of the galactose moieties with cellular receptors. 
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4.4 Experimental 
4.4.1 Materials and Instrumentation 
2-Dimethylamino ethyl acrylate (DMAEA, 98%), anhydrous methanol (99.8%) and 
anhydrous N,N-dimethylformamide (99.8%) were purchased from Aldrich. 
Azoisobutyronitrile (AIBN, 97%) was obtained from BDH, and purified by 
recrystallisation from methanol prior to use. DMAEA had inhibitor removed prior to 
use by passing through a plug of basic alumina. Hostasol monomer was supplied from 
Prof. D Haddleton's group, at the University of Warwick. Compound 2b was 
synthesised as described previously in Chapter 2 section 2.3.3.4. All other chemicals 
were used without further purification. 
NMR-spectra were recorded on a Varian Unity 300, Varian Mercury 200 or Bruker 
A vance 400 spectrometers; all chemical shifts were referenced to residual solvent as an 
internal standard. Infrared (IR) spectra were obtained using a Perkin Elmer 1600 Series 
FTIR spectrometer. UV spectra were measured on an A TI Unicam UV NIS UV2 
spectrophotometer, in stoppered quartz cuvettes with a 1 em path length. Fluorescence 
spectra were obtained using a Jobin-Yuon Horba Fluorolog 3-22 Tan-3 
spectrofluorimeter with 90° geometry. Samples analysed by aqueous GPC, were 
determined using a Viscotek TDA 301 with triple detection (refractive index, viscosity 
and right angle laser light scattering detectors), eluted through two 300 x 7.5 mm 
ViscoGel GMPW xl colunms. The light scattering detector was calibrated using a PEO 
standard of 82 500 gmor1• The mobile phase consisted of 80% water, 20% methanol, 
0.05 M NaN03 and 2.5 ml r' 1.0 M NaOH at a flow rate of 0.5 ml min-1• Elemental 
analyses were obtained with an Exeter Analytical Inc. CE-440 Elemental Analyser. 
Lyophilised products were obtained using a Christ ALPHA-1-4 freeze-dryer with a 
LDC-lM controller. Confocal and fluorescence microscope images were obtained 
using a Zeiss LSM 510 microscope fitted with an Argon laser (458, 477, 488 and 514 
nm). 
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4.4.2 Semen Quality 
4.4.2.1 Appearance 
The first and perhaps most primitive method of semen evaluation is its physical 
appearance. Undiluted fresh semen should be a white viscous liquid, whose viscosity is 
relative to the number of cells present. There should be no associated odour, and indeed 
any unpleasant odour is often an indication of infection or the presence of urine. 
Discoloration of the semen may indicate the presence of blood, urine or faeces. The 
sample may occasionally contain other debris such as mud or straw for example. 
Samples which have abnormalities in appearance should not be used for AI. 
4.4.2.2 Motilit/tt 
Motility was assessed using a Computer Assisted Sperm Analyzer (CASA, Hobson 
Tracking Systems (7V2B)). The sperm cells were diluted in BTS (Beltsville diluent) to 
a concentration of between 30-50 x 106 cells mr1• The samples were then incubated at 
37°C for 10 minutes, before a 10 )ll drop was deposited on a Makler chamber (which 
was kept at 3 7°C on a heating plate). The samples were then read using a Nikon 
microscope equipped with a heating plate (maintained at 37°C). A video camera (Sony) 
was connected to the computer. Motility was assessed on 200 tracks per sample. 
4.4.2.3 Viability 
There are a number of standard experimental techniques that can be used to assess 
cellular viability 18• 19• Most rely on some form of cell staining, and the number of dead 
(or live) cells is then counted either manually§§§ or by an automated fluorescence 
measurement111. 
m Conducted by Dr Andre Maldjian. 
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4.4.2.3.1 SYBR14/Propidium /odidettf20 
SYBR 14 was diluted 20 times with DMSO. The semen sample was then diluted to 
give a final concentration of between 25-40 x 106 cells mr1• An aliquot of semen (500 
j..tl) and an aliquot ofSYBR 14 solution (4 j..tl) were mixed together. This was incubated 
for 10 minutes, before adding propidium iodide solution (5 j..tl). The sample was then 
incubated for a further 5 min. Subsequently 5 - 10 j..tl of sample was spotted onto a 
slide, and covered with a slip. The slide was then read using a fluorescent microscope 
(blue light wavelength). Three populations were counted: live (green), dead (red), 
damaged (green and red) and the results expressed as a percentage. 
4.4.2.3.2 Eosin Staininfl§.§ 
Semen (~2 j..tl) and eosin dye (~2 j..tl) were spotted on a microscope slide. The spots 
were then smeared quickly across the slide using the edge of a cover slip. The resultant 
thin film was dried quickly and then observed at high magnification. One hundred cells 
were counted; those stained with the dye are damaged. The result is expressed as a ratio 
of percentages (live: dead). 
4.4.2.3.3 Lectin Bindinfl§§ 
Semen (1 ml, 10 x 106 cells mr1) was charged with peanut agglutinin (PNA) (5 J.ll) and 
propidium iodide [PI, 1mg mr1 in water] (5 j.ll). The sample was then mixed and 
incubated at 38°C for 4 minutes. The sample was then divided in two. To one half, 
para-formaldehyde ( 1 0 j..tl, 1% in water) was added and the cells were counted using 
fluorescence microscopy. To the other half, LPC (5 j..tl) was added and the sample was 
incubated for a further 5 minutes at 38°C, after which para-formaldehyde was added (as 
above) and the cells were counted as in section 4.4.2.3.1. 
§§§ Conducted by the author. 
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4.4.2.4 Morpholo~§ 
Cellular morphology was assessed using high-powered light microscopy (typically 
1 OOX); the cells were fixed using Hancock Solution.21 Key morphological features (see 
examples in Figures Figure 4.56 Figure 4.57 below) were assessed and the number of 
cells with/without defects was counted. The results were expressed as percentages. 
Normal Macrocephalic Ruffled Decapitated Tapered 
Acrosome 
Figure 4.56 - Morphological abnormalities of the head 
Proximal 
cytoplasmic 
droplet 
Tail 
openmg 
Figure 4.57 -Morphological abnormalities of the tail 
4.4.2.5 Enumeration§§§ 
Kinked 
tail 
Round 
Head 
Coiled Tail 
microcephalic 
The concentration of sperm cells in the ejaculate was calculated by counting the number 
of cells on a Thoma haemocytometer slide. The slide contains 2 grids of 2 x 25 squares 
and cells within 5 of the 25 squares on each grid are counted (Figure 4.58). The semen 
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was first diluted with water (5 J..ll of semen in 10 ml of water); this also serves to 
immobilise the cells. The total number of cells is multiplied by 5000 (a factor which 
takes into account the dimensions of the grid and the dilution factor) to give a 
concentration expressed as millions of cells per millilitre. 
Figure 4.58- Typical baemocytometer images 
4.4.2.6 TBARS Assayf11 
The ability of polymer treated/untreated cells to resist oxidation was assessed using the 
TBARS assay.3 Cell pellets were washed after various periods of incubation in the 
presence of a-tocopherol containing polymers (2 x with physiological solution after 
centrifugation (10 minutes at 5°C)). Pellets were re-suspended in 1 ml of a 1.15% KCl 
solution, before iron (III) sulphate (0.8 mM) was added to initiate peroxidation (1 hour 
at 37°C). A solution of BHT (butylated hydroxytoluene) (40 ml, 0.4% w/v in ethanol) 
was added at the end of the incubation period in order to stop oxidation. Subsequently 
acetic acid (1.5 ml, 20%, v/v; pH 3.5) and thiobarbituric acid solution (1.5 J..ll, 0.8% 
w/v) were added. After homogenisation, samples were incubated at 95°C and analysed 
for malonyldialdehyde (MDA) according to the method of Ohk:awa et al.3 To establish 
any potential errors in the assay due to protein-derived materials, additional assays on 
trichloroacetic acid-precipitated materials were also conducted; however no significant 
differences were observed. 
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4.4.2. 7 Sex sorted semen**** 
Semen was diluted to a concentration of 150 x 106 cells mr'. It was then stained with a 
fluorescent dye (Hoechst No. 33342 - 2' -[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-
2,5' -bi-lH-benzimidazole) at concentrations ranging between 15 and 30 f.!l per ml. The 
stained samples were incubated at 37°C for 1 hour prior to use. The cells were then 
passed through the sorter and separated based on DNA content into two tubes (X & Y). 
A basic schematic ofthe process is shown in Figure 4.59. 
Signal 
X/Y Fluorescence rt--~.:;.. ____ ...,. UV-
• Magnetic~i \' i plates • • 
• • • • 
• • 
Collection tube 
X bearing sperm 
• • 
Waste 
sample line 
Collection tube for 
Y bearing sperm 
Figure 4.59- A schematic of the flow cytometer 
LASER 
•••• These experiments were conducted by the author, with the assistance of staff at the Jnstitut fur 
Tierzucht und Tierverhalten, Hanover, Germany. 
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4.4.3 Synthesis of poly[2-(~-D-galactosyloxyl)ethyl methacrylate-ter-
hostasol methacrylate-ter-2-( dimethylamino )ethyl acrylate] (15) 
A mixture ofhostasol monomer (0.28 g, 0.612 mmol), DMAEA (0.499 g, 3.485 mmol), 
2b (0.20 g, 0.684 rnrnol) and AIBN (2 mg, 1.5 wt%) were dissolved in DMF (2.6 ml) 
and methanol (0.65 ml) (4:1). The mixture was degassed (by the freeze pump thaw 
method) and stirred under nitrogen at 70°C for 24 hours. After this time the solvents 
were removed under vacuum and the orange/red waxy residue was redissolved in water 
and recovered by freeze drying. The residue was re-dissolved in water, dialysed against 
distilled water (MWCO 12-14 kDa), and recovered again by freeze drying. This yielded 
15 (730 mg, 73%), however the elemental analysis data measured was not in good 
agreement with the expected values. This may be due to the monomers having very 
different reactivity ratios, which in tum impacts on the incorporation of the monomers 
into the polymer. Since this material is being synthesised by free radical 
polymerisation, there is very little control over the result of the polymerisation. In 
addition, there may be some water associated with the polymer, which would also skew 
these data. The polymer synthesized is analogous to polymer 14, with vitamin E 
monomer having been substituted for Hostasol monomer. 
(Expected C 60.27; H 7.52; N 5.85; S 2.00 Found C 56.62; H 6.51; N 3.13; S 2.38); IR 
(KBr, cm-1): -OH (broad) 3402; -CH (med.) 2962, 2936, 2865; -C=O (sharp) 1736, 
1720; - aromatic (sharp) 1653, 1642, 1560; CH (sharp) 1458; -CH3 (med.) 1390; 
aromatic -CH deformations (sharp) 764. 1H NMR (200 MHz, 0 20, significant peaks): 
3.04-3.82 (sugar ring protons), 4.30 (broad, -CH2-CH2-0-, DMAEA), 7.2-8.1 (broad, 
hostasolaromaticprotons). GPC(H20):M0 4.19x 105;Mw 1.13 x 106,PD=2.7. 
4.4.4 Synthesis of poly[methyl methacrylate-ter-hostasol methacrylate-ter-
2-(dimethylamino)ethyl acrylate] (16) 
A mixture of hostasol monomer (0.28 g, 0.612 rnrnol), DMAEA (0.5 g, 3.485 mmol), 
MMA (0.07 g, 0.684 mmol) and AIBN (0.013 mg, 1.5 wt%) were dissolved in DMF 
(2.82 ml). The mixture was degassed and stirred under nitrogen at 70°C for 24 hours. 
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After this time the solvents were removed under vacuum and the orange/red waxy 
residue was re-dissolved in water and recovered by freeze drying. The residue was re-
dissolved in water, dialysed against distilled water (MWCO 12-14 kDa), and recovered 
again by freeze drying. This yielded 16 (586 mg, 69%) as a bright orange solid. The 
polymer synthesized is analogous to polymer 15, with galactose monomer having been 
substituted for MMA. Once again, analysis of this material was difficult and clearly 
incorporatation of the monomers has not been as desired. The 1 H NMR spectrum was 
indicative of a high molecular weight polymer (also shown from the results of GPC 
analysis). Nevertheless, key areas of the spectrum indicated the presence of the 
components. 
(Expected C 62.9; H 7.7; N 6.8; S 2.3, Found C 42.34; H 5.33; N 3.28; S 1.95); IR 
(KBr, cm-1): -OH (broad) 3420; -CH (med.) 2949, 2866; -C=O (sharp) 1738, 1724; -CH 
(sharp) 1458; -CH3 (med.) 1408; aromatic -CH deformations (sharp) 850, 760. 1H 
NMR (300 MHz, CDCb, significant peaks): 4.1 (med, -O-CH3, MMA), 4.7 (broad,-
CH2-CH2-0-, DMAEA), 7.5-8.4 (broad, hostasol aromatic protons). GPC (H20): Mn 
6.64 X 104; Mw 1.11 X 106, PD = 16.66. 
4.4.5 Vitamin E analysistH 
HPLC analysis was conducted (excitation at 295 nm, emission at 330 nm) on a system 
fitted with a Hypersil column (250 x 4.6 mm, 5 mm) run with 97% MeOH: 3% water 
(v/v) as the eluent system. Prior to analysis spermatozoa were homogenized and 
tocopherols extracted as described by Dvorska et al2. In short, a pellet of 500 x 106 
spermatozoa was obtained after two centrifugations (2000g for 10 min at 5°C); the 
pellet was washed and re-suspended between centrifugations using a physiological 
solution in order to eliminate all contamination from the polymer remaining in solution. 
Then the pellet was re-suspended in aqueous NaCl (0.7 ml, 0.7% (w/v). Subsequently 
ethanol (1 ml) and hexane (3 ml) were added and the samples were mixed by vortexing 
for 20 s. Samples were centrifuged as described above, the hexane layer containing the 
tocopherols was collected and left in the dark. The hexane extraction was repeated 
thrice (3 ml each time). Finally, samples were dried under nitrogen at 40°C, re-
suspended in methanol and analysed by HPLC. 
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4.4.6 Confocal Microscopy 
In short, two or more 75 ml tubes of boar semen (supplied by JSR Newsham) were 
pooled. Each experimental group was conducted in triplicate (20 ml per sample) 
Incubations were carried out over a prescribed time period at 20°C. Following 
incubation, the cells were centrifuged (300 g, 5 minutes at 20°C), the supernatant 
removed and the cells re-suspended in BTS ( 15 ml). The cells were the centrifuged 
again (300 g, 5 minutes at 20°C) a further twice in order to ensure any polymer 
remaining in solution was discarded. 
Following the final wash the cells were re-suspended in BTS (15 ml). An aliquot (25 
!Jl) was removed from each sample and made up to 500 !Jl with BTS. These samples 
were then centrifuged in a CYTOSPIN centrifuge, which deposited the cells as a thin 
layer on a microscope slide. The cover slip was then "glued" to the slide using an 
adhesive that contains the DNA binding dye (DAPI). 
The samples were then analysed by laser scanning confocal microscopy (excitation 488 
& 514 nm). Images were taken at 40x and 63x magnification, and a 3D picture of the 
cells was built up using 0.2!Jm image stacks. The confocal images showed the dye to be 
inside, and not outside the cell, supporting the theory of RME. 
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5 DHA polymer synthesis 
5.1 Introduction 
DHA is a naturally occurring PUF A found mostly in oily fish such as haddock, tuna, 
salmon and mackerel. 1 DHA and other PUF As are recognised as being important 
constituents of mammalian diets although frequently they are consumed at levels below 
the recommended values. 1 In the human body DHA is found in the cell membranes in 
various parts of the body, namely the brain, retina, testes and in sperm cells and it has 
been suggested that it is an essential component in the development of such cells 1• Such 
is the awareness of the importance of these essential PUF As that many foodstuffs are 
now available (bread,2 eggs, spreads, milk, orange juice3) that have been enriched with 
PUF As through the manipulation of animal feeds. 4 Herein it is the presence and 
importance of DHA within the cell membranes of spermatozoa that are of greatest 
importance. 
As has been discussed previously, the delivery of antioxidants to spermatozoa is of 
importance due to the high levels of PUF As present, since the latter are susceptible to 
oxidation. As also alluded to earlier, the levels of DHA in boar sperm cells5 (or indeed 
the sperm cells of other species6-8), can be heightened through dietary means, but what 
is of further interest, is the delivery of DHA to sperm cells in vitro. This could 
potentially be achieved via two key mechanisms, the merits of which are discussed 
below. If we consider this problem as a "drug delivery" scenario, then it could be 
possible to deliver DHA to sperm cells using a targeted delivery method as described 
for vitamin E in the previous chapters. However, as in the case of some drug delivery 
examples,9-13 the delivery of DHA in vitro could be achieved by encapsulating DHA 
inside glycopolymer micelles, thus forgoing the need to chemically bond the DHA 
molecule to the polymer structure. One potential advantage of this is that the DHA is 
less likely to be degraded or attacked as may be the case during polymerisation (e.g. by 
free radicals), however the loading of micelles with the "correct" or indeed with an 
exact amount of DHA is not straightforward. Due to their high degree of unsaturation, 
PUF As that have two or more double bonds are highly sensitive to attack by reactive 
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oxygen species. This is detrimental especially with respect to the PUF As present within 
cell membranes. In sperm cells, the generation of reactive oxygen species results in a 
damage to the cells as a result ofthe attack on the PUFAs (particularly DHA) that are in 
abundance within the cell membrane. Mechanistically speaking the process starts with 
the removal of an allylic hydrogen, thus forming a lipid free radical. This can then in 
tum react with oxygen to produce lipid alkoxy and peroxyl radicals which will 
subsequently react with other fatty acids producing more stable lipid hydroperoxides as 
well as more radicals which can then propagate further oxidation. This process will 
continue un-hindered unless the process is blocked by chain-breaking antioxidants (e.g 
vitamin E). The structure of DHA, as well as the oxidation pathway of PUF As, is 
shown below in Figure 5.1 and Figure 5.2 respectively. 
OH 
Figure 5.1 - cis-4, 7 ,9,11, 13,16,19-docosahexaenoic acid 
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+R 
Figure 5.2 - Schematic pathway of peroxidation of PUF As 
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5.2 Results and discussion 
The delivery of DHA in vitro offers the possibility of increasing intracellular levels in 
order to compensate for any lost due to oxidation during the in vitro lifetime of the 
spem1 cell. The lipid composition of boar spermatozoa is shown in Table 5.1. 
Table 5.1- PUFAs as wt% of total fatty acids for spermatozoa 
Linoleic* (18:2 n-6)f 2.1 ± 0.12 
Alpha-linolenic (18:3 n-3) 0.8 ± 0.02 
Arachidonic (20:4 n-6) 3.0 ± 0.21 
Docosapentaenoic (22:5 n-6) 24.8 ± 2.3 
Docosahexaenoic (22:6 n-3) 33.1 ± 2.9 
Total polyunsaturates 63.8 ± 5.01 
From this it is obvious that the fatty acid composition of the cells is largely composed of 
DP A and DHA, meaning that the cell is susceptible to oxidative damage, since both 
fatty acids have high levels of unsaturation and are inherently susceptible to oxidative 
damage. Obviously, as discussed in earlier chapters, this can be combated by increasing 
the levels of anti-oxidants in the feed5, or by delivery of anti-oxidants in vitro using a 
I . d l" 14 15 po ymenc e Ivery system. ' However a complementary strategy is to deliver 
additional DHA to the sperm cells and therefore maintain a high level of this essential 
fatty acid. It has been suggested that these fatty acids are extremely important in the 
fertilisation process, not only in pigs but in other animals. 16-25 
For poultry and some mammals, for example bulls, it is possible to include DHA and 
other lipophilic media directly in the ejaculate, since the ejaculate of these species is 
largely lipophilic. In the case of porcine semen (as discussed for Vitamin E) this is not 
as straightforward. It is possible to use seminal plasma to aid the solubility; however 
' Trivial names of PUF As 
t Abbreviated nomenclature in the form (x:y n-z) where x = number of carbon atoms, y = number of 
double bonds, and n-z indicates the position of the first double bond relative to the carbon furthest from 
the acid functionalised end of the molecule. 
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this is not appropriate for commercial purposes so it is generally reserved for 
experimental testing purposes. 
One possible method of including DHA in aqueous diluents is to encapsulate the 
material inside a polymeric micelle or aggregate. As has been discussed in Chapter 3, 
the polymers containing vitamin E were found to aggregate in aqueous solution and it 
was demonstrated qualitatively that a water insoluble species (a red dye) could be 
"solubilised" in an aqueous polymer solution in this way. Some preliminary 
experiments of this nature were conducted by Joanne Leigh26 using 14 polymer solution 
and DHA, however there were a number of prohibitive problems associated with this 
approach. 
Firstly, micellisation of the DHA oil in the aqueous polymer solution is time consuming 
and difficult to monitor. Often, after vigorous mixing and vortexing the DHA appears 
to have dissolved and may remain so for 30 minutes or 1 hour, however, over time an 
oily layer begins to form on the surface of the water indicating that some (or all) of the 
DHA has not been micellised. This in itself means that it is very difficult to quantify 
how much (if any) DHA has been encapsulated. Since the double bonds in DHA are 
not conjugated, there is no strong chromophore for the molecule, ruling out the 
possibility of monitoring the progress of encapsulation by UV spectroscopy. 
Nevertheless, some experiments were conducted in this way which investigated the 
potential benefits of storing sorted bull semen into various collection fluids. From Ms 
Leigh's work it was clear that although the control groups had similar morphological 
integrity compared to the 14/DHA group, the motility of the latter group 24 hours after 
sex sorting, was zero compared to ~60% for the control group. This is clearly 
undesirable and would require further investigation to understand the reason(s) behind 
this. 
Another interesting result was obtained from the fatty acid analysis of sorted boar 
semen. Previous semen sorting work by the author and analysis by Dr. Andre Maldjian 
had shown some interesting changes in the fatty acid composition of boar semen 
subsequent to the sex sorting procedure. From Table 5.2 itcan be seen that there is a 
dramatic change in the relative fatty acid composition ofthe sperm cells, apparently as a 
result of the sorting procedure. DHA (C22:6 n-3) and DPA (C22:5 n-6) levels are 
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reduced significantly and in turn are "replaced" largely by saturated fatty acids. The 
lower levels of PUF As could go some way to explaining why the sperm cells are much 
less motile and viable after this process. There are many possible reasons why these 
changes take place, for example the laser light used in the sorting process may 
accelerate the oxidation of the PUF As, or perhaps the extremely high electric field used 
in the sorting process is detrimental to the cells, however the exact mechanisms 
involved are not obvious. It is the thesis of this author that one of the most probable 
factors is the use ofthe high powered laser, as it may result in the fragmentation of large 
molecules or generate radicals capable of oxidising these PUF As. 
It is perhaps easier to appreciate the differences in pre/post sort relative fatty acid 
composition by considering the data graphically. Figure 5.3 depicts the pre-sort data 
against the mean values for both X & Y sorted semen. It is evident from Figure 5.3 that 
the relative levels of unsaturated fatty acids decrease following the sorting procedure 
and consequently the saturated fatty acid content increases, ultimately to the detriment 
ofthe cell. 
60 .-
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~ 'Y Mean 
~ 'X' Mean 
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Figure 5.3- Comparision of relative fatty acid composition of pre/post sort boar semen 
Having identified this as a significant problem, a series of experiments was carried out 
by the author and Ms Leigh to establish if including DHA in the sorting medium could 
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help to counter some of the negative effects, and help to sustain or boost DHA levels 
within the cells. 
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Table 5.2 - Percentage of total fatty acids present in unsorted/sorted boar semen 
Boar Sam~le C14:0 C16:0 C16:1 C18:0 C18:1 C18:1 C18:2 C18:3 C20:4 C20:5 C22:0 C23:0 C22:4 C22:5 C22:5 C22:6 
Type n-9 n-7 n-6 n-3 n-6 n-3 n-6 n-6 n-3 n-3 
Sabo Pre-sort 6.7 18.5 0.3 9.1 2.3 1.7 2.4 1.0 3.8 0.0 0.2 0.1 2.9 21.7 0.5 29.0 
Sabo y 1.6 44.8 0.7 10.6 6.8 0.7 4.4 21.5 0.6 0.0 2.3 0.0 0.0 5.0 1.0 0.0 
Leo y 1.6 53.4 0.6 13.9 5.1 0.4 1.0 20.0 0.0 0.0 2.2 0.4 0.0 0.4 1.2 0.0 
In go y 1.4 45.1 0.9 12.4 8.6 0.6 1.4 11.3 0.0 0.0 1.9 0.0 12.9 2.3 1.2 0.0 
Mean 1.5 47.8 0.7 12.3 6.8 0.6 2.3 17.6 0.2 0.0 2.1 0.1 4.3 2.6 1.1 0.0 
Sabo X 1.2 44.6 1.1 10.3 6.1 0.7 1.6 21.5 0.0 0.0 2.0 0.0 8.8 1.0 0.9 0.0 
Leo X 1.3 53.4 0.3 10.6 8.8 0.7 1.8 18.2 0.0 0.0 2.3 0.4 0.0 1.5 0.9 0.0 
In go I X 1.1 37.8 0.4 8.2 4.4 0.3 10.2 18.2 1.7 0.0 1.3 1.8 0.9 10.2 2.0 1.1 
Mean 1.3 49 0.7 10.5 7.5 0.7 1.7 19.9 0 0 2.2 0.2 4.4 1.3 0.9 0 
Fatty acid analyses were conducted by Dr. Andre Maldjian. 
~ This sample is thought to have been contaminated with bacteria and as such many values were artificially exaggerated. The data is included for completeness but has not been used 
to calculate the average values. 
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There were 4 experimental groups considered in order to assess the impact of the DHA. 
The fatty acid composition of unsorted boar semen was compared with semen sorted 
into BTS, DHA (2% w/v) solubilised using OEP (Orvus ES paste), 14 (0.02 mg/ml in 
BTS) or DHA (2% w/v) in 14 (1 mg/ml in BTS). From Table 5.3 and Figure 5.4Figure 
5.5 we can see that inclusion of DHA in the sorting medium does seem to have a 
positive effect on the amount of DHA found during analysis of the cells. Furthermore, 
the amount of DHA present in the samples collected into the mixture of DHA and 14 
was much greater than the samples collected into the DHA micellised using a surfactant. 
Indeed the amount of DHA measured is approximately at the same level as the pre-sort 
sample. This difference may be due to the polymer aggregates of the 14 assisting in the 
delivery of DHA to the cells since these aggregates will have an outer surface 
containing the galactosyl residues which have been shown to aid in the uptake of 
material by the cells. It is worth highlighting that the cells are washed thoroughly by 
repeated centrifugation prior to analysis, so this should rule out errors associated with 
DHA in solution. 
Furthermore, it seemed possible that the inclusion of 14 in the sorting medium helped to 
reduce the amount of DHA lost immediately post sorting. This again highlights the 
complexity ofthe mechanism(s) by which this reduction in PUFAs takes place, but does 
suggest that it is a process, which left unchecked, will continue after the cells have 
passed through the cytometer. Nevertheless it is apparent that none of the collection 
media used completely halted the degradation within the cells. Indeed this would be an 
extremely interesting and worthwhile area of further study in the future. 
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Figure 5.4- Effect of sorting medium on relative fatty acid compostion of sorted semen ('X') 
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Figure 5.5- Effect of sorting medium on relative fatty acid composition of sorted semen ('Y') 
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Table 5.3 - Percentage of total fatty acids present in unsorted/sorted boar semen collected into various media 
Medium§ Sample 
Type 
C14:0 C16:0 C16:1 C18:0 C18:1 C18:1 C18:2 C18:3 C20:4 C20:5 C22:0 C23:0 C22:4 C22:5 C22:5 C22:6 
n-9 n-7 n-6 n-3 
Pre-sort 7.0 18.9 0.2 8.7 2.1 1.4 2.3 1.0 
A X 1.6 42.5 1.8 10.6 26.4 1.3 9.1 0.6 
A X 1.8 39.5 1.9 10.3 29.2 1.5 9.3 0.6 
B X 2.7 36.9 2.4 10.2 22.5 1.7 6.9 0.6 
c X 1.1 36.1 2.2 12.0 30.5 1.7 8.3 0.0 
D X 3.2 22.6 5.1 6.3 16.8 2.3 2.1 0.4 
Mean 2.1 35.5 2.7 9.9 25.1 1.7 7.1 0.4 
A y 1.7 44.6 1.5 10.4 26.3 1.2 8.1 0.8 
A y 3.5 60.8 0.6 10.3 7.8 0.6 1.1 1.7 
B y 4.6 44.1 2.6 8.9 12.5 1.5 1.1 1.1 
c y 2.4 52.2 3.4 15.7 7.8 0.0 2.5 0.0 
D y 3.0 21.6 5.0 6.1 2.3 15.6 1.4 0.4 
Mean 3.1 44.6 2.6 10.3 11.3 3.8 2.8 0.8 
§ A = BTS, B = 2% DHA in OEP, C = 14 (0.02 mg/m1 in BTS), D = 2% DHA in 14 (1 mg/ml in BTS) 
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n-6 n-3 n-6 n-6 n-3 n-3 
1.1 3.4 0.0 0.4 3.1 21.7 0.7 27.7 
0.2 1.7 0.0 1.1 0.1 0.9 0.5 1.0 
0.2 1.5 0.0 1.1 0.1 0.6 0.6 1.2 
0.2 2.3 1.7 0.9 0.3 1.1 0.4 8.7 
0.0 1.4 0.0 0.0 0.0 2.4 0.0 4.3 
0.1 2.2 6.3 0.3 0.3 2.0 1.2 27.4 
0.1 1.8 1.6 0.7 0.2 1.4 0.5 8.5 
0.1 1.3 0.0 1.4 0.1 0.5 0.2 0.9 
0.3 0.0 0.3 2.7 0.0 6.7 1.9 0.7 
0.2 1.1 2.9 1.6 0.0 4.2 0.5 11.9 
0.0 0.0 0.0 2.6 0.0 6.0 0.0 7.5 
0.1 2.2 6.9 0.3 0.3 2.0 1.3 30.1 
0.1 0.9 2.0 1.7 0.1 3.9 0.8 10.2 
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Despite these potentially positive results, it remained more in line with the focus of 
this thesis to synthesise a polymer containing both sugar and DHA, chemically 
attached - i.e. a polymer similar to those synthesised with vitamin E moieties. In 
principle this appeared to be straightforward and a synthetic route was proposed (see 
Figure 5.6). 
OH 
+ 
l EDCI HOBt 
Figure 5.6- Synthesis of methacrylate monomer of DHA 
Although this route is feasible, when attempts were made to homo/colter polymerise 
this monomer no reaction occurred. Indeed not only did the DHA monomer not react, 
but there was no evidence of any polymeric material being formed by any of the co-
monomers. In hindsight the reason for this is obvious; the arrangement of the double 
bonds in DHA is such that there are 10 allylic hydrogens present. These are easily 
abstracted by free radicals resulting in extremely stable radicals (stabilised by 
resonance - see Figure 5. 7). 
j 
'---~----
Figure 5. 7- Stabilisation of radicals following abstraction of allylic hydrogen 
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Obviously this process is likely to inhibit a free radical polymerisation and fully 
explains why there were no polymeric products obtained by following this route. 
An alternative strategy was developed by adapting work by Whitesides et al. 27 This 
focused on the use of N-acryloyloxy succinimide (NASI), or more precisely poly-
NASI, as a facile way to couple nucleophilic materials to polymers, post 
polymerisation. The principle being exploited in such examples is the fact that 
hydroxy succinimide is a good leaving group during nucleophilic attack. It also helps 
to activate the ester carbonyl, by making the carbon atom of the carbonyl more 
electropositive due to the electron withdrawing effect of the succinimide residue. 
~0 
RNH2 
NH 
I 
R 
Figure 5.8- Nucleophilic attack of NASI 
This mechanism can also be exploited on poly-NASI or indeed a copolymer 
containing NASI; as such, nucleophilic species can easily be coupled to NASI 
functionalised polymers. In this way it was possible to synthesise a polymer 
containing a DHA residue by first synthesising a functionalised derivative of DHA. 
This process involves several steps (see Figure 5.10 below), and although these are 
documented in the literature (in general terms) and each step is relatively 
straightforward, yields did decrease throughout. It was first necessary to synthesis 
azido-ethanol from 2-cholorethanol and sodium azide.28-31 The two were stirred 
together with heating for 24 hours before the product was extracted into chloroform. 
The product was recovered by evaporation and in reasonable yield (78% ). 
The next stage involved the esterification of DHA with azido-ethanol. This synthesis 
was designed based on examples of esterfication cited in the literature. 32' 33 The two 
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reactants were stirred overnight with EDCI and HOBt. After several aqueous washes 
and extraction into chloroform, the product, was recovered by evaporation in good 
yield (88%). The use of EDCI and HOBt in the reaction can be explained 
mechanistically, but essentially the carboxylic acid nucleophilically attacks the EDCI, 
which results in the carbonyl being activated to nucleophilic attack by an alcohol. 
Theoretically, either the HOBt, or the reactant alcohol can attack at this stage. If the 
latter occurs then clearly the desired product is formed immediately. However, if the 
HOBt attacks, the "wrong" ester is formed. This is actually beneficial since the HOBt 
is a good leaving group and so the preferred alcohol (in this case azido-ethanol) can 
displace the HOBt and the desired product is formed. Only a catalytic quantity of 
HOBt is required since (as shown in Figure 5.9) it is regenerated continuously during 
the reaction. 
0 
R'~O~R 
"'N~N=C-N~ I \H 0=) 
R 
j 
Figure 5.9- Esterification using EDCI and catalytic HOBt 
The analysis of both azido-ethanol, and azido-DHA was limited due to these products 
potentially being explosive, however in addition to the results obtained from 
conventional and safe methods of analysis, it was noted that the reaction between 
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azido-ethanol (a clear, colourless liquid) and DHA (a brown viscous oil) resulted in a 
brown amorphous solid with a fishy odour. Furthermore, since the DHA starting 
material contained impurities (as determined by HPLC), and since it is also sensitive 
to heat and light, there were invariably a considerable number of impurities present 
through the various reaction steps involving DHA derivatives. Ultimately this 
resulted in very noisy NMR spectra which were inherently difficult to interpret. 
The next stage of this process was to reduce the azide to the primary amine. The 
reaction utilised in this example was the Staudinger Reaction, of which there are 
several examples in the literature.28' 34-4° Clearly it is possible to transform an azide to 
an amine by hydrogenation, however in this case this would not be practical since it 
would also result in the saturation of the double bonds of the DHA, i.e. resulting in a 
fully saturated fatty acid derivative, which would be detrimental to the cells. 
From the information contained in the literature, an experiment was designed to 
reduce the azide using triphenylphosphine. Although it appears this reaction was 
successful, it did result in a large number of hi-products which were difficult to 
remove by chromatography. Indeed, a solvent system for flash chromatography was 
not immediately apparent; however some insight was gained from an article by 
Bezuglov et a/.,41 who described the purification of the dimethylamino analogue of 
amino-DHA. Using their solvent system, it was possible to purify partly the reaction 
mixture, and a yellow wax was obtained from the crude brown oil. However, this 
material still contained some triphenylphosphine byproduct in low quantities. Once 
again this severally hampered the interpretation of NMR spectra, however the target 
compound was indentified by LC-MS as being present amongst the impurities. 
Ultimately the objective of this synthetic procedure was to produce an amme-
functionalised derivative of DHA that could be reacted with a glycopolymer 
containing NASI such that the product of the two would be a glycopolymer containing 
pendant DHA moieties. This being the case, a glycopolymer was synthesised that 
contained GaiEMA, NASI and DMAEA (21 terpolymer). The polymer was 
synthesised in the same manner as has been described previously - briefly, the 
monomers and AIBN were dissolved in a mixture of DMF and methanol (4:1) at 
heated at 65°C for 24 hours - and was found to be of relatively high molecular weight 
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with a high polydispersity (5.9). Since the polymer was synthesised via conventional 
free radical polymerisation, it is not unsurprising that the polydispersity is broad. The 
polymer was found to be soluble in water and after purification by dialysis (against 
water, MWCO 12-14 kDa) the polymer was recovered by freeze drying as a pale 
brown solid. The difference between the predicted and measured elemental analysis 
values can be explained due to some of the monomers not being incorporated in the 
polymer (as discussed in previous chapters). 
Using the polymer described above a coupling reaction was attempted between the 21 
terpolymer and 20. The reaction conditions were adapted from those described by 
Whitesides et a/.27 Therein it is suggested that the reaction mixture should be heated, 
however in order to avoid oxidation of the DHA, this was avoided and the reagents 
were merely stirred at room temperature for 4 days. After this time the solvent was 
removed and the residue was re-dissolved in water and purified by dialysis (against 
water, MWCO 12-14 kDa). Subsequently the product was recovered by freeze 
drying. It was encouraging to note that the residue was soluble in water, which 
tentatively suggested that the 20 had been successfully coupled, since it in itself is not 
water soluble. Freeze drying of the solution resulted in a brown powder with a fishy 
odour. A brief analysis of the material was conducted by 1H NMR and IR and it is 
tentatively suggested from these experiments (notably by NMR) that the coupling 
reaction was successful, although it was also evident that some succinimide moieties 
remained attached to the polymer. This route therefore offers a relatively facile 
method of synthesising a water soluble polymer carrying pendant galactosyl and DHA 
moieties. 
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Figure 5.10- Schematic of proposed route to DHA functionalised glycopolymer 
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5.2.1 Concluding comments 
The synthesis of glycopolymers containing DHA moieties is achievable via the route 
described above. This route has several steps and as such, there are a number of 
impurities introduced progressively. As such, the analysis of these compounds was 
increasingly complex. High purity products may be achievable via painstaking 
purification at each reaction stage, or by selecting an alternative strategy for the 
reduction of the azide to the primary amine. Whilst the process described above may 
not have commercial viability, it is possible that the process could be further 
optimised. Furthermore, it has been demonstrated that hydrophobic materials can be 
included in aqueous systems either by attachment to hydrophilic polymers, or by 
micellisation within hydrophilic polymers. Ultimately it has been the primary 
objective of this thesis to derive methodologies of delivering hydrophobic metabolites 
to cells in hydrophilic environments, and to this end this has been shown to be 
feasible. 
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5.3 Experimental 
5.3.1 Materials 
1 ,2,3 ,4,6-Penta-0-acetyl-~-D-galactopyranose (98% ), boron trifluoride diethyl 
etherate (purified, redistilled), 2-chloroethanol (99%), sodium azide (99%), 2-
dimethylamino ethyl acrylate (DMAEA, 98%), anhydrous methanol (99.8%) and 
anhydrous N,N-dimethylformamide (99.8%) were purchased from Aldrich. NASI 
(99%) was purchased from Acros Organics. Azoisobutyronitrile (AIBN, 97%) was 
obtained from BDH, and purified by recrystallisation from methanol prior to use. 
DHA (98 %) was purchased from Cayman Chemicals. Dichloromethane (DCM) was 
distilled over calcium hydride under N2 . All other chemicals were used without 
further purification. 
5.3.2 Instrumentation 
NMR-spectra were recorded on a Varian Unity 300, Varian Mercury 200 or Bruker 
A vance 400 spectrometers; all chemical shifts were referenced to residual solvent as 
an internal standard. Infrared (IR) spectra were obtained using a Perkin Elmer 1600 
Series FTIR spectrometer. Mass spectra were obtained using a Micromass Platfrom 
spectrometer in ionisation mode ES+. Aqueous size exclusion chromatography was 
conducted with a Water 410 RI detector and a Wyatt DAWN DSP MALLS, using a 
TSK GMPW column. The mobile phase consisted of 80% water, 20% methanol, 0.05 
M NaN03 and 2.5 ml r' 1.0 M NaOH at a flow rate of 0.8 ml min- 1• Elemental 
analyses were obtained with an Exeter Analytical Inc. CE-440 Elemental Analyser. 
Lyophilised products were obtained using a Christ ALPHA-1-4 freeze-dryer with a 
LDC-1 M controller. 
5.3.3 2-Azido ethanol (17)42 
2-Chloroethanol (24.2g, 300 mmol) was added rapidly to a solution of sodium azide 
(23.5 g, 361 mmol) in 80 ml of water at room temperature. The reaction mixture was 
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stirred at 30°C for 1 hour, followed by a further 24 hours at 70°C. The solution was 
then cooled to room temperature, saturated with sodium sulfate, and extracted with 
chloroform ( 4 x 40 ml). The combined organic layers were dried over anhydrous 
sodium sulfate and concentrated to yield product 17 (24.5 g, 78 %) as a colourless 
liquid. 
2 ~ HO~N 
1 3 
N +~ N 
Elemental analysis and mass spectroscopy could not be completed due to the 
explosive hazard ofazides. IR (cm-1): -OH (broad) 3377; -CH2 (med.) 2927, 2854; N3 
(med.) 2101. 1H NMR (200 MHz, CDCh): 3.00 (s, 1H1), 3.39 (t, 2H3, J =5Hz), 3.73 
(t, 2H2, J =5Hz). 13C NMR (100 MHz, CDCh): 53.5 (C3), 61.7 (C2). 
5.3.4 2-(2', 3', 4', 6'-Tetra-0-acetyl-~-n-galactosyloxyl)ethyl azide (18) 
~-0-Galactose pentaacetate (5 g, 12.81 mmol) was dissolved in 25 ml of anhydrous 
dichloromethane. To this solution, 17 (2.2 g, 25.61 mmol, 2eq) was added via 
syringe. The resulting solution was stirred under N2 and cooled to 0°C. Boron 
triflouride diethyl etherate (2.1 ml, 16.65 mmol, 1.3eq) was then added dropwise. The 
reaction was stirred for 1 h at 0°C, then at room temperature overnight. The reaction 
mixture was then diluted with DCM (25 ml), washed with water (3 x 30 ml) and 
saturated aqueous NaHC03. The organic phase was dried over anhydrous Na2S04 
and evaporated under reduced pressure. The crude residue was purified by flash 
chromatography (n-hexane:ethyl Acetate, 1:1), yielding 18 (4.0 g, 76%) as a 
colourless oil. 
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Elemental analysis and mass spectroscopy could not be completed due to the 
explosive hazard of azides. IR (nujol mull, cm-1): -C-H (med.) 2930, 2850; N3 (med) 
2100; C=O (sharp) 1758,1744, 1720; C-0-C (sharp) 1246,1170,1078,1056. 1H 
NMR (400 MHz, CDCh): 1.98, 2.05, 2.06, 2.15 (s, 3H16, 3H14, 3Hl2, 3H10), 3.32 (m, 
2H8), 3.91 (t, 1H5, J = 6.57 Hz), 4.02 (m, 1H7), 4.10 (m 2H6, 1H7), 4.55 (d, 1H" J31-2 = 
8.08 Hz), 5.00 (dd, 1H3, J33-4 = 3.28 Hz, J\2 = 10.36 Hz), 5.22 (dd, 1H2, J32_, =8.08 
Hz, J32-3 = 10.36 Hz), 5.39 (d, 1H4, J34-3 = 3.28 Hz). 13C NMR (100 MHz, CDCi]): 
20.6-21.0 (C10, C12, C,4, C,6), 50.5 (C7), 60.3 (C6), 61.5 (Cs), 66.9 (C4), 68.5 (C2), 
70.8 (C3), 70.7 (Cs), 101.1 (C,), 169.5-171.1 (C9, C 11 , C13, C, 5). 
5.3.5 Docosa-4, 7, 10, 13, 16, 19-hexaenoic acid 2-azido-ethyl ester (19)** 
17 (264 mg, 3.04 mmol) was dissolved in DMF/THF (20 ml/20 ml). In sequential 
order DHA (1 g, 3.04 mmol), triethylamine (0.428 ml, 3.04 mmol), EDCI (582 mg, 
3.04 mmol), and HOBt (42 mg, 0.46 mmol) were added to the flask at room 
temperature. The reaction mixture was stirred overnight at room temperature. After 
this time a precipitate had formed in solution. This was removed by filtration, and the 
filtrate volume reduced under vacuum. Once the volume had been reduced by~ 75%, 
more precipitate began to form. At this stage the solution was diluted with 
•• The analysis of products derived from DHA was extremely difficult. As has been discussed in 
several sections of this thesis, DHA is highly succeptible to oxidation. As such, it was evident from 
most analyses conducted that any products contained impurities. Further purification seemed to be 
futile as over time (and possibly during purification), further impurities were formed. Due to time 
constraints at the end of the project, it was not possible to optimise these systems further. 
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chloroform, extracted with brine (3x), and the organic layer dried over magnesium 
sulphate before being evaporated to dryness. NMR studies showed some impurities 
so the product was redissolved in chloroform and extracted with aqueous sodium 
hydrogen carbonate (3x), dried over magnesium sulphate and evaporated to dryness, 
giving 1.06 g (2.67 mmol; 88%) of 19 as a brown amorphous solid. 
11 10 8 7 5 4 2 o~N 
12 23 ~ + N 
0 ~-N 
13 14 16 17 19 20 22 
Elemental analysis and mass spectroscopy could not be completed due to the 
explosive hazard of azides. IR (KBr, cm-1): =C-H (med.) 3014; -C-H (med.) 2966, 
2940, 2878; N-CH2 (med.) 2776; N3 (s) 2112; C=O (s) 1742; C=C (s) 1662; -C-H 
(med.) 1460; -CH3 (s) 1394. 1H NMR (400 MHz, CDCh): 0.94 (m, 3H22), 1.95-2.99 
(m, 2H2, 2H3, 2H6, 2H9, 2H12, 2Hls, 2HJs, 2H21), 3.18-4.22 (m, 2H23, 2H24) 5.15-5.40 
(m, 1H4, 1Hs, 1H7, 1Hs, 1HJO, 1H11, 1Hl3, IH14, 1HJ6, IH17, 1HJ9, 1H2o). 13C NMR 
(100 MHz, CDCh): 7.6 (C22), 13.2 (C3), 19.5 (C21), 23.8 (C6, C9, C12, C1s, C1s), 32.3 
(C2), 35.4 (C24) 44.7 (C23), 126.0-131.1 (C4, Cs, C7, Cs, C10, C1 J, C13, C14, C16, C17, 
C19, C2o) 162.0 (CJ). 
5.3.6 Docosa-4, 7, 10, 13, 16, 19-hexaenoic acid 2-amino-ethyl ester (20)** 
Compound 19 (500 mg, 1.26 mmol) was dissolved in a solution of THF (40 ml), 
water (5 ml) and aqueous NaOH (0.5 ml, 1 M). The reaction mixture was cooled in 
an ice bath, and a solution of triphenylphosphine (330 mg, 1.26 mmol) in THF (10 
ml) was added drop-wise. The reaction was stirred at 0°C for 1.5 hours, before being 
allowed to reach room temperature, and stirred for a further 2.5 hours. Subsequently 
the solvents were removed in vacuo, the crude residue redissolved in ethyl acetate, 
and washed with a saturated aqueous sodium chloride solution. Analysis by both 1H 
NMR and mass spectroscopy indicated the presence of the target molecule; however a 
large number of impurities remained. This crude product was recovered as a dark 
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brown viscous oil, which had a fishy odour (400 mg, 85%). A portion of this crude 
material (150 mg) was purified by flash column chromatography (toluene:acetone, 
5:1, rf0.3) to yield 20 as a yellow wax with a fishy odour (~100 mg), however further 
analysis established that some additional impurities remained. Nevertheless, the 
disappearance of the azide signature and appearance of the amine signature in the IR 
was encouraging qualitative evidence of the reduction. 
11 10 8 7 5 4 2 O~NH 
23 2 12 
13 14 16 17 20 22 
(Expected C 77.58; H 10.04; N 3.77, Found C 77.26; H 7.19; N 1.37). IR (nujol, cm-
1): N-H (med.) 3282; =C-H (med.) 3014; -C-H (med.) 2966, 2930, 2874; C=O (s) 
1776; C=C (s) 1660; -NH2 (med.) 1574; -C-H (med.) 1438; -CH3 (s) 1388. 1H NMR 
(400 MHz, CDCh): 0.90 (m, 3H22), 1.90-2.80 (m, 2H2, 2H3, 2H6, 2H9, 2H,2, 2H,s, 
2H 18, 2H21 ), 3.40-4.35 (m, 2H23, 2H24) 5.20-5.40 (m, 1H4, 1H5, lH7, 1Hs, 1HJO, lH11, 
1H13, 1H14, 1H16, 1H17, 1H19, 1H20). Although 13C NMR spectroscopy was attempted 
on this material, there was not sufficient material available to collect a satisfactory 
spectrum. Even after several hours, the signal to noise ratio was still unsatisfactory, 
making a thorough assignment extremely difficult. 
5.3. 7 Poly[2-(~-D-galactosyloxyl)ethyl methacrylate-ter-N-
acryloyloxysuccinimide-ter-2-( dimethylamino )ethyl acrylate 
Galema/NASIIDMAEA Terpolymer (21) 
A solution of 2b (300 mg, 1.08 mmol), NASI (122 mg, 0.72 mmol), DMAEA (258 
mg, 1.8 mmol) and AIBN (10.2 mg, 1.5 wt% w.r.t. monomers) in DMF (1.8 
ml):MeOH (0.45 ml) (4:1) was prepared and purged with nitrogen. The solution was 
heated at 65°C, with stirring, under nitrogen for 24 hours. The solvent was removed 
under vacuum and the crude mixture redissolved in water. The crude product was 
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subsequently purified by dialysis against water (MWCO 12-14 kDa) and recovered by 
freeze drying to yield a pale brown amorphous solid (150 mg- low yield due to burst 
dialysis membrane). 
(Expected C 52.9; H 9.8; N 5.1, Found C 49.71; H 6.83; N 2.75). IR (KBr, cm-1):-
OH (broad) 3414; -CH (med.) 2956, 2926; -C=O (sharp) 1738; tertiary amine 
(succinimide) (sharp) 1658; -CH (sharp) 1458; -C-0 (sharp) 1162, 1076. 1H NMR 
(300 MHz, D20, significant peaks): 2.76-2.79 (-RO-CH2-CH2-0R-, NASI), 3.37-3.87 
(sugar ring protons), 4.28 (broad, -CH2-CH2-0-, DMAEA). GPC (H20): Mn 1.05 x 
105, Mw 6.24 x 105; PD = 5.9. 
5.3.8 Coupling of 20 to 21 ** 
100 mg of21 (contains approx. 18 mg ofNASI) was dissolved in DMF (0.35 ml). To 
this was added a solution of 20 (50 mg) in triethylamine (6 !J.I). The solution was 
stirred for 96 hours at room temperature. 
The reaction mixture was then evaporated to dryness, re-dissolved in water and 
purified by dialysis against distilled water (MWCO 12-14 kDa). The modified 
polymer product (22) was recovered by freeze drying (approximately 85 mg was 
recovered). 
IR (KBr, cm-1): -OH (broad) 3420; =C-H (med.) 3014; -CH (med.) 2966, 2930, 2878; 
-C=O (sharp) 1738; C=C (sharp) 1649; -CH (sharp) 1460, 1402; -C-0 (sharp) 1164, 
1077. 1H NMR (300 MHz, D20, significant peaks): 2.78 (-RO-CH2-CH2-0R-, 
NASI), 3.35-3.84 (sugar ring protons), 4.64 (broad, -CH2-CH2-0-, DMAEA), 5.06 
(broad, 1H4, 1H5, 1H7, 1Hs, 1HJO, 1H11 , 1HI3, lH14, 1HJ6, 1H17, 1H19, 1H20, DHA). 
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